publication_id,tool,quote,best_match_source,best_match,similarity
1528,PRECIS-2,"The BDI-II was evaluated as an alternative indicator of the effectiveness of the intervention. A Levene's test for equality showed a statistically significant difference (p=0.01) in the point reduction in the BDI between the intervention and control group over eight months (intervention mean −2.38 SD 4.72, control mean −0.67 SD 3.44, mean difference −1.70, 95% confidence interval −3, −0.4).",fulltext,"The BDI-II was evaluated as an alternative indicator of the effectiveness of the intervention. A Levene’s test for equality showed a statistically significant difference (p=0.01) in the point reduction in the BDI between the intervention and control group over eight months (intervention mean −2.38 SD 4.72, control mean −0.67 SD 3.44, mean difference −1.70, 95% confidence interval −3, −0.4).",100.0
1528,PRECIS-2,"People with multiple sclerosis were screened on the General Health Questionnaire 12 and Hospital Anxiety and Depression Scale, and those with low mood were recruited.",fulltext,"People with multiple sclerosis were screened on the General Health Questionnaire 12 and Hospital Anxiety and Depression Scale, and those with low mood were recruited.",100.0
1528,PRECIS-2,"Participants randomly allocated to the adjustment group received six group treatment sessions. The control group received usual care, which did not include psychological interventions.",fulltext,"Participants randomly allocated to the adjustment group received six group treatment sessions. The control group received usual care, which did not include psychological interventions.",100.0
1528,PRECIS-2,Participants: People with multiple sclerosis presenting with low mood between June 2008 and September 2009.,fulltext,Participants were recruited for a randomized trial of adjustment groups for people with multiple sclerosis and low mood between June 2008 and September 2009.,86.91588785046729
1528,PRECIS-2,Participants randomly allocated to the adjustment group received six group treatment sessions.,fulltext,Participants randomly allocated to the adjustment group received six group treatment sessions.,100.0
1528,PRECIS-2,Participants were recruited for a randomized trial of adjustment groups for people with multiple sclerosis and low mood between June 2008 and September 2009.,fulltext,Participants were recruited for a randomized trial of adjustment groups for people with multiple sclerosis and low mood between June 2008 and September 2009.,100.0
1528,PRECIS-2,The details of this study have been published elsewhere.,fulltext,The details of this study have been published elsewhere.,100.0
1528,PRECIS-2,"Four and eight months after randomization, participants were visited by a researcher who was unaware of their group allocation, who completed the questionnaires with them.",fulltext," were visited by a researcher who was unaware of their group allocation, who completed the questionnaires with them.",67.83625730994152
1529,PRECIS-2,"Because the patients were not hospitalized and regularly referred to the Association, to follow randomized assignment, we decided to run the sampling within two consecutive months until we enrolled an adequate number of participants.",fulltext,"Because the patients were not hospitalized and regularly referred to the Association, to follow randomized assignment, we decided to run the sampling within two consecutive months until we enrolled an adequate number of participants.",100.0
1529,PRECIS-2,"The intervention consisted of: defining depression, stress, anxiety, and their symptoms, defining happiness, and explaining its necessity, reviewing the results of previous studies on happiness (the first session); the technique of increasing physical activity, the technique of being productive, and doing useful and meaningful things (the second session); the principles of planning and better organization–the technique of removing concerns, the technique of reducing expectations and wishes (the third session); the technique of enhancing creativity, the technique of living at present (the fourth session); the technique of increasing social relationships, the technique of expressing emotions, the technique of laughing (the fifth session).",fulltext,"The intervention consisted of: defining depression, stress, anxiety, and their symptoms, defining happiness, and explaining its necessity, reviewing the results of previous studies on happiness (the first session); the technique of increasing physical activity, the technique of being productive, and doing useful and meaningful things (the second session); the principles of planning and better organization–the technique of removing concerns, the technique of reducing expectations and wishes (the third session); the technique of enhancing creativity, the technique of living at present (the F. Khayeri et al. / Complementary Therapies in Clinical Practice 25 (2016) 130e135 131 fourth session; the technique of increasing social relationships, the technique of being the real self (the fifth session). The technique of increasing intimacy as the ",96.24664879356568
1529,PRECIS-2,"This study demonstrated a significant difference in levels of stress, depression, and total fatigue between before and after the intervention, representing the optimal effect of FHM in decreasing the severity of stress, depression, and total fatigue.",fulltext,"This study demonstrated a significant difference in levels of stress, depression, and total fatigue between before and after the intervention, representing the optimal effect of FHM in decreasing the severity of stress, depression, and total fatigue.",100.0
1529,PRECIS-2,The inclusion criteria were being definitely diagnosed with MS and having records in the Society and the exclusion criteria having history of psychiatric disorders including major depression disorder (according to the medical records and the physician's examinations).,fulltext,The inclusion criteria were being definitely diagnosed with MS and having records in the Society and the exclusion criteria having history of other psychiatric disorders including major depressive disorder (according to the medical records and the physician's examinations) ,99.25373134328358
1529,PRECIS-2,To know that a disease in the mean score was not significant between before and after the intervention.,fulltext,"however, the difference in the mean score was not significant between before and after the intervention.",88.3495145631068
1529,PRECIS-2,"The data obtained before and after conduction of the program were analyzed by chi-square test, Mann-Whitney, covariance test statistics, repeated measures ANOVA, and independent t-test in SPSS 18.",fulltext,"The data obtained before and after conduction of the program were analyzed by chi-square test, Mann-Whitney, covariance statistics, repeated measures ANOVA, and independent t-test in SPSS 18.",97.44897959183673
1529,PRECIS-2,The patients were ensured that the data are analyzed as confidential and anonymous and the findings are reported in general rather than as case-specific.,fulltext,The patients were ensured that the data are analyzed as confidential and anonymous and the findings are reported in general rather than as case-specific.,100.0
1567,PRECIS-2,"The facilitator prescribed exercises from a study-specific protocol addressing the most common deficits experienced by persons with MS (attention, memory, flexibility, and problem solving). The games/tasks (see Table 1) were arranged so that the most basic cognitive skills (attention) were addressed first.",fulltext,"The facilitator prescribed exercises from a study-specific protocol addressing the most common deficits experienced by persons with MS (attention, memory, flexibility, and problem solving). The games/tasks (see Table 1) were arranged so that the most basic cognitive skills (attention) were addressed first.",100.0
1567,PRECIS-2,Participants ranged in age from 26 to 60 years (mean = 50 or 51 years) and had completed high school and 60% had completed a bachelor's degree or higher (See Table 2).,fulltext,"Participants ranged in age from 26 to 60 (mean ¼ 49.6 ± 8.0 years). In general, the study participants were well-educated as almost all (96%) had completed high school and 60% had completed a bachelor's degree or higher (See Table 2).",93.41317365269461
1567,PRECIS-2,"The MAPSS-MS intervention aims to help persons with MS acquire the highest level of cognitive functioning and functional independence. The intervention includes group sessions (2 h per week for 8 weeks) focused on building efficacy for use of cognitive strategies and a home-based computer training program (45 min three times per week). Based on the integration of abilities, knowledge and skills, the program's conceptual model proposes that knowledge of cognitive problems, lifestyle adjustments (sleep, stress management, physical activity) that support cognitive functioning, and self-efficacy to manage cognitive challenges will support persons with MS in the use of compensatory cognitive strategies and cognitive skills.",fulltext,"The MAPSS-MS intervention aims to help persons with MS acquire the highest level of cognitive functioning and functional independence. The intervention includes group sessions (2 h per week for 8 weeks) focused on building efficacy for use of cognitive strategies and a home-based computer training program (45 min three times per week). Based on the integration of Bandura's selfefficacy theory 20 with the investigators' prior intervention studies, 21,22 the program's conceptual model proposes accurate knowledge of cognitive problems, lifestyle adjustments (sleep, stress management, physical activity) that support cognitive functioning, and self-efficacy to manage cognitive challenges will support persons with MS in the use of compensatory cognitive strategies and cognitive skills.",97.8021978021978
1567,PRECIS-2,facilitator,fulltext,facilitator,100.0
1567,PRECIS-2,"The computer component enabled participants (N = 63) to engage in practice sessions without leaving their homes. Overall, the study supported the feasibility of the MAPSS-MS intervention (compliance with the intervention was high and computer training delivered in the home was acceptable)",fulltext,"The computer component enabled participants (N ¼ 63) to engage in practice sessions without leaving their homes. Overall, the study supported the feasibility of the MAPSS-MS intervention (compliance with the intervention was high and computer training delivered in the home was acceptable)",99.65397923875432
1567,PRECIS-2,"Using effect size estimates from prior research a total sample size of 180 was determined to be sufficient to detect an effect (f) of .28 as statistically significant (assuming an alpha level of .05). Following approval by the Institutional Review Board for the University of Texas at Austin, participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas. Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",fulltext,"Using effect size estimates from prior research 2 a total sample size of 180 was determined to be sufficient to detect an effect size (f) of .28 as statistically significant (assuming an alpha level of .05). 18 Following approval by the Institutional Review Board for the University of Texas at Austin, participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas. Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",100.0
1567,PRECIS-2,"Although positive change in the verbal memory domain was seen in the intervention group, it was not statistically significant. Changes in scores over time were statistically significant and in the desired direction for both groups— including greater self-efficacy, more compensatory strategies, and improved performance on neuropsychological tests.",fulltext," the intervention delivery. Changes in scores over time were statistically significant and in the desired direction for both groupse including greater selfefficacy, more frequent use of compensatory strategies, and improved performance on neuropsychological tests.",69.54022988505747
1567,PRECIS-2,"Data analyses were conducted using SPSS, version 24.0 for Windows (SPSS Inc., Chicago, IL, USA). Neuropsychological data were scored by the testers and verified by a second staff member. Data were entered and checked for accuracy. Internal consistency reliability coefficients for all self-report measures were .80 or above. Descriptive analyses were performed to obtain a profile of the sample. The groups were compared at baseline on demographic and disease variables. Preliminary analysis for tests of assumptions such as normality, independence of errors, homogeneity of variance, and outliers suggested that assumptions had generally been met and therefore data transformations were deemed unnecessary.",fulltext,"Data analyses were conducted using SPSS, version 24.0 for Windows (SPSS Inc., Chicago, IL, USA). Neuropsychological data were scored by the testers and verified by a second staff member. Data were entered and checked for accuracy. Internal consistency reliability coefficients for all self-report measures were .80 or above. Descriptive analyses were performed to obtain a profile of the sample. The groups were compared at baseline on demographic and disease variables. Preliminary analysis for tests of assumptions such as normality, independence of errors, homogeneity of Table 1 Selected examples of cognitive tasks/games in Lumosity program. Game Cognitive Domain Construct Birdwatching Attention Visual field WordBubbles Flexibility/Executive Functioning Verbal fluency MonsterGarden Memory Working memory BytheRules Problem Solving Logical reasoning PenguinPursuit Processing Speed Spatial orientation A.K. Stuifbergen et al. / Disability and Health Journal 11 (2018) 427e434 429 variance, and outliers suggested that assumptions had generally been met and therefore data transformations were deemed unnecessary.",100.0
1567,PRECIS-2,"The Perceived Deficits Questionnaire (PDQ) was administered at baseline, immediately after the intervention, and 3 and 6 months post-intervention.",fulltext," period, with measurements at baseline, immediately after the 8-week MAPPS intervention, and at 3 and 6 months postintervention.",70.54794520547945
1567,PRECIS-2,"Participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas. Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",fulltext,"Participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas. Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",100.0
1567,PRECIS-2,The researchers monitored exercise practice and completion.,fulltext,The researchers monitored exercise practice and completion.,100.0
1567,PRECIS-2,The 347 persons who were initially screened as ,fulltext,The 347 persons who were initially screened as ,100.0
1567,PRECIS-2," were later contacted by phone to invite their participation during specific dates. Those who agreed to the schedule (repeated neuropsychological testing, classes and computer practice) were mailed a packet containing a written consent form and baseline data collection packet to complete.",fulltext," were later contacted by phone to invite their participation during specific dates. Those who agreed to the schedule (repeated neuropsychological testing, classes and computer practice) were mailed a packet containing a written consent form and baseline data collection packet to complete.",100.0
1568,PRECIS-2,"All patients were scanned using the exact same 3-Tesla MRI scanner (MAGNETOM Skyra, Siemens Medical Systems, Erlangen, Germany) at the same location, for all patients, and at all timepoints. Global brain atrophy rate was quantified by the two most common methods found in the MS literature. First, as percentage brain volume change (PBVC) determined by the automated longitudinal brain change analysis tool, SIENA, part of FSL,15 using improved brain masks16 and second as percentage change of brain parenchymal fraction (BPF).",fulltext,"All patients were scanned using the exact same 3-Tesla MRI scanner (MAGNETOM Skyra, Siemens Medical Systems, Erlangen, Germany) at the same location, for all patients, and at all timepoints. Global brain atrophy rate was quantified by the two most common methods found in the MS literature. First, as percentage brain volume change (PBVC) determined by the automated longitudinal brain change analysis tool, SIENA, part of FSL, 15 using improved brain masks 16 and second as percentage change of brain parenchymal fraction (BPF).",100.0
1568,PRECIS-2,Patients (n=84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society.,fulltext,Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society.,100.0
1568,PRECIS-2,The relapse rate and the global brain atrophy rate were the primary outcomes of this study.,fulltext,The relapse rate and the global brain atrophy rate were the primary outcomes of this study.,100.0
1568,PRECIS-2,"The supervised exercise sessions were performed twice weekly for the full study period of 48 weeks, and was planned on the basis of four principles (adapted from Dalgas et al.): (1) individual tailoring, (2) application of exercise types matching the goal of the intervention, (3) progressive overload and (4) sufficient intensity to induce the desired effects of the intervention.",fulltext,"The supervised exercise sessions were performed twice weekly for the full study period of 48 weeks, and was planned on the basis of four principles (adapted from Stathopoulos and Felson Duchan) 13 : (1) individual tailoring, (2) application of exercise types matching the goal of the intervention, (3) progressive overload and (4) sufficient intensity to induce the desired effects of the intervention.",98.68766404199475
1568,PRECIS-2,The number of relapses in the study period was obtained from the medical records of the included patients in the RCT by project nurses (blinded to group allocation) and from The Danish MS Registry for the population-based control group.,fulltext,"The number of relapses in the study period was obtained from the medical records of the included Figure 1. Flow diagram of study phases. None of the dropouts were, to the knowledge of the authors, related to the exercise intervention. M Riemenschneider, LG Hvid et al. journals.sagepub.com/home/msj 1623 patients in the RCT by project nurses (blinded to group allocation) and from The Danish MS Registry for the population-based control group.",100.0
1568,PRECIS-2,"Patients (n=84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society. Inclusion criteria were (1) 18–60 years of age, (2) ≤2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.",fulltext,"Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society. Inclusion criteria were (1) 18–60 years of age, (2) ⩽2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.",100.0
1568,PRECIS-2,Eligibility was controlled in medical records. Patients gave informed written consent prior to inclusion.,fulltext,Eligibility was confirmed by project nurses based on patients’ medical records. Patients gave informed written consent prior to inclusion.,97.14285714285714
1568,PRECIS-2,In addition to usual care the control group of this study received four 1.5-hour health educational sessions throughout the study period of 48 weeks.,fulltext,In addition to usual care the control group of this study received four 1.5-hour health educational He,68.45637583892618
1568,PRECIS-2,"The purpose of providing health educational sessions was primarily to facilitate adherence in the control group, as a previous study showed no effect of health education on MS-related symptoms and a null effect on the outcomes of the present study was therefore expected.",fulltext,"The purpose of providing health educational sessions were primarily to facilitate adherence in the control group, as a previous study showed no effect of health education on MS-related symptoms and a null effect on the outcomes of the present study was therefore expected.",99.2619926199262
1568,PRECIS-2,"Patients were randomized to the two study conditions by the sealed envelope principle in a 1:1 ratio stratified by line of treatment. Data from The Danish MS Registry served as a national population-based control group, in addition to the two RCT groups.",fulltext,"Patients were randomized to the two study conditions by the sealed envelope principle in a 1:1 ratio stratified by line of treatment. Data from The Danish MS Registry served as a national population-based control group, in addition to the two RCT groups.",100.0
1569,PRECIS-2,"Five patients in the TOCT group did not complete the 12-weeks home-based TOCT (1 due to MS worsening, 3 for personal issues, 1 discontinued the intervention).",fulltext,"Five patients in the TOCT group did not complete the 12-weeks home-based TOCT (1 due to MS worsening, 3 for personal issues, 1 discontinued the intervention).",100.0
1569,PRECIS-2,"A full description of exercise protocol is available elsewhere (Straudi et al., 2014). They were encouraged to increase their level of functioning among sessions. They underwent two laps during each session that take about 60 min (6 workstations x 5 min x 2 laps), with 10 min of rest after each lap. In addition, the walking practice was trained by 30 min walking on the treadmill, including rests if necessary.",fulltext,"A full description of exercise protocol is available elsewhere (Straudi et al., 2014). They were encouraged to increase their level of functioning among sessions. They underwent two laps during each session that take about 60 min (6 workstations x 5 min x 2 laps), with 10 min of rest after each lap. In addition, the walking practice was trained by 30 min walking on the treadmill, including rests if necessary.",100.0
1569,PRECIS-2,"The 12-weeks follow-up after TOCT was collected in the entire population (n = 36), confirming how the positive effects on the primary outcome measure, the 6MWT, were maintained after the end of treatment (p<0.001).",fulltext," The 12-weeks follow-up after TOCT was collected in the entire population (n = 36), confirming how the positive effects on the primary outcome measure, the 6MWT, were maintained after the end of treatment (p<0.001)",99.53271028037383
1569,PRECIS-2,The Multiple Sclerosis Task-Oriented Circuit Training (MS TOCT) trial is an assessor-blinded randomized controlled trial approved by the Ferrara Ethics Committee (registration number 140489) and registered on the ClinicalTrials.gov database (NCT02421744). Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation. They signed informed consent before any evaluation or treatment.,fulltext, The Multiple Sclerosis Task-Oriented Circuit Training (MS_TOCT) trial is an assessor-blinded randomized controlled trial approved by the Ferrara Ethics Committee (registration number 140489) and registered on the ClinicalTrials.gov database (NCT02421744). Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation. They signed informed consent before any evaluation or treatment,99.57173447537473
1569,PRECIS-2,"The primary outcome measure was the 6-minute walking test (6MWT) for walking endurance (Goldman et al., 2008). As secondary outcomes, we selected: i) Timed 25-Foot Walk (T25FW) (Gijbels et al., 2012) for gait speed; ii) Timed Up and Go Test (TUG) for mobility (Podsiadlo and Richardson, 1991); iii) Dynamic Gait Index (DGI) for balance (Forsberg et al., 2013); iv) Modified Fatigue Impact Scale (MFIS) (Téllez et al., 2005) for physical (MFIS-phy), cognitive (MFIS-c) and psychosocial fatigue (MFIS-psy); Multiple Sclerosis Walking Scale-12 (MSWS-12) (Hobart et al., 2003) for perceived walking abilities.",fulltext," The primary outcome measure was the 6-minute walking test (6MWT) for walking endurance (Goldman et al., 2008). As secondary outcomes, we selected: i) Timed 25-Foot Walk (T25FW) (Gijbels et al., 2012) for gait speed; ii) Timed Up and Go Test (TUG) for mobility (Podsiadlo and Richardson, 1991); iii) Dynamic Gait Index (DGI) for balance (Forsberg et al., 2013); iv) Modified Fatigue Impact Scale S. Straudi et al. Multiple Sclerosis and Related Disorders 60 (2022) 103721 3 (MFIS) (T ´ ellez et al., 2005) for physical (MFIS-phy), cognitive (MFIS-c) and psychosocial fatigue (MFIS-psy); Multiple Sclerosis Walking Scale–12 (MSWS-12) (Hobart et al., 2003) for perceived walking abili",99.00826446280992
1569,PRECIS-2,"Thirty-six PwMS were enrolled in the study (mean age 50.82, 13 males, 11.6 MS years). One patient in the TOCT group and one in the delayed-TOCT group did not receive the allocated treatment due to a post-randomization drop-out.",fulltext,"Thirty-six PwMS were enrolled in the study (mean age 50.82, 13 males, 11.6 MS years). One patient in the TOCT group and one in the delayed-TOCT group did not receive the allocated treatment due to a post-randomization drop-out.",100.0
1569,PRECIS-2,"Thirty-six PwMS were enrolled in the study (mean age 50.82, 13 males, 11.6 MS years). One patient in the TOCT group and one in the delayed-TOCT group did not receive the allocated treatment due to a post-randomization drop-out. Five patients in the TOCT group did not complete the 12-weeks home-based TOCT (1 due to MS worsening, 3 for personal issues, 1 discontinued the intervention).",fulltext,"Thirty-six PwMS were enrolled in the study (mean age 50.82, 13 males, 11.6 MS years). One patient in the TOCT group and one in the delayed-TOCT group did not receive the allocated treatment due to a post-randomization drop-out. Five patients in the TOCT group did not complete the 12-weeks home-based TOCT (1 due to MS worsening, 3 for personal issues, 1 discontinued the intervention).",100.0
1570,PRECIS-2,"The study was a randomized clinical trial and included all the patients with MS referring to the Farshchian Hospital, Hamadan (West Iran) during the year 2005-2006, who had the following criteria:",fulltext,"Methods The study was a randomized clinical trial and included all the patients with MS referring to the Farshchian Hospital, Hamadan (West Iran) during the year 20052006, who had the following c",95.40816326530613
1570,PRECIS-2,"The patients' EDSS was calculated and the necessary lab tests for possible drug reactions were performed. The patients in all three groups were evaluated at the end of months 6, 12, 18, 24 and in case of development of reactions were excluded from the study. At the end of 24 months the patients were again evaluated for EDSS, and the number of relapses for each patient was calculated (cases of pseudoexacerbation were not considered as relapse).",fulltext,"The patients' EDSS was calculated and the necessary lab tests for possible drug reactions were performed. The patients in all three groups were evaluated at the end of months 6, 12, 18, 24 and in case of development of reactions were excluded from the study. At the end of 24 months the patients were again evaluated for EDSS, and the number of relapses for each patient was calculated (cases of pseudoexacerbation were not considered as relapse).",100.0
1570,PRECIS-2,At the onset of treatment all of the patients had an EDSS of less than 6.,fulltext,At the onset of treatment all of the patients had an EDSS of less than 6.,100.0
1570,PRECIS-2,Ninety patients were included in this study with an average age of 31.11± 8.62 with a minimum of 14 and maximum age of 50.72(80%) were female and 18(20%) were male.,fulltext,Ninety patients were included in this study with an average age of 31.11± 8.62 with a minimum of 14 and maximum age of 50.72(80%) were female and 18(20%) were male.,100.0
1570,PRECIS-2,"The obtained information were entered in a questionnaire so that the amount of increase or decrease of the patients' disability after the end of treatment in the three groups could be evaluated and compared. For comparison of the primary and final EDSS in each group the paired samples t.test, for comparison of the changes in the primary and final EDSS between the groups, the One-Way ANOVA test and for comparison of side effects between the three drugs, the Pearson- chi-square were used.",fulltext," analysis The obtained information were entered in a questionnaire so that the amount of increase or decrease of the patients` disability after the end of treatment in M. Mazdeh, et al. Acta Medica Iranica, Vol. 48, No. 2 (2010) 85 the three groups could be evaluated and compared. For comparison of the primary and final EDSS in each group the paired samples t.test, for comparison of the changes in the primary and final EDSS between the groups, the One-Way ANOVA test and for comparison of side effects between the three drugs, the Pearson- chi-square ",97.9633401221996
1570,PRECIS-2,"Exclusion criteria were as follows: 1) history of malignancy within the past five years 2) history of HIV infection, positive serology for hepatitis B and C 3) history of previous disease within six weeks prior to the study and need for hospitalization from an infectious cause within two months prior to the study 4) any kind of hematological abnormality such as lymphocyte count ≤ 1 x 109/ L , platelet count ≤ 100 x 109/ L , neutrophil count ≤ 1.5 x 109/ L ,and hemoglobin level ≤ 8.5 g/dl 5)any kind of definite functional abnormality in body organs that disables the patient for treatment with β-interferons(criteria for functional abnormality in such cases included:creatinin ≥ 1.6 mg/dl , AST or ALT ≥ 2.5 x maximum normal values , alkaline phosphatase ≥2.5 x maximum normal values ,and history of heart failure, myocardial infarction or arrhythmia within six months prior to the study) 6)vaccination using live virus vaccines within four weeks prior to the study 7) use of antimetabolites or cytotoxic drugs within six months prior to the study 8) patients with PPMS 9)any kind of elective surgery during the study 10)rise in hepatic enzymes or severe drug reactions during the follow up period.",fulltext," than 6. Exclusion criteria were as follows: 1) history of malignancy within the past five years 2) history of HIV infection, positive serology for hepatitis B and C 3) history of infectious disease within six weeks prior to the study and need for hospitalization from an infectious cause within two months prior to the study 4) any kind of hematological abnormality such as lymphocyte count ≤ 1 x 10 9 / L , platelet count ≤ 100 x 10 9 / L , neutrophil count ≤ 1.5 x 10 9 / L ,and hemoglobin level ≤ 8.5 g/dl 5)any kind of definite functional abnormality in body organs that disables the patient for treatment with βinterferons(criteria for functional abnormality in such cases included:creatinin ≥ 1.6 mg/dl , AST or ALT ≥ 2.5 x maximum normal values , alkaline phosphatase ≥2.5 x maximum normal values ,and history of heart failure, myocardial infarction or arrhythmia within six months prior to the study) 6)vaccination using live virus vaccines within four weeks prior to the study 7) use of antimetabolites or cytotoxic drugs within six months prior to the study 8) patients with PPMS 9)any kind of elective surgery during the study 10)rise in hepatic enzymes or severe drug reactions during the follow ",98.83624272651704
1769,PRECIS-2,"The total results were obtained by adding the results from the three cities; this was considered justifiable since the methods of selection, treatment, and scoring were essentially the same. Altogether there were 181 treated patients and 169 control patients followed up for an average period of eighteen and a half months.",fulltext,"The total results were obtained by adding the results from the three cities; this was considered justifiable since the methods of selection, treatment, and scoring were essentially the same. Altogether there were 181 treated patients and 169 control patients followed up for an average period of eighteen and a half months.",100.0
1769,PRECIS-2,"patients received treatment for three months, and their experience and other published work and presented new evidence to show that short-term high-dosage treatment gave statistically significant improvement in 94 patients compared with 18 untreated controls.",fulltext, their experience and other published work and presented new evidence to show that short-term high-dosage treatment gave statistically significant improvement in 94 patients compared with 18 untreated controls.,81.08108108108108
1769,PRECIS-2,"Their evidence that long-term maintenance treatment continued for years is effective is less convincing, however.",fulltext,"Their evidence that long-term maintenance treatment continued for years is effective is less convincing, however.",100.0
1769,PRECIS-2,"Again there was no evidence to show that corticotrophin adversely affected the disease process, apart from side-effects due to the drug itself.",fulltext,"s there any evidence that corticotrophin adversely affected the disease process, apart from side-effects due to the drug itself.",88.11188811188812
1769,PRECIS-2,181 patients with multiple sclerosis were treated with corticotrophin daily for eighteen months. There was no evidence that treatment prevented deterioration or reduced the number or severity of the relapses when compared with 169 control patients observed and scored in a similar way for the same period of time.,fulltext,81 patients with multiple sclerosis were treated with corticotrophin daily for eighteen months. There was no evidence that treatment prevented deterioration or reduced the number or severity of the relapses when compared with 169 control patients observed and scored in a similar way for the same period of time.,99.68051118210862
1770,PRECIS-2,"Bed rest has traditionally been prescribed in our clinic, because of a positive clinical experience, though no firm scientific ground can be presented to support this form of treatment (5).",fulltext,"Bed rest has traditionally been prescribed in our clinic, because of a positive clinical experience, though no fkm scientific ground can be presented to support this form of treatment (5)",98.41269841269842
1770,PRECIS-2,"Only 29 patients entered the trial. The number of patients was much smaller than was hoped for when the study was envisaged. This was due to a changing attitude towards bed rest and the introduction of short term high dose methylprednisolone treatment (9), which rapidly has gained a wide acceptance among neurologists.",fulltext,"Only 29 patients entered the trial. The number of patients was much smaller than was hoped for when the study was envisaged. This was due to a changing attitude towards bed rest and the introduction of short term high dose methylprednisolone treatment (9), which rapidly has gained a wide acceptance among neurologists.",100.0
1770,PRECIS-2,"Follow-up lasted one year. In some Kurtzke Functional Systems, the Ambulation Index and the Kurtzke Incapacity Scale a transient greater improvement in the ACTH-treated patients was observed. These superior results in the ACTH group were no longer present at 6 months. Significantly more side-effects were reported in the ACTH-group.",fulltext,"Follow-up lasted one year. In some Kurtzke Functional Systems, the Ambulation Index and the Kurtzke Incapacity Scale a transient greater improvement in the ACTH-treated patients was observed. These superior results in the ACTH group were no longer present at 6 months. Significantly more side-effects were reported in the ACTHgroup.",99.69969969969969
1770,PRECIS-2,"A controlled, randomized study of the long-term effects of ACTH-treatment (100 units intramuscular, tapered over 12 weeks) of acute relapse in 29 MS patients was performed.",fulltext,"A controlled, randomized study of the long-termeffects of ACTH-treatment (100 units intramuscular, tapered over 12 weeks) of acute relapse in 29 MS patients was performed.",99.4186046511628
1770,PRECIS-2,Only 29 patients entered the trial. The number of patients was much smaller than was hoped for when the study was envisaged.,fulltext,Only 29 patients entered the trial. The number of patients was much smaller than was hoped for when the study was envisaged.,100.0
1770,PRECIS-2,"Only patients with a clinical or laboratory supported definite diagnosis of MS according to the Poser criteria (6), suffering from a relapse in multiple sclerosis, were included.",fulltext,"ported definite diagnosis of MS according to the Poser criteria (6), suffering from a relapse, were included.",61.23595505617978
1770,PRECIS-2,These superior results in the ACTH group were no longer present at 6 months. Significantly more side-effects were reported in the ACTH-group.,fulltext,These superior results in the ACTH group were no longer present at 6 months. Significantly more side-effects were reported in the ACTHgroup.,99.29078014184397
1770,PRECIS-2,"Patients were allocated in a stratified randomisation to treatment with either bed rest during 3 weeks and a synthetic ACTH depopreparation (1 mg, 100 units, tapered over 12 weeks), and Vitamin B-complex or bed rest and Vitamin B-complex intramuscular injections in the same scheme (5).",fulltext,"Patients were allocated in a stratified randomisation to treatment with either bed rest during 3 weeks and a synthetic ACTH depotpreparation (1 mg, 100 units, tapered over 12 weeks), and Vitamin B-complex or bed rest and Vitamin B-complex intramuscular injections in the same scheme (5)",99.65034965034964
1770,PRECIS-2,"The overall impression scores, both by the patient and the doctor, and the EDSS were comparable at any assessment in both treatment groups.",fulltext,"The overall impression scores, both by the patient and the doctor, and the EDSS were comparable at any assesment in both treatment groups.",99.28057553956835
1770,PRECIS-2,"Assessment included: EDSS, FS, AI, ISS, in the 6th and 12th week an overall impression by both the patient and the neurologist in a 7-point scale (from much worse via unchanged to much better), and on a 3-point scale (worse, unchanged, better) in the 6th, 9th and 12th month.",fulltext,"Assessment included: EDSS, FS, AI, ISS, in the 6th and 12th week an overall impression by both the patient and the neurologist in a 14 7-point scale (from much worse via unchanged to much better), and on a 3-point scale (worse, unchanged, better) in the 6th, 9th and 12th month.",100.0
1770,PRECIS-2,"Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.",fulltext,"Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.",100.0
1771,PRECIS-2,"Consistent with contemporary statistical guidelines, the use of p values for secondary and other comparisons was toned down when interpreting the results of this study (i.e. p values were included but not in the conventional, dichotomous way).",fulltext,"Consistent with contemporary statistical guidelines, the use of p values for secondary and other comparisons was toned down when interpreting the results of this study (i.e. p values were included but not in the conventional, dichotomous way).",100.0
1771,PRECIS-2,"Supervised PAE sessions were conducted twice weekly during the 24 weeks, with one continuous and one interval exercise session performed each week.",fulltext,"Supervised PAE sessions were conducted twice weekly during the 24 weeks, with one continuous and one interval exercise session performed each week.",100.0
1771,PRECIS-2,"Participants underwent the BRB-N which is a cognitive performance test battery purposely developed to examine cognitive performance in specific cognitive domains in pwMS.25 In order to avoid a training effect from T0 to T24, two alternative Danish versions (A or B) of the BRB-N were administered in a randomized and stratified alternating order (i.e. A-B-A or B-A-B) under the same circumstances.",fulltext,"Participants underwent the BRB-N which is a cognitive performance test battery purposely developed to examine cognitive performance in specific cognitive domains in pwMS. 25 In order to avoid a training effect from T0 to T24, two alternative Danish versions (A or B) of the BRB-N were administered in a randomized and stratified alternating order (i.e. A-B-A or B-A-B) under the same circumstances.",100.0
1771,PRECIS-2,"For inclusion and exclusion criteria, see Langeskov-Christensen et al.23 All participants were screened and participants to determine the Expanded Disability Status Scale (EDSS) score, unless a recent score (<6months) followed by a disease stable period existed.",fulltext,"For inclusion and exclusion criteria, see LangeskovChristensen et al. 24 At inclusion, a neurologist examined participants to determine the Expanded Disability Status Scale (EDSS) score, unless a recent score (<6 months) followed by a disease stable period existed.",91.6030534351145
1771,PRECIS-2,"Cognition. Long-term retrieval (+5.3 (2.0–8.6); p<0.01), consistent long-term retrieval (+5.6 (1.1–10.1); p=0.01), and delayed recall (+0.6 (0.1–1.1); p=0.02) in the SRT improved along with the verbal domain (+0.4 (0.1–0.6); p < 0.01) and total BRB-N (0.2 (0.0–0.4); p=0.02) Z-scores.",fulltext,". Long-term retrieval (+5.3 (2.0–8.6); p < 0.01), consistent long-term retrieval (+5.6 (1.1– 10.1); p = 0.01), and delayed recall (+0.6 (0.1–1.1); p = 0.02) in the SRT improved along with the verbal domain (+0.4 (0.1–0.6); p < 0.01) and total BRB-N (0.2 (0.0–0.4); p = 0.02) Z-scores.",96.83098591549296
1771,PRECIS-2,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)).",fulltext,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)).",100.0
1771,PRECIS-2,"Exercise adherence was high with 44.8 ± 2.6 completed sessions, corresponding to 93.3 ± 5.4% of the planned sessions. Twelve pwMS were unable to adhere with the prescribed intensity of 90%–95% of HRmax during the last 8 weeks of the intervention (mean intensity for the 12 subjects=87.8% of HRmax). There were 13 dropouts after 24 weeks (RCT dropout=15.1%), with no difference between PAE and waitlist (7 and 6 dropouts, respectively). The PAE intervention was well tolerated, with no serious adverse events.",fulltext,"Exercise adherence was high with 44.8 ± 2.6 completed sessions, corresponding to 93.3 ± 5.4% of the planned sessions. Twelve pwMS were unable to adhere with the prescribed intensity of 90%–95% of HR max during the last 8 weeks of the intervention (mean intensity for the 12 subjects = 87.8% of HR max ). There were 13 dropouts after 24 weeks (RCT dropout = 15.1%), with no difference between PAE and waitlist (7 and 6 dropouts, respectively). The PAE intervention was well tolerated, with no serious adverse events.",100.0
1771,PRECIS-2,"Total group. For the initial exercise group, results at T48 showed that after 24 weeks of self-guided physical exercise, the improvements in cardiorespiratory fitness following PAE disappeared (−2.8 (−3.8 to −1.8) mL O2/ min/kg; p < 0.01).",fulltext,"Total group. For the initial exercise group, results at T48 showed that after 24 weeks of self-guided physical exercise, the improvements in cardiorespiratory fitness following PAE disappeared (–2.8 (–3.8 to –1.8) mL O 2 / min/kg; p < 0.01).",100.0
1771,PRECIS-2,"Progressive aerobic exercise protocol Supervised PAE sessions were conducted twice weekly during the 24 weeks, with one continuous and one interval exercise session performed each week. In brief, the session volume increased from 30 to 60 minutes during the intervention while the intensity increased from 65% to 95% of individual maximum heart rate (HRmax).",fulltext,"Progressive aerobic exercise protocol Supervised PAE sessions were conducted twice weekly during the 24 weeks, with one continuous and one interval exercise session performed each week. In brief, the session volume increased from 30 to 60 minutes during the intervention while the intensity M Langeskov-Christensen, LG Hvid et al. journals.sagepub.com/home/msj 3 increased from 65% to 95% of individual maximum heart rate (HR max ",99.72067039106145
1772,PRECIS-2,"For the primary and secondary post hoc study endpoints, individual comparisons were conducted for all outcome measures for switching to fingolimod compared with remaining on any of the four individual iDMTs.",fulltext,"For the primary and secondary post hoc study endpoints, individual comparisons were conducted for all outcome measures for switching to fingolimod compared with remaining on any of the four individual iDMTs.",100.0
1772,PRECIS-2,"Of 1053 patients randomized to treatment, 790 were randomized to an iDMT.",fulltext,". Of 1053 patients randomized to treatment, 790 were randomized t",86.3013698630137
1772,PRECIS-2,Patients were required to have received a single iDMT (except natalizumab) continuously for at least 6 months prior to study initiation and to be candidates for therapy change.,fulltext,Patients were required to have received a single iDMT (except natalizumab) continuously for at least 6 months prior to study initiation and to be candidates for therapy change.,100.0
1772,PRECIS-2,EPOC was the first trial comparing a switch to fingolimod versus remaining on any of four iDMTs (either GA or one of three IFN betas) on a range of physician-related outcomes and PROs [12].,fulltext,EPOC was the first trial comparing a switch to fingolimod versus remaining on any of four iDMTs (either GA or one of three IFN betas) on a range of physician-related outcomes and PROs [12].,100.0
1772,PRECIS-2,"Secondary endpoints included changes in scores for TSQM Effectiveness, Side Effects and Convenience subscales, Beck Depression Inventory-II (BDI-II), Fatigue Severity Scale (FSS), Patient-Reported Outcome Indices for Multiple Sclerosis (PRIMUS) Activities, 36-item Short-Form Health Survey (SF-36) and Physical Component Summary (PCS) and mean investigator-reported Clinical Global Impressions of Improvement (CGI-I).",fulltext,"Secondary endpoints included changes in scores for TSQM Effectiveness, Side Effects and Convenience subscales, Beck Depression Inventory-II (BDI-II), Fatigue Severity Scale (FSS), Patient-Reported Outcome Indices for Multiple Sclerosis (PRIMUS) Activities, 36-item Short-Form Health Survey (SF-36) Mental Component Summary (MCS) and Physical Component Summary (PCS) and mean investigator-reported Clinical Global Impressions of Improvement (CGI-I).",100.0
1772,PRECIS-2,"The differences in LSM change from baseline to 6 months between the treatment groups are reported, with the exception of CGI-I where the differences between the mean scores after 6 months of treatment are reported.",fulltext,". The differences in LSM change from baseline to 6 months between the treatment groups are reported, with the exception of CGI-I where the differences between the mean scores after 6 months of treatment are reporte",99.06542056074767
1772,PRECIS-2,"EPOC showed that, after switching to fingolimod therapy for 6 months, patients had significant improvements in most self-reported outcomes when compared with those who continued to receive an iDMT, including satisfaction with treatment, fatigue severity, depression severity, physical function and mental health [13].",fulltext,"EPOC showed that, after switching to fingolimod therapy for 6 months, patients had significant improvements in most self-reported outcomes when compared with those who continued to receive an iDMT, including satisfaction with treatment, fatigue severity, depression severity, physical function and mental health [13].",100.0
1772,PRECIS-2,"Of the patients switched to fingolimod, 262 switched from GA, 205 switched from IM IFN beta-1a, 196 switched from SC IFN beta-1a and 125 switched from IFN beta-1b.",fulltext,"Of the patients switched to fingolimod, 262 switched from GA, 205 switched from IM IFN beta-1a, 196 switched from SC IFN beta-1a and 125 switched from IFN beta-1b.",100.0
1772,PRECIS-2,The primary post hoc study endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months [15].,fulltext,t The primary post hoc study endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months [15,98.97435897435898
1772,PRECIS-2,"For patients from the USA, the treating physician determined whether the patient was a suitable candidate for therapy change.",fulltext,"For patients from the USA, the treating physician determined whether the patient was a suitable candidate for therapy change.",100.0
1772,PRECIS-2,"Patients were excluded from the study for any of the following reasons: chronic immune system disease other than MS; immunodeficiency; malignancy other than localized basal cell carcinoma within the past 5 years; a history of cardiac arrest, myocardial infarction, ischemic heart disease or coronary spasm within the past 6 months; Mobitz type II second-degree or third-degree atrioventricular block or an increased corrected QT (QTc) interval (>470 ms); having undergone a bone marrow transplant; a history of alcohol abuse within the past 5 years.",fulltext,"a Patients were excluded from the study for any of the following reasons: chronic immune system disease other than MS; immunodeficiency; malignancy other than localized basal cell carcinoma within the past 5 years; a history of cardiac arrest, myocardial infarction, ischemic heart disease or coronary spasm within the past 6 months; Mobitz type II second-degree heart block, third-degree atrioventricular block or an increased corrected QT (QTc) interval (>470 ms); having undergone a bone marrow transplant; a history of alcohol abuse within the past 5 year",99.4535519125683
1773,PRECIS-2,A 12-week resistance training program similar to the one described in this study was offered to CG after completion of the intervention. The study was approved by the Research Ethics Committee of the University of Leon.,fulltext,A 12-week resistance training program similar to the one described in this study was offered to CG after completion of the intervention. The study was approved by the Research Ethics Committee of the University of Leon.,100.0
1773,PRECIS-2,All training sessions took place in MS rehabilitation centers and the patients were continuously supervised by physical therapists.,fulltext,All training sessions took place in MS rehabilitation centers and the patients were continuously supervised by physical therapists.,100.0
1773,PRECIS-2,"Dependent variables included maximal voluntary isometric contraction (MVIC), maximal torque, average power and muscle endurance.",fulltext,"Dependent variables included maximal voluntary isometric contraction (MVIC), maximal torque, aver",75.78125
1773,PRECIS-2,All participants were recruited among six MS rehabilitation centers within the region of Castilla y León (Spain).,fulltext,All participants were recruited among six MS rehabilitation centers within the region of Castilla y Le´on (Spain).,99.11504424778761
1773,PRECIS-2,"All participants were recruited among six MS rehabilitation centers within the region of Castilla y León (Spain). After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",fulltext,"All participants were recruited among six MS rehabilitation centers within the region of Castilla y Le´on (Spain). After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",99.70326409495549
1773,PRECIS-2,"The patient inclusion criteria included a confirmed disease diagnosis by a neurologist, according to Mc-Donald criteria (McDonald, 2001); ability to walk (with or without assistance); absence of other diseases that might have affected muscle function.",fulltext,"ing to Mc-Donald criteria (McDonald, 2001); ability to walk (with or without aid) at least 20 m without rest; absence of other diseases that might have affected muscle function.",60.1593625498008
1773,PRECIS-2,"The experimental period lasted 24 weeks. During the first 12 weeks, the EG performed a resistance training program for the knee extensors (2 sessions per week), followed by 12 weeks of detraining (e.g. no resistance exercise at all). The CG followed their habitual daily activities during the study period and they did not follow any kind of structured physical activity.",fulltext,"The experimental period lasted 24 weeks. During the first 12 weeks, the EG performed a resistance training program for the knee extensors (2 sessions per week), followed by 12 weeks of detraining (e.g. no resistance exercise at all). The CG followed their habitual daily activities during the study period and they did not follow any kind of structured physical activity.",100.0
1773,PRECIS-2,"Dependent variables included maximal voluntary isometric contraction (MVIC), maximal torque, average power and muscle endurance. Testing was performed on three different occasions: before (week 0) and after (week 12) the training program, and after the detraining period (week 24).",fulltext,"Dependent variables included maximal voluntary isometric contraction (MVIC), maximal torque, averTable 2 Progressive resistance training Weeks Set 1 Set 2 Set 3 Load reps Load reps Load reps 1–2 35 10–12 50 8–10 35 10–12 3–4 40 10–12 55 8–10 40 10–12 5–6 45 10–12 60 8–10 45 10–12 7–8 50 10–12 65 8–10 50 10–12 9–10 55 10–12 70 8–10 55 10–12 11–12 55 10–12 70 8–10 55 10–12 Note: Load = percentage of MVIC; reps = repetitions. age muscle power and muscle endurance. Testing was performed on three different occasions: before (week 0) and after (week 12) the training program, and after the detraining period (week 24).",100.0
648,PRECIS-2,Even settings that seem rather restrictive could still be a highly pragmatic design choice if this setting is the usual care setting where patients are treated for the particular health condition.,prompt,Even settings that seem rather restrictive could still be a highly pragmatic design choice if this setting is the usual care setting where patients are treated for the particular health condition.,100.0
648,PRECIS-2,A highly pragmatic approach to eligibility criteria would be to include in the trial anyone with the condition of interest who is likely to be a candidate for the intervention if it was being provided in usual care for this condition.,prompt,A highly pragmatic approach to eligibility criteria would be to include in the trial anyone with the condition of interest who is likely to be a candidate for the intervention if it was being provided in usual care for this condition.,100.0
648,PRECIS-2,The most extreme pragmatic approach to recruitment would be to do this in usual care so that only the people who attend a clinic with the condition of interest are recruited after they present on their own behalf without any overt recruitment effort.,prompt,The most extreme pragmatic approach to recruitment would be to do this in usual care so that only the people who attend a clinic with the condition of interest are recruited after they present on their own behalf without any overt recruitment effort.,100.0
648,PRECIS-2,The PRECIS-2 organisation score will be reduced to the degree trialists make changes in how care is delivered compared with the usual recipients and care delivery.,prompt,The PRECIS-2 organisation score will be reduced to the degree trialists make changes in how care is delivered compared with the usual recipients and care delivery.,100.0
648,PRECIS-2,"Trials that choose outcomes of obvious importance to patients, and measure them in a way that is the same or similar to the way they are measured in usual care would be likely to score at or close to 5 on PRECIS-2.",prompt,"Trials that choose outcomes of obvious importance to patients, and measure them in a way that is the same or similar to the way they are measured in usual care would be likely to score at or close to 5 on PRECIS-2.",100.0
648,PRECIS-2,"A highly pragmatic design would aim to slot the intervention into the usual organisation of care for the condition of interest, making use of no more than the existing healthcare staff and resources in that setting.",prompt,"A highly pragmatic design would aim to slot the intervention into the usual organisation of care for the condition of interest, making use of no more than the existing healthcare staff and resources in that setting.",100.0
648,PRECIS-2,Recruiting through usual appointments at a diverse range of clinics is likely to score at or close to 5 on the PRECIS-2 scale.,prompt,Recruiting through usual appointments at a diverse range of clinics is likely to score at or close to 5 on the PRECIS-2 scale.,100.0
648,PRECIS-2,"There was only one component of the primary outcome, which was for the intervention pair chromic catgut versus polyglactin-910 for uterine repair and the outcome of blood transfusion greater than 1 unit (risk ratio 0·53, 99% CI 0·30–0·93; table 2).",fulltext," There was only one statistically significant difference in one component of the primary outcome, which was for the intervention pair chromic catgut versus polyglactin-910 for uterine repair and the outcome of",66.12903225806453
648,PRECIS-2,"A highly specified, protocol driven intervention. For example, specific direction is given for how to the administer the intervention (such as dose, dosing schedule, surgical procedures, educational material, and delivery)",prompt,"A highly specified, protocol driven intervention. For example, specific direction is given for how to the administer the intervention (such as dose, dosing schedule, surgical procedures, educational material, and delivery)",100.0
648,PRECIS-2,"The most pragmatic design approach to delivery flexibility would leave the details of how to implement the intervention up to providers, in other words, what happens in usual care.",prompt,"The most pragmatic design approach to delivery flexibility would leave the details of how to implement the intervention up to providers, in other words, what happens in usual care.",100.0
648,PRECIS-2,The most pragmatic position with regard to follow-up would be to have no more follow-up of recipients than would be the case in usual care.,prompt,The most pragmatic position with regard to follow-up would be to have no more follow-up of recipients than would be the case in usual care.,100.0
648,PRECIS-2,The focus of the primary analysis was the main effects of the five intervention pairs analysed separately. Pairwise interactions were planned if the analyses showed any statistically significant main effects for the primary outcome only.,fulltext,The focus of the primary analysis was the main effects of the five intervention pairs analysed separately. Pairwise interactions were planned if the analyses showed any statistically significant main effects for the primary outcome only.,100.0
648,PRECIS-2,Excluding people using tests or measures that are not used or available in usual care.,prompt,Excluding people using tests or measures that are not used or available in usual care.,100.0
648,PRECIS-2,The most pragmatic approach with regard to the analysis would typically be an intention-to-treat analysis using all available data. This sort of analysis would score at or close to 5 on PRECIS-2.,prompt,the pragmatic approach to the analysis would typically be an intention-to-treat analysis using all available data. This sort of analysis would score at or close to 5 on PRECIS-2.,91.28205128205128
648,PRECIS-2,Follow-up visits that are more frequent than would typically occur under usual care.,prompt,Follow-up visits that are more frequent than would typically occur under usual care.,100.0
648,PRECIS-2,The most extremely pragmatic approach to setting would be to do the trial in an identical setting to which you intend the results to be applied.,prompt,The most extremely pragmatic approach to setting would be to do the trial in an identical setting to which you intend the results to be applied.,100.0
648,PRECIS-2,"More extensive data are collected, particularly intervention related data, than would be typical outside the trial",prompt,"More extensive data are collected, particularly intervention related data, than would be typical outside the trial",100.0
648,PRECIS-2,Excluding people not known or shown to be highly adherent to the intervention.,prompt,Excluding people not known or shown to be highly adherent to the intervention.,100.0
650,PRECIS-2,"The starting point was a nurse-led minimal psychological intervention. A previous randomised trial has shown that this intervention was cost-effective for patients with diabetes with minor to moderate depression: 9 months after receiving the intervention, patients' emotional symptoms were significantly reduced.",fulltext,"The starting point was a nurse-led minimal psychological intervention. A previous randomised trial has shown that this intervention was cost-effective for patients with diabetes with minor to moderate depression: 9 months after receiving the intervention, depressive symptoms were significantly ",92.62820512820514
650,PRECIS-2,The effect of SMS on patients' daily functioning was measured by means of the DFT. The DFT was dichotomised to compare the number of patients who were improved in their daily functioning and had apparently found a satisfactory way to live with the consequences of their diabetes (DFT ≤4) with patients who still perceived a burden of diabetes on their daily functioning (DFT >4).,fulltext,"The effect of SMS on patients’ daily functioning was measured by means of the DFT. The DFT was dichotomised to compare the number of patients who were improved in their daily functioning and had apparently found a van Dijk-de Vries A, et al. BMJ Open 2015;5:e007014. doi:10.1136/bmjopen-2014-007014 3 Open Access on July 17, 2023 at University of Basel. Protected by copyright. http://bmjopen.bmj.com/ BMJ Open: first published as 10.1136/bmjopen-2014-007014 on 25 June 2015. Downloaded from satisfactory way to live with the consequences of their diabetes (DFT ≤4) with patients who still perceived a burden of diabetes on their daily functioning (DFT >4).",100.0
650,PRECIS-2,Practice nurses in the intervention arm (n=19) were trained to integrate SMS into their routine consultations.,fulltext,Practice nurses in the intervention arm (n=19) were trained to integrate SMS into their routine consultations.,100.0
650,PRECIS-2,The primary outcome measure was a dichotomised score on a Visual Analogue Scale that measured the perceived effect of diabetes on daily functioning.,fulltext,The primary outcome measure was a dichotomised score on a Visual Analogue Scale that measured the perceived effect of diabetes on daily functioning.,100.0
650,PRECIS-2,"Multilevel models were used with an unstructured covariance structure for repeated measures, and patients and PNs as random factors. These models account for the correlation between the repeated measurements for each patient and also for the hierarchical structure of the data, with measurements (level-1) clustered within patients (level-2) who in turn were clustered within PNs (level-3).",fulltext,"c multilevel models were used with an unstructured covariance structure for repeated measures, and patients and PNs as random factors. These models account for the correlation between the repeated measurements for each patient and also for the hierarchical structure of the data, with measurements (level-1) clustered within patients (level-2) who in turn were clustered within PNs (level-3",99.48717948717949
650,PRECIS-2,The training sessions were followed up by booster sessions to maintain and improve PNs' skills in SMS. PNs attended these booster sessions three or four times during the year of follow-up.,fulltext,The training sessions were followed up by booster sessions to maintain and improve PNs' skills in SMS. PNs attended these booster sessions three or four times during the year of follow-up.,100.0
650,PRECIS-2,Financial reimbursement for the extra time spent on SMS was added to the bundled payment arrangement for diabetes care.,fulltext,Financial reimbursement for the extra time spent on SMS was added to the bundled payment arrangement for diabetes care.,100.0
650,PRECIS-2,Patients with type 2 diabetes (n=264) selected by a self-administered questionnaire aimed at measuring emotional distress and diabetes-related reduced daily functioning.,fulltext,Patients with type 2 diabetes (n=264) selected by a self-administered questionnaire aimed at measuring emotional distress and diabetes-related reduced daily functioning.,100.0
650,PRECIS-2,Inclusion criteria: Practice nurses in the intervention arm (n=19) were trained to integrate SMS into their routine consultations. SMS included detection of patients with emotional distress or reduced daily functioning by supporting them when needed through problem solving and reattribution techniques.,fulltext,"nctioning. Intervention: Practice nurses in the intervention arm (n=19) were trained to integrate SMS into their routine consultations. SMS included detection of patients with emotional distress and reduced daily functioning, and supporting them when needed through problem solving and reattribution techniques.",96.36963696369637
650,PRECIS-2,Analyses were performed on an intention-to-treat basis.,fulltext,Analyses were performed on an intention-to-treat basis.,100.0
650,PRECIS-2,"After the training sessions, PNs started to integrate SMS into their routine care practice. PNs were blinded regarding the outcomes of the recruitment procedure and study participation of their patients. They applied SMS in all their consultations with patients with diabetes.",fulltext,"After the training sessions, PNs started to integrate SMS into their routine care practice. PNs were blinded regarding the outcomes of the recruitment procedure and study participation of their patients. They applied SMS in all their consultations with patients with diabetes.",100.0
650,PRECIS-2,"In collaboration with a regional care group of general practitioners (GPs) in the Netherlands, the SMS ('Self-Management Support') implementation project was initiated to realise a shift from biomedically oriented care towards a biopsychosocial approach in diabetes care.",fulltext,"In collaboration with a regional care group of general practitioners (GPs) in the Netherlands and a health insurer, the SMS (‘Self-Management Support’) implementation project was initiated to realise a shift from biomedically oriented care towards a biopsychosocial approach in diabetes care.",100.0
650,PRECIS-2,"A previous randomised trial has shown that this intervention was cost-effective for patients with diabetes with minor to moderate depression: 9 months after receiving the intervention, patients' emotional symptoms were significantly reduced.",fulltext,"A previous randomised trial has shown that this intervention was cost-effective for patients with diabetes with minor to moderate depression: 9 months after receiving the intervention, depressive symptoms were significantly ",90.45643153526972
650,PRECIS-2,The study protocol was initiated to realise a shift from biomedically oriented care towards a biopsychosocial approach in diabetes care.,fulltext, project was initiated to realise a shift from biomedically oriented care towards a biopsychosocial approach in diabetes care.,90.44117647058823
651,PRECIS-2,"The protocol discouraged substantial treatment changes between randomization and the 2-month visit. If a patient required a change in therapy during this period, this fact was noted, and the patient remained in the study.",fulltext,"The protocol discouraged substantial treatment changes between randomization and the 2-month visit. If a patient required a disallowed asthma medication, this fact was noted, and the patient remained in the study.",89.14027149321267
651,PRECIS-2,"Clinical and lung-function data were recorded by clinic staff who were aware of the treatment assignments. Data collection and statistical analyses were performed by study personnel who were unaware of the treatment assignments; questionnaire-based data were collected under blinded conditions, and routine practice data (including a history of exacerbations) were extracted with the use of dedicated software.",fulltext,"Clinical and lung-function data were recorded by clinic staff who were aware of the treatment assignments. Data collection and statistical analyses were performed by study personnel who were unaware of the treatment assignments; questionnaire-based data were collected under blinded conditions, and routine practice data (including a history of exacerbations) were extracted with the use of dedicated software.",100.0
651,PRECIS-2,Practice staff were asked to provide each patient with a written individualized asthma-action plan.,fulltext,Practice staffs were asked to provide each patient with a written individualized asthma-action plan.,100.0
651,PRECIS-2,"The primary outcome measure was the MiniAQLQ score. Secondary outcome measures included the ACQ score, the score on the not-yet-validated Royal College of Physicians 3-item asthma questionnaire (RCP3) (range of scores, 0 to 3, with higher scores indicating worse asthma control), the score on the validated 14-item Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) (range of scores, 0 to 6, with higher scores indicating worse rhinitis-related impairment and with an MID of 0.7), and the frequency of asthma exacerbations, which were defined as the need for an oral course of glucocorticoids or hospitalization for asthma.",fulltext,"The primary outcome measure was the MiniAQLQ score. 25,26 Secondary outcome measures included the ACQ score 27 ; the score on the not-yet-validated Royal College of Physicians 3-item asthma questionnaire (RCP3) (range of scores, 0 to 3, with higher scores indicating worse asthma control) 30 ; the score on the validated 14-item Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) (range of scores, 0 to 6, with higher scores indicating worse rhinitis-related impairment and with an MID of 0.7) 31 ; and the frequency of asthma exacerbations, which were defined as the need for an oral course of glucocorticoids or hospitalization for asthma.",100.0
651,PRECIS-2,"The primary effectiveness analysis was an intention-to-treat analysis of the MiniAQLQ score at 2 months (the primary time point) and at 2 years. Analysis of covariance was used, with treatment as a fixed effect and the baseline value as a covariate.",fulltext,"The primary effectiveness analysis was an intention-to-treat analysis of the MiniAQLQ score at 2 months (the primary time point) and at 2 years. Analysis of covariance was used, with treatment ",77.51004016064257
651,PRECIS-2,"Practice staff were asked to provide each patient with a written individualized asthma-action plan. For each of the assigned treatments, choices of individual drugs and devices were made according to normal clinical practice and British asthma guidelines.",fulltext,"Practice staffs were asked to provide each patient with a written individualized asthma-action plan. For each of the assigned treatments, choices of individual drugs and devices were made according to normal clinical practice and British asthma guidelines.",100.0
651,PRECIS-2,"We conducted two parallel, multicenter, pragmatic trials to evaluate the real-world effectiveness of a leukotriene-receptor antagonist (LTRA) as compared with either an inhaled glucocorticoid for first-line asthma-controller therapy or a long-acting beta2-agonist (LABA) as add-on therapy in patients already receiving inhaled glucocorticoid therapy.",fulltext,"We conducted two parallel, multicenter, pragmatic trials to evaluate the real-world effectiveness of a leukotriene-receptor antagonist (LTRA) as compared with either an inhaled glucocorticoid for first-line asthma-controller therapy or a long-acting beta 2 agonist (LABA) as add-on therapy in patients already receiving inhaled glucocorticoid therapy.",100.0
651,PRECIS-2,"For each of the assigned treatments, choices of individual drugs and devices were made according to normal clinical practice and British asthma guidelines.",fulltext,"For each of the assigned treatments, choices of individual drugs and devices were made according to normal clinical practice and British asthma guidelines.",100.0
651,PRECIS-2,"An automated, computerized telephone center randomly assigned eligible patients at baseline to open-label treatment",fulltext,"An automated, computerized telephone center randomly assigned eligible patients at baseline to open-label treatment",100.0
651,PRECIS-2,Eligible primary care patients 12 to 80 years of age had impaired asthma-related quality of life (Mini Asthma Quality of Life Questionnaire [MiniAQLQ] score ≤6) or inadequate asthma control (Asthma Control Questionnaire [ACQ] score ≥1).,fulltext,Eligible primary care patients 12 to 80 years of age had impaired asthmarelated quality of life (Mini Asthma Quality of Life Questionnaire [MiniAQLQ] score ≤6) or inadequate asthma control (Asthma Control Questionnaire [ACQ] score ≥1).,99.57627118644068
651,PRECIS-2,"An automated, computerized telephone center randomly assigned eligible patients at baseline to open-label treatment with either an LTRA (montelukast or zafirlukast) or an inhaled glucocorticoid (beclomethasone, budesonide, or fluticasone) in the first-line controller therapy trial and with either an LTRA or LABA (salmeterol or formoterol) together with an inhaled glucocorticoid in the add-on therapy trial.",fulltext,"An automated, computerized telephone center randomly assigned eligible patients at baseline to open-label treatment with either an LTRA (montelukast or zafirlukast) or an inhaled glucocorticoid (beclomethasone, budesonide, or fluticasone) in the first-line controller therapy trial and with either an LTRA or LABA (salmeterol or formoterol) together with an inhaled glucocorticoid in the addon therapy trial.",99.75550122249389
651,PRECIS-2,"We randomly assigned patients to 2 years of open-label therapy, under the care of their usual physician, with LTRA (148 patients) or an inhaled glucocorticoid (135 patients) as the first-line controller therapy trial and LTRA (170 patients) or LABA (182 patients) added to an inhaled glucocorticoid in the add-on therapy trial.",fulltext,"We randomly assigned patients to 2 years of open-label therapy, under the care of their usual physician, with LTRA (148 patients) or an inhaled glucocorticoid (158 patients) in the first-line controller therapy trial and LTRA (170 patients) or LABA (182 patients) added to an inhaled glucocorticoid in the add-on therapy trial.",99.08256880733946
655,PRECIS-2,The hospital-based outpatient programme consisted of three training sessions a week which included 30 min of weight lifting and 30 min of leg cycle ergometry along with four educational sessions which included chest physiotherapy training (see online supplementary material).,fulltext,The hospital-based outpatient programme consisted of three training sessions a week which included 30 min of weight lifting J.B. Galdiz et al. / Arch Bronconeumol. 2021;57(3):195–204 197 and 30 min of leg cycle ergometry along with four educational sessions which included chest physiotherapy training (see online supplementary material).,100.0
655,PRECIS-2,"Recruited patients (recruitment visit, −1) attended an initial 8-week outpatient-based intensive pulmonary rehabilitation programme conducted in a hospital rehabilitation department.",fulltext,"Recruited patients (recruitment visit, −1) attended an initial 8-week outpatient-based PR programme conducted in each hospital rehabilitation department.",82.41758241758241
655,PRECIS-2,The Intervention group (IG) patients were given appropriate training equipment and instructed to perform three weekly training sessions and send performance data through an app to a web-based platform.,fulltext, Intervention group (IG) patients were given appropriate training equipment and instructed to perform three weekly training sessions and send performance data through an app to a web-based platform.,98.50746268656717
655,PRECIS-2,"The primary outcome was the change in the 6-min walk distance (6MWD) between baseline (randomization visit, 0) and 12 months later.",fulltext, Change Over Time in the 6-Minute Walk Test Distance in Each Group Stratified by the Presence of at Least One Exacerbation Episode. Randomization 12 Months ,58.778625954198475
655,PRECIS-2,Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital.,fulltext,Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital.,100.0
655,PRECIS-2,This was a multicentre open-label pragmatic parallel-group randomized clinical trial involving 13 hospitals and was conducted between 2014 and 2017.,fulltext,This was a multicentre open-label pragmatic parallel-group randomized clinical trial involving 13 hospitals and was conducted between 2014 and 2017,99.32432432432432
655,PRECIS-2,"Exclusion criteria were having a diagnosis of moderate-to-severe COPD (a Body mass index, Airflow obstruction, Dyspnoea and Exercise capacity index [BODE] index of 7–10) according to international guidelines and having been clinically stable for the previous 4 weeks (see the online supplementary material).",fulltext,"ction criteria were having a diagnosis of moderate-to-severe COPD (a Body mass index, Airflow obstruction, dyspnoea and Exercise capacity [BODE] index score of 3–7) according to international guidelines 9 and having been clinically stable for the previous 4 weeks (see the online supplementary material).",95.43973941368078
655,PRECIS-2,"After the randomization visit, follow-up appointments were arranged for both groups at 3, 9 and 12 months. At each follow-up visit, the general health status of the patient was assessed, medical treatment was revised and optimized, educational reinforcement was provided, 6-minute walk test (6MWT) and spirometry tests were carried out and HRQoL measures were taken.",fulltext,"After the randomization visit, follow-up appointments were arranged for both groups at 3, 9 and 12 months. At each follow-up visit, the general health status of the patient was assessed, medical treatment was revised and optimized, educational reinforcement was provided, 6-minute walk test (6MWT) and spirometry tests were carried out and HRQoL measures were taken.",100.0
655,PRECIS-2,Analysed (n = 41) Excluded from analysis (no 12 months results) (n = 5),fulltext,Analysed (n = 40) ♦ Excluded from analysis (no 12 months results) (n = 5),98.59154929577466
655,PRECIS-2,This was a multicentre open-label pragmatic parallel-group randomized clinical trial was conducted. Two groups were created at completion of an 8-week intensive outpatient hospital PR programme.,fulltext, A multicentre open-label pragmatic parallel-group randomized clinical trial was conducted. Two groups were created at completion of an 8-week intensive outpatient hospital PR programme.,95.87628865979381
655,PRECIS-2,Analysed (n = 40) Excluded from analysis (no 12 months results) (n = 5),fulltext,Analysed (n = 40) ♦ Excluded from analysis (no 12 months results) (n = 5),100.0
655,PRECIS-2,"At each follow-up visit, patients were advised to continue doing exercise and attending follow-up appointments even if they decided not to comply with the assigned maintenance exercises, supporting the intention-to-treat principle (see online supplementary material).",fulltext,"At each visit, patients were advised to continue doing exercise and attending follow-up appointments even if they decided not to comply with the assigned maintenance exercises, supporting the intention-to-treat principle (see online supplementary material).",96.25468164794007
655,PRECIS-2,"Patients in the CG received usual care, that is, they were advised to exercise regularly (at least walking for 1 hour a day) and provided with general educational material, following current clinical practice at participating sites.",fulltext,"Patients in the CG received usual care, that is, they were advised to exercise regularly (at least walking for 1 hour a day) and provided with general educational material, following current clinical practice at participating sites.",100.0
657,PRECIS-2,Eighty people with Expanded Disability Status scores of 1 to 6.5 participated in this trial.,fulltext,Eighty people with Expanded Disability Status scores of 1 to 6.5 participated in this trial.,100.0
657,PRECIS-2,"Individual balance checkpoints and participants should perform balance challenges simultaneously at the beginning and end of each session, perceive and reflect on their own balance that day, and compare their own balance before and after each session. The physical therapist links a participant's balance challenges with the choice of exercises.",fulltext,"Individual balance checkpoints: all participants perform balance challenges simultaneously at the beginning and end of each session, perceive and reflect on their own balance that day, and compare their own balance before and after each session. The physical therapist links a participant’s balance challenges with the choice of exercises.",97.3913043478261
657,PRECIS-2,"The physical therapists had varied experience (1–25 years) and certification (2 had both a master's degree in neurological physical therapy and were clinical specialists in neurological physical therapy, 1 was a clinical specialist in neurological physical therapy, and 3 were generalists in physical therapy).",fulltext,"The physical therapists had varied experience (between 7–25 years) and certification (2 had both a master’s degree in neurological physical therapy and were clinical specialists in neurological physical therapy, 1 was a clinical specialist in neurological physical therapy, and 3 were generalists in physical therapy).",99.67741935483872
657,PRECIS-2,"Assessments were undertaken at baseline and at weeks 7, 18, and 30. Outcomes were measured with the Trunk Impairment Scale–Norwegian Version, Mini Balance Evaluation Systems Test, and Patient Global Impression of Change–Balance.",fulltext,"Assessments were undertaken at baseline and at weeks 7, 18, and 30. Outcomes were measured with the Trunk Impairment Scale–Norwegian Version, Mini Balance Evaluation Systems Test, and Patient Global Impression of Change–Balance.",100.0
657,PRECIS-2,"Two assessors masked with regard to group allocation carried out the assessments. The assessors had received training in the standardized test procedures, and each was trained to apply uniform scoring criteria to all the participants and to perform scoring equivalently to the other assessor.",fulltext,"Two assessors masked with regard to the group allocation carried out the assessments. The assessors had received 3 days of training in the standardized test procedures, and each was trained to apply uniform scoring criteria to all the participants and to perform scoring equivalently to the other assessor.",100.0
657,PRECIS-2,"Eighty persons completed baseline testing. An electronic randomization system was conducted by a web-based system developed and administered by the Unit of Applied Clinical Research, Institute of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway",fulltext,"Eighty persons completed baseline testing. An electronic randomization was conducted using a web-based system developed and administered by the Unit of Applied Clinical Research, Institute of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway",97.00996677740864
657,PRECIS-2,"Six neurological physical therapists conducted the intervention over being trained in GroupCoreDIST for 5 days. The training included practical and theoretical training. The physical therapists received a booklet with descriptions and photos of all exercises and variations, as well as the theoretical framework for the intervention.",fulltext,"Six neurological physical therapists conducted the intervention after being trained in GroupCoreDIST for 5 days. The training included practical and theoretical training. The physical therapists received a booklet with descriptions and photos of all exercises and variations, as well as the theoretical framework for the intervention.",99.3993993993994
657,PRECIS-2,"The system was stratified by EDSS scores (1–3.5 and 4–6.5) to ensure a mix of people with high and low EDSS scores in both groups, and the participants were randomly assigned to the intervention group or the control group.",fulltext,"The system was stratified by EDSS scores (1–3.5 and 4–6.5) to ensure a mix of people with high and low EDSS scores in both groups, and the participants were randomly assigned to the intervention group or the control group.",100.0
657,PRECIS-2,"Inclusion criteria were as follows: (1) diagnosed with MS in accordance with the McDonald criteria27; (2) registered at the MS outpatient clinic; (3) living in 1 of 6 selected municipalities; (4) aged 18 years or older; (5) capable of providing signed written informed consent; and (6) EDSS score between 1 and 6.5 (1 = minor disability, 6.5 = able to walk 20 m with or without a walking aid).",fulltext,"inclusion criteria were as follows: (1) diagnosed with MS in accordance with the McDonald criteria 27 ; (2) registered at the MS outpatient clinic; (3) living in 1 of 6 selected municipalities; (4) aged 18 years or older; (5) capable of providing signed written informed consent; and (6) EDSS score between 1 and 6.5 (1 = minor disability, 6.5 = able to walk 20 m with or without a walking aid).",100.0
657,PRECIS-2,"Planning the group sessions: Consider each participant's main problem and which symptoms are related to it; use the appropriate position and variations of exercises (5 variations for each of the 33 exercises, 6 exercise categories to that each participant can perform the exercises with optimal movement quality.",fulltext,"Planning the group sessions: consider each participant’s main problem and which symptoms are related to it; use the appropriate position and variations of exercises (5 variations for each of the 33 exercises, 6 exercise categories) so that each participant can perform the exercises with optimal movement quality.",99.67948717948718
657,PRECIS-2,"Among the 67 persons who did not respond, 57% had EDSS scores of 0 to 3.5, 21% had EDSS scores of 4 to 7, and 22% had an unknown EDSS score.",fulltext,"Among the 67 persons who did not respond, 57% had EDSS scores of 0 to 3.5, 21% had EDSS scores of 4 to 7, and 22% had an 1",86.42857142857143
657,PRECIS-2,"At the 18-week postintervention test, 1 person from the control group became ill and was lost to follow-up, and 3 other participants from the control group missed their assessments. At the 30-week postintervention test, 2 individuals from each group missed assessments.",fulltext,"At the 18-week postintervention test, 1 person from the control group became ill and was lost to follow-up, and 3 other participants from the control group missed their assessments. At the 30-week postintervention test, 2 individuals from each group missed assessments.",100.0
657,PRECIS-2,"The TIS-NV is a modified version of the original Trunk Impairment Scale, which has been validated and tested for reliability in people with MS.30 The Mini-BESTest measures dynamic balance and includes 14 test items scored from 0 to 2, with a total score from 0 to 28.",fulltext,"The TIS-NV is a modified version of the original Trunk Impairment Scale, which has been validated and tested for reliability in people with MS. 30 The Mini-BESTest measures ",64.41947565543072
657,PRECIS-2,"One individual missed all postintervention tests, leaving 79 participants in the intention-to-treat analysis.",fulltext,"One individual missed all postintervention tests, leaving 79 participants in the intention-to-treat analysis.",100.0
657,PRECIS-2,"The TIS-NV measures dynamic sitting balance and trunk control and includes 6 test items scored from 0 to 2 or 3, with a total score from 0 to 16 (0 = severe problem).",fulltext,"The TIS-NV measures dynamic sitting balance and trunk control and includes 6 test items scored from 0 to 2 or 3, with a total score from 0 to 16 (0 = severe problem).",100.0
657,PRECIS-2,Assessments at all time points took place at a Norwegian hospital.,fulltext,Assessments at all time points took place at a Norwegian hospital.,100.0
662,PRECIS-2,"Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).",fulltext,"Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).",100.0
662,PRECIS-2,Recruitment took place between December 2012 and May 2013. We administered the screening questionnaires via telephone.,fulltext,Recruitment took place between December 2012 and May 2013. We administered the screening questionnaires via telephone.,100.0
662,PRECIS-2,"Teaching standards and teacher competence are important in mindfulness especially when working with vulnerable groups.23 AB, a health psychologist, facilitated the courses. AB was supervised by PC, a clinical psychologist and expert mindfulness practitioner. AB and PC met weekly, and PC listened to excerpts of each and every session for supervision and fidelity purposes.",fulltext,"Teaching standards and teacher competence are important in mindfulness especially when working with vulnerable groups. 23 AB, a health psychologist, facilitated the courses. AB was supervised by PC, a clinical psychologist and expert mindfulness practitioner. AB and PC met weekly, and PC listened to excerpts of each and every session for supervision and fidelity purposes.",100.0
662,PRECIS-2,"Participants allocated to the waiting-list group received the treatment as usual (TAU) and were offered the mindfulness course after the end of the controlled trial, and completed the intervention and assessments.",fulltext,Participants allocated to the waiting-list group received the treatment ,33.80281690140845
662,PRECIS-2,The GHQ27 is designed to measure general levels of distress. The GHQ is uncontaminated by the experience of MS-related somatic symptoms and is the most treatment-responsive measure of psychological distress in MS.26 Higher scores on this scale represent high distress.,fulltext,The GHQ 17 is designed to measure general levels of distress. The GHQ is uncontaminated by the experience of MS-related somatic symptoms and is the most treatment-responsive measure of psychological distress in MS. 26 Higher scores on this scale represent high distress.,99.6268656716418
662,PRECIS-2,The study was approved by London City Road and Hampstead Research Ethics Committee (12/LO/1394),fulltext,The study was approved by London City Road and Hampstead Research Ethics Committee (12/LO/1394),100.0
662,PRECIS-2,"Participants completed standardised questionnaires to measure mood, impact of MS and symptom severity, quality of life and service costs at baseline, post-intervention and three-month follow-up.",fulltext,"Participants completed standardised questionnaires to measure mood, impact of MS and symptom severity, quality of life and service costs at baseline, post-intervention and threemonth follow-up.",99.48453608247422
662,PRECIS-2,Treatment effects on the primary and secondary outcomes were estimated using an intention-to-treat analysis where we analysed participants in the group to which they were randomised.,fulltext, an intention-to-treat basis where we analysed participants in the group to which they were randomised.,56.043956043956044
662,PRECIS-2,"The eight chapters, one for each session, introduced key mindfulness concepts, addressed issues common to progressive MS and described homework for the week ahead (see online supplementary material for content of each session).",fulltext,"The eight chapters, one for each session, introduced key mindfulness concepts, addressed issues common to progressive MS, and described homework for the week ahead (see online supplementary material for content of each session).",100.0
662,PRECIS-2,Secondary outcomes were estimated using linear mixed modelling where the outcome variables at the two post-intervention time points are the dependent variable.,fulltext,secondary outcomes were estimated using linear mixed modelling where the outcome variables at the two post-intervention time points were the dependent variable.,99.37106918238993
662,PRECIS-2,We recruited potential participants through adverts on the MS Society website and from National Health Service (NHS) MS centres across the UK.,fulltext,We recruited potential participants through adverts on the MS Society website and from National Health Service (NHS) MS centres across the UK.,100.0
662,PRECIS-2,"Fifty participants were recruited and completed baseline questionnaires. Of these, 19 (38%) participants were lost to follow-up.",fulltext, participants (10.5%) did not complete the postintervention questionnaires and four participants (21%) the three-month follow-up ,64.0625
662,PRECIS-2,A pilot trial of at least 30 participants is adequate for obtaining estimates of the standard deviation of the outcome variable to determine sample size for an efficacy trial.,fulltext,A pilot trial of at least 30 participants is adequate for obtaining estimates of the standard deviation of the outcome variable to determine sample size for an efficacy trial.,100.0
662,PRECIS-2,"We adapted these cognitive behavioural therapy (CBT) techniques so that instead of exploring how thoughts and feelings are linked and how this can lead to low mood, we discussed thoughts regarding having MS and how these thoughts are linked to anxiety and low mood.",fulltext,"We adapted these cognitive exercises so that instead of exploring how thoughts and feelings are linked and how this can lead to low mood, we discussed thoughts regarding having MS and how these thoughts are linked to anxiety and low mood.",89.05660377358491
662,PRECIS-2,"In the mindfulness group, two participants (10.5%) did not complete the post-therapy and three-month follow-up assessments.",fulltext,"In the mindfulness group, two participants (10.5%) did not complete the postintervention questionnaires and four participants (21%) the three-month follow-up questionna",89.43089430894308
662,PRECIS-2,"Recruitment took place between December 2012 and May 2013. We administered the screening questionnaires via telephone. Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).",fulltext,"Recruitment took place between December 2012 and May 2013. We administered the screening questionnaires via telephone. Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).",100.0
662,PRECIS-2,"Of the 40 randomised participants, 17 (42%) had PPMS, and 23 (57.5%) had SPMS. The overall sample was 55% female, predominantly white British (90%), with a mean age of 52.7 years (SD = 9.5), with the majority married or cohabiting (77.5%).",fulltext,"Of the 40 randomised participants, 17 (42%) had PPMS, and 23 (57.5%) had SPMS. The overall sample was 55% female, predominantly white British (90%), with a mean age of 52.7 years (SD = 9.5), with the majority married or cohabiting (77.5%).",100.0
663,PRECIS-2,"The inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS) score 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no change in disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks.",fulltext,"The inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks.",97.15025906735751
663,PRECIS-2,Allocation of interventions was done by a cluster randomization conducted whenever groups could be established at three different participating clinics.,fulltext,Allocation of interventions was done by a cluster randomization conducted whenever three groups could be established at three different participating clinics.,100.0
663,PRECIS-2,"A research assistant (L.A.) assigned patients with an ID number and pseudonyms, which were used during baseline and follow-up assessments.",fulltext,"A research assistant (L.A.) assigned patients with an ID number and pseudonyms, which were used during baseline and follow-up ",91.30434782608697
663,PRECIS-2,BMCT The BMCT intervention consisted of 20 1-hour training sessions over 10 weeks (two sessions/ week). All sessions started with a 10-minute warm-up on a stationary bicycle or treadmill.,fulltext,BMCT. The BMCT intervention consisted of 20 1-hour training sessions over 10 weeks (two sessions/ week). All sessions started with a 10-minute warm-up on a stationary bicycle or treadmill.,100.0
663,PRECIS-2,The primary outcomes were walking speed assessed by the T25FW20 and complex walking assessed by the SSST.21,fulltext,The primary outcomes were walking speed assessed by the T25FW 20 and complex walking assessed by the SSST. ,98.13084112149532
663,PRECIS-2,"Walking devices were allowed, but ankle foot orthotics or nerve-stimulating devices were detached.",fulltext,"Walking devices were allowed, but ankle foot orthotics or nerve-stimulating devices were detached.",100.0
663,PRECIS-2,"Analyses were carried out as intention-to-treat, where all participants were included regardless of their adherence to the allocated intervention. Carry forward imputations were not used to replace missing data in the primary intention to treat analysis.",fulltext,"Analyses were carried out as intention-to-treat, where all participants who completed the baseline assessment were included regardless of their adherence to the allocated intervention. Carry forward imputations were not used to replace missing data in the primary intention to treat analysis.",100.0
663,PRECIS-2,"Exclusion criteria were as follows: inability to walk, spasticity level O=0 in terms of cognitive disorders or alcohol abuse (based on clinical judgment), pathologies that did not allow systematic PRT and BMCT and PRT for at least 3 months.",fulltext,"Exclusion criteria were as follows: co-morbidity in terms of cognitive disorders or alcohol abuse (based on clinical judgment), pathologies that did not allow systematic PRT >1 session/week within the last 3 months.",79.16666666666666
663,PRECIS-2,PRT PRT consisted of 21-hour training sessions over 10 weeks (two sessions/week). Each session started with a 10-minute warm-up on a stationary bicycle or treadmill. The program predominantly targeted knee and hip flexion and extension where the exercises progressed from three sets of 10 repetitions at 15 RM toward four sets of 8 repetitions at 8 RM (Table 1).,fulltext,PRT. PRT consisted of 21-hour training sessions over 10 weeks (two sessions/week). Each session started with a 10-minute warm-up on a stationary bicycle or treadmill. The program predominantly targeted knee and hip flexion and extension where the exercises progressed from three sets of 10 repetitions at 15 RM toward four sets of 8 repetitions at 8 RM (Table 1).,100.0
663,PRECIS-2, section) and targeted advertisements sent out via the Danish MS Society.,fulltext, section) and targeted advertisements sent out via the Danish MS Society.,100.0
663,PRECIS-2,"Two adverse events occurred in the PRT group. One participant experienced exacerbation of fatigue following PRT sessions and dropped out; one experienced intermittent low back pain during PRT, but continued in the study.",fulltext,"Two adverse events occurred in the PRT group. One participant experienced exacerbation of fatigue following PRT sessions and dropped out; one experienced intermittent low back pain during PRT, but continued in the study.",100.0
663,PRECIS-2,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in ",fulltext,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in ",100.0
663,PRECIS-2,Groups of 3–6 patients were referred to physiotherapy clinics that were randomly assigned to provide either PRT or BMCT or to a waitlist CON. Allocation of interventions was done by a cluster randomization conducted whenever groups could be established at three different participating clinics.,fulltext,Groups of 3–6 patients were referred to physiotherapy clinics that were randomly assigned to provide either PRT or BMCT or to a waitlist CON. Allocation of interventions was done by a cluster randomization conducted whenever three groups could be established at three different participating clinics.,100.0
663,PRECIS-2,"Of particular interest is the finding of an increase in gait speed from BMCT despite no change in strength compared to CON. However, the increase in maximal gait speed in PRT (0.06 m/s) on the T25FW was also not significant when compared to CON.",fulltext,"Of particular interest is the finding of an increase in gait speed from BMCT despite no change in strength compared to CON. However, the increase in maximal gait speed in PRT (0.06 m/s) on the T25FW was also not significant when compared to CON.",100.0
664,PRECIS-2,Aerobic exercise was the core component and was accessible (i.e. includes community-based walking exercise) and does not require equipment.,fulltext,Aerobic exercise was the core exercise modality as it is accessible (i.e. includes community-based walking exercise) and does not require equipment.,93.5251798561151
664,PRECIS-2,"A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches. All patients were assessed by a consultant neurologist with an interest in MS prior to entering the trial. The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria, with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.",fulltext,"A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches. All patients were assessed by a consultant neurologist with an interest in MS prior to entering the trial. The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria, 9 with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.",100.0
664,PRECIS-2,A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.,fulltext,A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.,100.0
664,PRECIS-2,"Participants on disease-modifying therapy (interferon beta, glatiramer acetate and natalizumab) had been stable on this treatment for at least three months.",fulltext,"Participants on disease-modifying therapy (interferon beta, glatiramer acetate and natalizumab) had been stable on this treatment for at least three months.",100.0
664,PRECIS-2,Primary outcome was self-reported exercise behaviour at three months using the Godin Leisure Time Exercise Questionnaire (GLTEQ).,fulltext,Primary outcome was self-reported exercise behaviour at three months using the Godin Leisure Time Exercise Questionnaire (GLTEQ).,100.0
664,PRECIS-2,"Supervised exercise sessions involved up to three participants and lasted for approximately one hour. Studies show that aerobic exercise, resistance exercise and combined programmes bring health benefits to PwMS. Hence, the programme was designed to be pragmatic and accessible, taking into account exercise preferences and giving choices.",fulltext,"Supervised exercise sessions involved up to three participants and lasted for approximately one hour. Studies show that aerobic exercise, resistance exercise and combined programmes bring health benefits to PwMS. 10,11 Hence, the programme was designed to be pragmatic and accessible, taking into account exercise preferences and giving choices.",100.0
664,PRECIS-2,"An additional period of follow-up in comparison with participants randomised to usual care alone, full details of the protocol have been published previously.",fulltext," of follow-up in comparison with participants randomised to usual care alone. Materials and methods Randomised controlled trial This was a two-arm, parallel, randomised controlled trial. PwMS were randomised (1:1) to receive either the EXIMS intervention plus usual care or usual care only. Full details of the protocol have been published previously.",87.34177215189874
664,PRECIS-2,"An exercise physiologist supervised the delivery of the intervention but with physiotherapist input during the early stages of the programme. During weeks 1–6, participants attended two supervised sessions per week at a university exercise research facility and engaged in one additional self-directed exercise session in their home or local community.",fulltext,"An exercise physiologist supervised the delivery of the intervention but with physiotherapist input during the early stages of the programme. During weeks 1–6, participants attended two supervised sessions per week at a university exercise research facility and engaged in one additional self-directed exercise session in their home ",94.60227272727273
664,PRECIS-2,Objective: The objective of this study was to assess the effects of a practically implemented exercise programme on self-directed exercise behaviour and important health outcomes in PwMS to nine months of follow-up.,fulltext,Objective: The objective of this study was to assess the effects of a practically implemented exercise programme on self-directed exercise behaviour and important health outcomes in PwMS to nine months of follow-up.,100.0
664,PRECIS-2,Participants who were lost to follow-up at three months were treated as non-exercisers and included in the analysis.,fulltext,participants were lost to follow-up at nine months ,42.241379310344826
664,PRECIS-2,"Adherence to the supervised and home-exercise sessions was very good, with participants attending an average of 16.2 of the 18 supervised sessions (90%; range 7–18 sessions) and participating in an average of 14.6 of the 18 prescribed home-exercise sessions (81%, range 2–18 sessions). Home exercise during the intervention period comprised walking.",fulltext,"Adherence to the supervised and home-exercise sessions was very good, with participants attending an average of 16.2 of the 18 supervised sessions (90%; range 7–18 sessions) and participating in an average of 14.6 of the 18 prescribed home-exercise sessions (81%, range 2–18 sessions). Home exercise during the intervention period comprised walking.",100.0
664,PRECIS-2,Participants were encouraged to exercise in community-based settings.,fulltext,Participants were encouraged to seek out opportunities to exercise in the local community ,78.26086956521739
664,PRECIS-2,Participants were followed up to nine months after recruitment.,fulltext,participants were lost to follow-up at nine months (f,68.25396825396825
665,PRECIS-2,Participants with a diagnosis of MS and clinical levels of depression were recruited through out-patient clinics and postal screening questionnaires at two UK centres and randomised to CCBT or usual care.,fulltext,Participants with a diagnosis of MS and clinical levels of depression were recruited through out-patient clinics and postal screening questionnaires at two UK centres and randomised to CCBT or usual care.,100.0
665,PRECIS-2,"Exclusion criteria were: poor English language skills or cognitive function (score of less than 24 on Mini Mental State Examination [20]); BDI score of at least 29 on two consecutive occasions; active suicidal ideas; current or life-time diagnosis of psychosis, organic mental disorder or addictive disorder; Kurtzke Expanded Disability Status Scale (EDSS) score of 8.5 or above [21]).",fulltext,"Exclusion criteria were: poor English language skills or cognitive function (score of less than 24 on Mini Mental State Examination [20]); BDI score of at least 29 on two consecutive occasions; active suicidal ideas; current or life-time diagnosis of psychosis, organic mental disorder or substance dependency; Kurtzke Expanded Disability Status Scale (EDSS) score of 8.5 or above [21]).",97.14285714285714
665,PRECIS-2,"A client service receipt inventory was used at baseline, 8 weeks to identify concomitant medication and service use in both arms: the research protocol did not manualise or restrict treatment as usual.",fulltext,"A client service receipt inventory was used at baseline, 8 weeks and 21 weeks to identify concomitant medication and service use in both arms: the research protocol did not manualise or restrict treatment as usual.",100.0
665,PRECIS-2,"The pre-specified primary outcome was the recruitment rate, calculated as the proportion of those invited to fill in a screening questionnaire who entered the trial.",fulltext,"The pre-specified primary outcome was the recruitment rate, calculated as the proportion of those invited to fill in a screening questionnaire who were consented into the trial.",98.7878787878788
665,PRECIS-2,"A short semi-structured telephone interview was conducted with all study participants on completion of CCBT during which they were asked how they felt about the processes of recruitment and randomisation, the location of CCBT, their reasons for dropping out or not completing (where appropriate) and the appropriateness of the quantitative outcome measures used in the study.",fulltext,"A short semi-structured telephone interview was conducted with all study participants on completion of CCBT during which they were asked how they felt about the processes of recruitment and randomisation, the location of CCBT, their reasons for dropping out or not completing (where appropriate) and the appropriateness of the quantitative outcome measures used in the study.",100.0
665,PRECIS-2,"Delivery of CCBT (home/external) and variation in delivery and use In the Sheffield region, Primary Care Trust (PCT) mental health care teams administered the CCBT, facilitating access and undertaking safety monitoring (PCTs were publicly funded organisations responsible for commissioning acute services for local populations). The CCBT service provided to trial participants was the routine",fulltext,"Delivery of CCBT (home/external) and variation in delivery and use In the Sheffield region, Primary Care Trust (PCT) mental health care teams administered the CCBT, facilitating access and undertaking safety monitoring (PCTs were publicly funded organisations responsible for commissioning acute services for local populations). The CCBT service provided to trial participants was the routine",100.0
665,PRECIS-2,The CCBT service provided to trial participants was the routine service provided by the Sheffield Care Trust.,fulltext,The CCBT service provided to trial participants was the routine Patients approached to take part n=582 (Sheffield c,80.73394495412845
666,PRECIS-2,"Key exclusion criteria were previous exposure to GA40, a progressive form of MS or neuromyelitis optica, the use of experimental or investigational drugs, participation in clinical drug studies within the 6 months before screening, recent use of immunosuppressive medications (other than systemic corticosteroids), antibiotics, or vaccines use of alemtuzumab, cladribine, cyclophosphamide, or mitoxantrone.",fulltext,"Key exclusion criteria were previous exposure to GA40, a progressive form of MS or neuromyelitis optica, the use of experimental or investigational drugs, participation in clinical drug studies within the 6 months before screening, recent use of immunosuppressive medications or immunoglobulins/monoclonal antibodies, or previous use of alemtuzumab, cladribine, cyclophosphamide, or mitoxantrone.",90.88669950738917
666,PRECIS-2,"The CONFIDENCE study was a multinational, multicenter, randomized, parallel-group, phase 4, open-label study conducted at 88 study centers in 14 countries (Russia, Poland, Italy, France, Croatia, US [including Puerto Rico], Mexico, Spain, Austria, Turkey, Belgium, Argentina, Germany, and Finland) across different geographic regions.",fulltext,"The CONFIDENCE study was a multinational, multicenter, randomized, parallel-group, phase 4, open-label study conducted at 88 study centers in 14 countries (Russia, Poland, Italy, France, Croatia, US [including Puerto Rico], Mexico, Spain, Austria, Turkey, Belgium, Argentina, Germany, and Finland) across different geographic regions.",100.0
666,PRECIS-2,"Patients' adherence to treatment measured at Months 1, 3, and 6 using the MS-TAQ questionnaire showed consistently greater adherence to treatment in patients receiving GA40 compared with those receiving GA20 (Fig. 5). RM ANOVA analyses of MS-TAQ total scores during the 6-month treatment period showed significantly lower MS-TAQ scores in patients treated with GA40 than with GA20 during that time, indicating higher adherence to GA40 versus GA20 (table e-4).",fulltext,"Patients' adherence to treatment measured at Months 1, 3, and 6 using the MS-TAQ questionnaire showed consistently greater adherence to treatment in patients receiving GA40 compared with those receiving GA20 (Fig. 5). RM ANOVA analyses of MS-TAQ total scores during the 6-month treatment period showed significantly lower MS-TAQ scores in patients treated with GA40 than with GA20 during that time, indicating higher adherence to GA40 versus GA20 (table e-4).",100.0
666,PRECIS-2,"A total of 876 patients were screened for eligibility, and 861 were randomly assigned to receive GA40 (n = 431) or GA20 (n = 430). In the GA40 group, 430 patients received the treatment and were included in the safety analysis set, and 428 patients were included in the FAS. In the GA20 group, 427 patients received the treatment and were included in the safety analysis set and FAS (Fig. 1). A total of 794 (92%) patients completed the core phase with similar percentages of completers in each group (92.6% [399/431] in GA40 and 91.9% [395/430] in GA20, p = 0.695).",fulltext,"A total of 876 patients were screened for eligibility, and 861 were randomly assigned to receive GA40 (n = 431) or GA20 (n = 430). In the GA40 group, 430 patients received the treatment and were included in the safety analysis set, and 428 patients were included in the FAS. In the GA20 group, 427 patients received the treatment and were included in the safety analysis set and FAS (Fig. 1). A total of 794 (92%) patients completed the core phase with similar percentages of completers in each group (92.6% [399/431] in GA40 and 91.9% [395/430] in GA20, p = 0.695).",100.0
666,PRECIS-2,"The CONFIDENCE study was designed to assess the potential advantages of a less frequently administered (GA40) versus a more frequently administered (GA20) formulation of glatiramer acetate. The question of interest between the GA40 and GA20 formulations has been evaluated in previous trials designed for that purpose (Khan et al., 2013; Zivadinov et al., 2018, 2015).",fulltext," study design was the desire to assess the potential advantages of a less frequently administered (GA40) versus a more frequently administered formulation (GA20). The question of relatively efficacy between the GA40 and GA20 formulations has been evaluated in previous trials designed for that purpose (Khan et al., 2013; Zivadinov et al., 2018, 2015).",87.5
666,PRECIS-2,Patients withdrawn (n=32) Death (n=1) Adverse event (n=14) Withdrawal by patient (n=10) Protocol violation (n=1) Lost to follow-up (n=2) Other (n=4),prompt,Patients judged to not be adherent are excluded. * Withdrawing patient,31.081081081081084
666,PRECIS-2,"Patients were randomized to GA40 or GA20 and received allocated intervention (n=430, safety population; n=428, full analysis set).",prompt,patients who actually received (or did not receive) the intervention ,36.15384615384616
666,PRECIS-2,"The overall treatment-emergent adverse event (TEAE) profile in both treatment groups was consistent with previous findings (Wolinsky et al., 2015) (Table 2). A significantly lower percentage of patients in the GA40 cohort (8.6%) reported injection-site pruritus than those in the GA20 group (13.6%, p = 0.023).",fulltext,"The overall treatment-emergent adverse event (TEAE) profile in both treatment groups was consistent with previous findings (Wolinsky et al., 2015) (Table 2). A significantly lower percentage of patients in the GA40 cohort (8.6%) reported injection-site pruritus than those in the GA20 cohort (13.6%, p = 0.023).",98.70967741935483
666,PRECIS-2,"Key inclusion criteria permitted the participation of men or women ≥18 years of age with confirmed RRMS (diagnosed using the revised McDonald criteria) (Polman et al., 2011), Kurtzke Expanded Disability Status Scale (EDSS) score of 0 to 5.5 at the screening visit, and, for women of childbearing, a stable neurological condition, relapse-free status, and no use of any corticosteroid or adrenocorticotropic hormone treatment.",fulltext,"Key inclusion criteria permitted the participation of men or women ≥18 years of age with confirmed and documented RRMS diagnosis (as defined by the Revised McDonald criteria) (Polman et al., 2011), Kurtzke Expanded Disability Status Scale (EDSS) score of 0 to 5.5 at the screening visit, and, 30 days prior to randomization, a stable neurological condition, relapse-free status, and no use of any corticosteroid or adrenocorticotropic hormone treatment.",95.29411764705881
668,PRECIS-2,The exercises targeted the key lower limb muscles for supporting body weight and for generating and absorbing power during walking (Table 1).,fulltext,The exercises targeted the key lower limb muscles for supporting body weight and for generating and absorbing power during walking (Table 1).,100.0
668,PRECIS-2,"The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.",fulltext,"The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.",100.0
668,PRECIS-2,"To determine the effectiveness of PRT for people with MS, focusing on improving the gait deficits common in this population.",fulltext,"To determine the effectiveness of PRT for people with MS, focusing on improving the gait deficits common in this population.",100.0
668,PRECIS-2,"All exercises were completed on weight machines. The training intensity was based on recommendations of the American College of Sports Medicine (2009)7 and consisted of two sets of 10–12 repetitions of each exercise, at a training intensity of 10–12 repetition maximum (that is, only 12 consecutive repetitions of each exercise could be completed before muscle fatigue was reached). The weight lifted was increased when two sets of 12 repetitions of an exercise could be completed.",fulltext,"All exercises were completed on weight machines. The training intensity was based on recommendations of the American College of Sports Medicine (2009) 7 and consisted of two sets of 10–12 repetitions of each exercise, at a training intensity of 10–12 repetition maximum (that is, only 12 consecutive repetitions of each exercise could be completed before muscle fatigue was reached). The weight lifted was increased when two sets of 12 repetitions of an exercise could be completed.",100.0
668,PRECIS-2,"At 10 weeks, no differences were detected in walking performance. However, compared with the comparison group PRT demonstrated increased leg press strength (16.8%, SD 4.5), increased reverse leg press strength (29.8%, SD 12.7), and increased muscle endurance of the reverse leg press (38.7%, SD 32.8).",fulltext,"At 10 weeks, no differences were detected in walking performance. However, compared with the comparison group PRT demonstrated increased leg press strength (16.8%, SD 4.5), increased reverse leg press strength (29.8%, SD 12.7), and increased muscle endurance of the reverse leg press (38.7%, SD 32.8).",100.0
668,PRECIS-2,"Intention-to-treat analysis was applied, with all participants who were allocated and commenced their program included in analysis.",fulltext,"Intention-to-treat analysis was applied, with all participants who were allocated and commenced their program included in analysis.",100.0
668,PRECIS-2,"Participants attended 92% of training sessions, with no serious adverse events.",fulltext,"Participants attended 92% of training sessions, with no serious adverse events.",100.0
668,PRECIS-2,Changes in walking endurance were measured with the 2MWT.,fulltext,Changes in walking endurance were measured with the 2,92.98245614035088
668,PRECIS-2,"To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score19 of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.",fulltext,"To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score 19 of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.",100.0
668,PRECIS-2,"Objective: To determine the effectiveness of PRT for people with MS, focusing on improving the gait deficits common in this population.",fulltext,"Objective: To determine the effectiveness of PRT for people with MS, focusing on improving the gait deficits common in this population.",100.0
668,PRECIS-2,"Participants were recruited through a statewide organization providing education and support to people with MS, and a large specialist MS outpatient clinic.",fulltext,"Participants were recruited through a statewide organization providing education and support to people with Dodd et al. 1363 MS, and a large specialist MS outpatient clinic.",100.0
668,PRECIS-2,"Using a single blind randomized controlled trial, people with relapsing–remitting MS were randomly allocated to either a PRT program targeting the lower limb muscles twice a week for 10 weeks (n = 36), or usual care plus attention and social program conducted once a week for 10 weeks (n = 35). Outcomes were recorded at baseline, week 10 and week 22.",fulltext,"Using a single blind randomized controlled trial, people with relapsing–remitting MS were randomly allocated to either a PRT program targeting the lower limb muscles twice a week for 10 weeks (n ¼ 36), or usual care plus an attention and social program conducted once a week for 10 weeks (n ¼ 35). Outcomes were recorded at baseline, week 10 and week 22.",99.43019943019942
668,PRECIS-2,"Where data were missing, the carry forward technique was used.",fulltext,"Where data were missing, the carry forward technique was used.",100.0
669,PRECIS-2,An illustration of a training protocol is provided in supplementary material S1.,fulltext,An illustration of a training protocol is provided in supplementary material S1.,100.0
669,PRECIS-2,Four pwMS (two in each group) were not imaged due to contraindications for magnetic resonance (MR) scanning and logistical reasons. One scan from a participant in each group had to be excluded due to errors in the automated segmentation.,fulltext,Four pwMS (two in each group) were not imaged due to contraindications for magnetic resonance (MR) scanning and logistical reasons. One scan from a participant in each group had to be excluded due to errors in the automated segmentation.,100.0
669,PRECIS-2,pwMS received training instructions by email. They were asked to train three times weekly according to a personalized training intensity schedule that was based on their baseline aerobic capacity.,fulltext,pwMS received training instructions by email. They were asked to train three times weekly according to a personalized training intensity schedule that was based on their baseline aerobic capacity.,100.0
669,PRECIS-2,"If a participant had been inactive, a phone call was made for extra motivation. Besides, two group training sessions were organized (weeks 4 and 8) at a 400-m outdoor running track at KULeuven.",fulltext,"If a participant had been inactive, a phone call was made for enquiry. Besides, two group training sessions were organized (weeks 4 and 8) at a 400-m outdoor running track at KULeuven.",92.74611398963731
669,PRECIS-2,"Secondary outcome measures were fatigue, cognitive function, brain volumes, and structural connectivity.",fulltext,"Secondary outcome measures were fatigue, cognitive function, brain volumes, and structural connectivity.",100.0
669,PRECIS-2,The relative amount of running gradually increased until participants were able to run 5 km without interruption at 12 weeks.,fulltext,The relative amount of running gradually increased until participants were able to run 5 km without interruption at 12 weeks.,100.0
669,PRECIS-2,"Besides, two group training sessions were organized (weeks 4 and 8) at a 400-m outdoor running track at KULeuven.",fulltext,"Besides, two group training sessions were organized (weeks 4 and 8) at a 400-m outdoor running track at KULeuven.",100.0
669,PRECIS-2,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport.",fulltext,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport.",100.0
669,PRECIS-2,"Oxygen uptake (VO2), expiratory exchange ratio were collected breath-by-breath and averaged every minute.",fulltext,"ygen uptake (VO 2 ), expiratory volume, and respiratory exchange ratio were collected breath-by-breath and averaged every minute.",98.09523809523809
669,PRECIS-2,"Measures were physical (VO2max, sit-to-stand test, MSWS-12, Spatial Recall Test, FSMC, MSIS-29, and pallidum volume. VO2max improved by 1.5 mL/kg/min, MSWS-12 by 4, FSMC by 11, and MSIS-29 by 14 points.",fulltext," were found for VO 2max , sit-to-stand test, MSWS-12, Spatial Recall Test, FSMC, MSIS-29, and pallidum volume. VO 2max improved by 1.5 mL/kg/min, MSWS-12 by 4, FSMC by 11, and MSIS-29 by 14 points.",92.07920792079209
669,PRECIS-2,Adults diagnosed with MS were included on the basis of a neurologist's diagnosis and the ability to walk 5 km without rest or use of assistive device.,fulltext,Adults diagnosed with MS were included based on the ability to walk 5 km without rest or use of assistive device.,74.66666666666666
669,PRECIS-2,Participants who completed the training program showed high adherence. The EXP group completed 607 of 648 prescribed sessions (94%).,fulltext,Participants who completed the training program showed high adherence. The EXP group completed 607 of 648 prescribed sessions (94%).,100.0
669,PRECIS-2,"Aerobic capacity was assessed on an electronically braked cycle ergometer (eBike Basic®, General Electric GmbH, Bitz, Germany) with continuous pulmonary gas exchange analysis (Oxycon, Erich Jaeger GmbH, Germany), and heart rate (HR) monitoring (Polar®).",fulltext,"Aerobic capacity was assessed on an electronically braked cycle ergometer (eBike Basic ® ; General Electric GmbH, Bitz, Germany) with continuous pulmonary gas exchange analysis (Oxycon, Erich Jaeger GmbH, Germany), and heart rate (HR) monitoring (Polar ®",99.60474308300395
669,PRECIS-2,"If a participant had been inactive, a phone call was made for extra motivation.",fulltext,"If a participant had been inactive, a phone call was made for e",79.74683544303798
670,PRECIS-2,The outcome measures for the current research were the scores yielded by the Multiple Sclerosis Self Efficacy (MSSE) survey.,fulltext,The outcome measures for the current research were the scores yielded by the Multiple Sclerosis Self Efficacy (MSSE) survey.,100.0
670,PRECIS-2,"Participants were clients seen in the multiple sclerosis clinics at Sutherland-Chan School, in which the study was conducted.",fulltext,"Participants were clients seen in the multiple sclerosis clinics at Sutherland-Chan School, in which the study was conducted.",100.0
670,PRECIS-2,"The MSSE survey was originally developed and validated by Schwartz et al. (1996), based on the work of Lorig et al. (1989), who created a similar tool for use with people suffering from arthritis.",fulltext,"The MSSE survey was originally developed and validated by Schwartz et al. (1996), based on the work of Lorig et al. (1989), who created a similar tool for use with people suffering from arthritis.",100.0
670,PRECIS-2,"Of the fifteen study participants, all had previously received a diagnosis of multiple sclerosis, and multiple sclerosis was confirmed for three to forty-one years (with a mean of 19 years) at the time of the study.",fulltext,"Of the fifteen study participants, all had previously received a diagnosis of multiple sclerosis. The time since diagnosis ranged from three to forty-one years (with a mean of 19 years) at the time of the study.",90.69767441860466
670,PRECIS-2,"Clients were provided with information about the clinic by the local chapter of the Multiple Sclerosis Society, and self selected on that basis.",fulltext,"Clients were provided with information about the clinic by the local chapter of the Multiple Sclerosis Society, and self selected on that basis.",100.0
670,PRECIS-2,Neither treatment nor control groups received massage therapy for the follow up period of eight weeks. At this point the study was concluded and the control group received treatment twice a week during the eight week post study period.,fulltext,neither treatment nor control groups received massage therapy for the follow up period of eight weeks. At this point the study was concluded and the control group received treatment once a week during the eight week post study period.,98.72340425531915
670,PRECIS-2,"The outcome measures for the current research were the scores yielded by the Multiple Sclerosis Self Efficacy (MSSE) survey. For both treatment and control groups, self-efficacy scores were obtained before the first treatment, mid-treatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.",fulltext,"The outcome measures for the current research were the scores yielded by the Multiple Sclerosis Self Efficacy (MSSE) survey. For both treatment and control groups, self-efficacy scores were obtained before the first treatment, midtreatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.",99.74489795918367
671,PRECIS-2,"The primary clinical outcome was motor function measured by the Amended Motor Club Assessment (AMCA) score at week 36, analysed in the modified intention-to-treat population (excluding only patients who were deemed ineligible after randomisation, those who withdrew from the trial and were unwilling for their previously collected data to be used, or those who did not provide baseline and week 36 measurements).",fulltext,"The primary clinical outcome was motor function measured by the Amended Motor Club Assessment (AMCA) score at week 36, analysed in the modified intention-to-treat population (excluding only patients who were deemed ineligible after randomisation, those who withdrew from the trial and were unwilling for their previously collected data to be used, or those who did not provide baseline and week 36 measurements).",100.0
671,PRECIS-2,"These serious adverse events were in line with expectations: urinary tract infections (n=2), and arrhythmia (n=1), breast cancer (n=1), falls (n=4, of whom two participants fractured their wrist), respiratory infections (n=2), and burns (n=1).",fulltext,"These serious adverse events were in line with expectations: urinary tract infections (n=8), cardio vascular events (stroke [n=2] and arrhythmia [n=1]), breast cancer (n=1), falls (n=3, of whom two participants fractured a hip), respiratory infections (n=2), and burns (n=1).",95.47325102880659
671,PRECIS-2,"At the primary endpoint, 36 weeks post-randomisation, the pooled (ie, across both groups) SD of the AMCA score was 16·9 points, with a correlation between baseline and week 36 AMCA score of 0·86.",fulltext,"At the primary endpoint, 36 weeks post randomisation, the pooled (ie, across both groups) SD of the AMCA score was 16·9 points, with a correlation between baseline and week 36 AMCA score of 0·86.",100.0
671,PRECIS-2,"Key inclusion criteria were age older than 18 years, a diagnosis of progressive multiple sclerosis according to McDonald's criteria, and a score of 6·5–8·0 on the Expanded Disability Status Scale (EDSS). Key exclusion criteria were being within 3 months of ceasing a multiple sclerosis disease-modifying drug, receiving steroid treatment within the preceding 3 months, or participating in another clinical trial.",fulltext,"Key inclusion criteria were age older than 18 years, a diagnosis of pro gressive multiple sclerosis (primary or secondary) accord ing to McDonald’s criteria, 21 and a score of 6·5–8·0 on the Expanded Disability Status Scale (EDSS). Key exclusion criteria were being within 3 months of ceasing a multiple sclerosis disease modifying drug, receiving steroid treat ment within the preced ing month, or participating in another clinical trial.",99.27184466019418
671,PRECIS-2,Six follow-up telephone calls (15 min per call) were made by a physiotherapist (not involved in the delivery of the intervention) to check for any problems and to provide advice as needed.,fulltext,six follow-up telephone calls (15 min per call). Participants were aske,35.1063829787234
671,PRECIS-2,"The usual care group was not offered an intervention and hence, we could not exclude that placebo effects might have contributed to the benefits gained from the standing frame group.",fulltext,"The usual care group was not offered an intervention and hence, we could not exclude that placebo effects might have contributed to the benefits experienced by the standing frame group.",96.7032967032967
671,PRECIS-2,"The analyses were pre-specified in a statistical analysis plan approved by the trial steering committee before analysis started, except for the analysis method for spasm frequency, which was adjusted for the stratification factors (region and baseline EDSS) as fixed effects and baseline scores where appropriate (ie, fully adjusted models); results adjusted for baseline scores alone are also presented.",fulltext,"The analyses were pre specified in a statistical analysis plan approved by the trial steering committee before analysis started, except for the analysis method for spasm frequency. Primary analyses were adjusted for the stratification factors (region and baseline EDSS) as fixed effects and baseline scores where appropriate (ie, fully adjusted models); results adjusted for baseline scores alone are also presented.",98.76237623762376
671,PRECIS-2,"Participants were recruited through eight health-care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.",fulltext,"Participants were recruited through eight health-care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.",100.0
671,PRECIS-2,"Nevertheless, further research is needed to disentangle the intrinsic effects of standing frame use from, for example, attention.",fulltext,"Nevertheless, further research is needed to disentangle the intrinsic effects of standing from non specific effects due to, for example, attention.",96.12403100775194
671,PRECIS-2,"The trial methods, previously published in detail, are briefly described in line with existing guidelines.",fulltext,"The trial methods, previously published in detail, 16 are briefly described in line with existing guidelines.",100.0
671,PRECIS-2,"People with multiple sclerosis were actively involved throughout the study, including in the development of the research questions, study design, trial management and steering group meetings, writing of study materials, and dissemination activities.",fulltext,"People with multiple sclerosis were actively involved throughout the study, including in the development of the research questions, study design, trial manage ment and steering groups, writing of study materials, and dissemination activities.",96.78714859437751
671,PRECIS-2,The primary analysis was defined as a 9-point between-group difference in AMCA score at week 36 in the modified intention-to-treat population and analysed in a regression-based analysis (ANCOVA approach).,fulltext,"the primary analysis, with a significant between group difference in mean AMCA score at week 20 ",38.23529411764706
673,PRECIS-2,"All three exercise interventions were compared to the control group using a statistically significant improvement on the MSIS-29 psychological component and both the MFIS total and physical subscales, which were greater than the control (p < 0.05). Only the PT-led and FI-led interventions significantly improved the MSIS-29 physical and 6MWT to levels greater than the control (p < 0.05).",fulltext,"All three exercise interventions led to a statistically significant improvement on the MSIS-29 psychological component and both the MFIS total and physical subscales, which were greater than the control (p < 0.05). Only the PT-led and FI-led interventions significantly improved the MSIS-29 physical and 6MWT to levels greater than the control (p < 0.05).",91.00257069408741
673,PRECIS-2,"Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist. Persons with MS were excluded if they had a previous relapse or began steroid therapy in the 12 weeks prior to participating in the first assessment, were pregnant, or had a comorbidity that severely impacted their ability to safely participate in exercise.",fulltext,"Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist. Persons with MS were excluded if they had a previous relapse or began steroid therapy in the 12 weeks prior to participating in the first assessment, were pregnant, or had a comorbidity that severely impacted their ability to safely participate in exercise.",100.0
673,PRECIS-2,"The primary outcome measure was the physiological component of the Multiple Sclerosis Impact Scale-29, version 2 (MSIS-29v2), a patient-reported outcome measure that assesses the physical impact of MS. It consists of 20 questions and it is scored from 20 to 100, with the higher scores indicating a greater impact of MS.",fulltext,"The primary outcome measure was the physical component of the Multiple Sclerosis Impact Scale29, version 2 (MSIS-29v2), a patient-reported outcome measure that assesses the physical impact of MS. It consists of 20 questions and it is scored from 0–100, with the higher scores indicating a greater impact of MS.",96.875
673,PRECIS-2,"Once consent for eight people of a strand in a specific geographical area was obtained, the regional office of MSI contacted the participants to enroll following their eligibility assessments, performed by the regional offices of MSI.",fulltext,"Once consent for eight people of a strand in a specific geographical area was obtained, the regional office of MSI contacted the national coordinator (AL) who allocated that block of participants to the control or an intervention. The sequence was generated by the national ",79.05982905982906
673,PRECIS-2,"Outcome was assessed at week 24 for the intervention groups only, as it was felt that withholding a potentially beneficial treatment for longer than 12 weeks, from the controls, could be considered unethical. As all groups were not treated similarly between weeks 12 and 24, and due to the high attrition rates at weeks 12 and 24, the results of our follow-up phase will be presented in a separate paper.",fulltext,"Outcome was assessed at week 24 for the intervention groups only, as it was felt that withholding a potentially beneficial treatment for longer than 12 weeks, from the controls, could be considered unethical. As all groups were not treated similarly between weeks 12 and 24, and due to the high attrition rates at weeks 12 and 24, the results of our follow-up phase will be presented in a separate paper.",100.0
673,PRECIS-2,"They were conducted in community centres such as local gyms, hotels and health centres.",fulltext,"They were delivered in community centres such as local gyms, hotels and health centres.",93.10344827586206
673,PRECIS-2,"The PT-led exercise provided was pre-defined. It consisted of a circuit-style class of exercises that were either resisted by body weight or by the addition of free weights. The exercises were to sit to stand/squat, bridging, resisted shoulder flexion, walking/cycling, resisted elbow flexion, lunges or resisted knee extension, hip extension and calf raises; working to an intensity whereby the aim was to be failing on the 12th repetition of the exercise, with the load increased by 2–5%, when 12 repetitions were achieved with ease.",fulltext,"The PT-led exercise provided was pre-defined. It consisted of a circuit-style class of exercises that were either resisted by body weight or by the addition of free weights. The exercises were to sit to stand/squat, bridging, resisted shoulder flexion, walking/cycling, resisted elbow flexion, lunges or resisted knee extension, hip extension and calf raises; working to an intensity whereby the aim was to be failing on the 12th repetition of the exercise, with the load increased by 2–5%, when 12 repetitions were achieved with ease.",100.0
673,PRECIS-2,"All interventions took place in groups of eight, for an hour per week, for 10 weeks. They were delivered in community centres such as local gyms, hotels and health centres. Participants were randomised to a physiotherapist (PT)-led class, fitness instructor (FI)-led class, yoga instructor (YI)-led class, or control group (CG). The CG was asked not to change their exercise habit for the 10-week period between assessments.",fulltext,"All interventions took place in groups of eight, for an hour per week, for 10 weeks. They were delivered in community centres such as local gyms, hotels and health centres. Participants were randomised to a physiotherapist (PT)-led class, fitness instructor (FI)-led class, yoga class (Y) or to the control group (CG). The CG was asked not to change their exercise habit for the 10-week period between assessments.",95.28301886792453
674,PRECIS-2,"Exclusion criteria included active-controlled, double-blind, placebo-controlled trial.",fulltext,"icenter, randomized, double-blind, placebo-controlled trial",60.46511627906976
674,PRECIS-2,SC IFN-β-1a patients received 44 μg 3 times weekly.,fulltext," SC IFN-b-1a (Rebif; EMD Serono, Rockland, MA; 44 mg 3 times weekly",74.50980392156863
674,PRECIS-2,Kaplan-Meier estimates of risk for 6-month CDI with stratification by baseline Expanded Disability Status Scale (EDSS).,fulltext,Kaplan-Meier estimates of risk for 6-month CDI with stratification by baseline Expanded Disability Status Scale (EDSS).,100.0
674,PRECIS-2,Patients with RRMS with an inadequate response to prior therapy were enrolled.,fulltext, patients with RRMS with an inadequate response to prior therapy. The resu,87.17948717948718
674,PRECIS-2,"Integrated disability score of area under the curve (AUC) and AUC as previously described for EDSS from quarterly EDSS scores was considered more sensitive than CDI Kaplan-Meier analysis and odds ratios (ORs) for improvement vs stability or worsening on individual EDSS functional systems (visual [optic], brainstem, pyramidal, cerebellar, sensory, bowel/bladder, and cerebral [mental]) from baseline to month 24.",fulltext," integrated disability score of area under the curve (AUC SUM and AUC CHANGE as previously described) 21 for EDSS from quarterly visits over 2 years (considered more sensitive than CDI Kaplan-Meier analysis) 21 and odds ratios (ORs) for improvement vs stability or worsening on individual EDSS functional systems (visual [optic], brainstem, pyramidal, cerebellar, sensory, bowel/bladder, and cerebral [mental]) from baseline to month 24",98.06295399515739
674,PRECIS-2,"Percentage of patients with 6-month CDI was also significantly greater with alemtuzumab than SC IFN-β-1a (35.4% vs 15.3%, p = 0.0005 [HR = 2.76]).",fulltext,n of patients with 6-month CDI was also significantly greater with alemtuzumab than SC IFNb-1a (35.4% vs 15.3%; p 5 0.0005 [HR 5 2.76]),90.41095890410959
674,PRECIS-2,"Patients were randomized to SC IFN-β-1a 44 μg and alemtuzumab 12 mg, respectively.",fulltext," patients were randomized to SC IFN-b-1a 44 mg and alemtuzumab 12 mg, respectively",96.34146341463415
674,PRECIS-2,Alemtuzumab patients had more favorable visual outcomes than those receiving SC IFN-β-1a.,fulltext, Alemtuzumab patients had more favorable visual outcomes than those receiving SC IFN,93.25842696629213
674,PRECIS-2,Alemtuzumab-treated patients received 12 mg/d intravenously on 5 consecutive days at month 0 and on 3 consecutive days at month 12.,fulltext," alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12",80.91603053435115
674,PRECIS-2,Patients had up to 3 years of follow-up.,prompt,n of follow-up ,37.5
674,PRECIS-2,Patients were assessed with EDSS every 3 months.,fulltext, Patients were also assessed,45.833333333333336
674,PRECIS-2,Patients were enrolled at 128 sites in 28 countries.,fulltext, patients were randomiz,36.53846153846154
674,PRECIS-2,Alemtuzumab-treated patients were more likely than SC IFN-β-1a–treated patients to show improvement in EDSS scores (p < 0.0001) on all 7 functional systems.,fulltext,"Alemtuzumab-treated patients were more likely than SC IFN-b-1a–treated patients to show improvement in EDSS scores (p , 0.0001) on all 7 functional systems.",99.35897435897436
675,PRECIS-2,"Assessments were made at baseline, postintervention, and 6 months follow-up.",fulltext,"Assessments were made at baseline, postintervention, and 6 months follow-up.",100.0
675,PRECIS-2,"MBI closely followed the program of mindfulness-based stress reduction and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes (10–15 participants/group; exercises did not exceed patients' level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day); emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills.",fulltext,"MBI closely followed the program of mindfulness-based stress reduction 23 and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10 –15 participants/group; exercises did not exceed patients’ level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills.",100.0
675,PRECIS-2,"Intention-to-treat analyses are reported. Data of missing study patients were imputed by linear multiple regression that adjusted for age, gender, and disease progression (entry EDSS score; STATISTICA 6.0). Statistical power calculation of this study was based on earlier studies.",fulltext,"Intention-to-treat analyses are reported. Data of missing study patients were imputed by linear multiple regression that adjusted for age, gender, and disease progression (entry EDSS score; STATISTICA 6.0). Statistical power calculation of this study was based on earlier studies.",100.0
675,PRECIS-2,Analyzed (n=76) Intention-to-treat; Excluded from analysis (n=0),prompt,analysis.) The intention-to-treat analysis ,57.8125
675,PRECIS-2,"Primary outcomes included disease-specific and disease-aspecific HRQOL, depression, and fatigue.",fulltext,"Primary outcomes included disease-specific and disease-aspecific HRQOL, depression, and fatigue.",100.0
675,PRECIS-2,Patients completed written informed consent.,fulltext,pants completed written informed consent.,93.18181818181819
675,PRECIS-2,"MBI is based upon concepts of mental training that propose that nonjudgmental awareness moment-to-moment experience (i.e., mindfulness) may positively affect accuracy of perception, acceptance of unchangeable health-related changes, realistic sense of control, and appreciation of available life experiences.",fulltext,"MBI is based upon concepts of mental training that propose that nonjudgmental awareness of moment-tomoment experience (i.e., mindfulness) may positively affect accuracy of perception, acceptance of intractable health-related changes, realistic sense of control, and appreciation of available life experiences.",97.72727272727273
675,PRECIS-2,A total of 150 patients were randomly assigned to the intervention (n = 76) or to UC (n = 74).,fulltext,A total of 150 patients were randomly assigned to the intervention (n = 76) or to UC (n = 74).,100.0
675,PRECIS-2,Excluding people using tests or measures that are not used or available in usual care.,prompt,Excluding people using tests or measures that are not used or available in usual care.,100.0
675,PRECIS-2,Lost to post-treatment (n=4); Additionally lost to 6-month follow-up (n=1),fulltext, to postintervention and preintervention to 6-monthfollow-up. To ,60.810810810810814
675,PRECIS-2,Neurologists verified all patients for the following inclusion criteria: 1) diagnosis of relapsing-remitting (but no more than 2 exacerbations within the last year) or secondary progressive MS,fulltext,Neurologists verified all patients for the following inclusion criteria: 1) diagnosis of relapsing-remitting (but no more than 2 exacerbations within the last year) or secondary progressive MS,100.0
675,PRECIS-2,"HRQOL psychosocial impairment shows great variation among patients with MS and is, to an important degree, independent of extent of disease.",fulltext,"HRQOL psychosocial impairment shows great variation among patients with MS and is, to an important degree, independent of extent of disease.",100.0
675,PRECIS-2,The study was conducted from February 2007 to March 2009.,fulltext,The study was conducted from February 2007 to March 2009.,100.0
675,PRECIS-2,"Eligible patients completed all preintervention assessments before randomization. Randomization was conducted by the principal investigator who had no prior contact with patients and was fully blinded to all patient information, except study identification number of patients.",fulltext,"Eligible patients completed all preintervention assessments before randomization. Randomization was conducted by the principal investigator who had no prior contact with patients and was fully blinded to all patient information, except study identification number of patients.",100.0
675,PRECIS-2,Homework assignments (approximately 40 minutes/day); emphasized as essential to success of the program,fulltext,"homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program",100.0
675,PRECIS-2,MBI closely followed the program of mindfulness-based stress reduction,fulltext,MBI closely followed the program of mindfulness-based stress reduction,100.0
675,PRECIS-2,Excluding people not known or shown to be highly adherent to the intervention.,prompt,Excluding people not known or shown to be highly adherent to the intervention.,100.0
677,PRECIS-2,"The therapists – basically the same therapists as before the actual month of exercising with the H-CAD system at home started. The exercise compliance during treatment varied; the average days exercising with the system was 24 days (SD = 9, range 7-39 days).",fulltext,"ssions before the actual month of exercising with the H-caD system at home started. the exercise compliance during treatment varied; the average days exercising with the system was 24 days (SD = 9, range 7-39 days).",82.55813953488372
677,PRECIS-2,"The primary objective of the project was to validate the EU market – more specifically in Italy, Spain, The Netherlands and Belgium – for a home-care service.",fulltext,"The primary objective of the project was to validate the EU market – more specifically in Italy, Spain, The Netherlands and Belgium – for a home-care service.",100.0
677,PRECIS-2,Main aim of the service is to extend the rehabilitation treatment at patient's home under close supervision of the hospital.,fulltext,Main aim of the service is to extend the rehabilitation treatment at patient's home under close supervision of the hospital.,100.0
677,PRECIS-2,"The hypothesis is that the H-CAD system is at least as effective as the usual care for arm/hand function, measured with outcome measures for arm/hand function, given to the stroke, TBI and MS patients when they are living at home.",fulltext,"the hypothesis is that the H-caD system is at least as effective as the usual care for arm/hand function, measured with outcome measures for arm/hand function, given to the stroke, tBI and MS patients when they are living at home.",100.0
677,PRECIS-2,For this multiple testing: 1) the month of usual care before the intervention (T0-T1) was compared to the month of using the H-CAD system (T1-T2); 2) the month of usual care after the intervention (T2-T3) was compared to the intervention month (T1-T2).,fulltext,For this multiple testing: 1) the month of usual care before the intervention (T0-T1) was compared to the month of using the H-CAD system (T1-T2); 2) the month of usual care after the intervention (T2-T3) was compared to the intervention month (T1-T2).,100.0
677,PRECIS-2,"The primary outcome measures at T0 (baseline), T1, T2 and T3 are reported in Table 2 for all three diagnoses groups and presented separately for the control and intervention group. In general, the ARA test showed constant slight improvement in the usual care as well as in the intervention group.",fulltext,"the primary outcome measures at t0 (baseline), t1, t2 and t3 are reported in Table 2 for all three diagnoses groups and presented separately for the control and intervention group. In general, the ara test showed constant slight improvement in the usual care as well as in the intervention group.",100.0
677,PRECIS-2,The treatment time of the H-CAD was thus slightly higher – but not significantly different – compared to usual care.,fulltext,the treatment time of the H-caD was thus slightly higher – but not significantly different – compared to usual care.,100.0
677,PRECIS-2,All horizontal differences were calculated as a percentage of the seconds of improvement with respect to the mean execution time at the beginning of the intervention month.,fulltext,nt difference from zero. the relative improvement was calculated as a percentage of the seconds of improvement with respect to the mean execution time at the beginning of the intervention month.,91.86046511627907
677,PRECIS-2,"The H-CAD system in this validation trial was: is the use of the H-CAD system for one month at least as good as usual care for the arm/hand function in stroke, TBI and MS patients?",fulltext,"lItAtIon clInIcAl trIAl was: is the use of the H-caD system for one month at least as good as usual care for the arm/hand function in stroke, tBI and MS patients?",85.55555555555556
677,PRECIS-2,"The outcome measures used in the present study are in line with the international classification of functioning, disability, and health (ICF) model. The outcome measures on functioning level were: the Action Research Arm Test (ARA), Wolf Motor Function Test (WMFT), the Barthel index (BI) and the Abilhand questionnaire.",fulltext,"The outcome measures used in the present study are in line with the international classification of functioning, disability, and health (ICF) model. The outcome measures on functioning level were: the Action Research Arm Test (ARA), Wolf Motor Function Test (WMFT), the Barthel index (BI) and the Abilhand questionnaire.",100.0
677,PRECIS-2,"As most patients were recruited from a chronic phase when they use the H-CAD system the aim is to at least maintain the arm/hand functioning. However the use of H-CAD, patients are able to train much more intense compared to in hospital settings which could have additional positive effects.",fulltext,"as most patients are in a chronic phase when they use the H-caD system the aim is to at least maintain the arm/hand functioning. However by the use of H-caD, patients are able to train much more intense compared to in hospital settings which could have additional positive effects.",94.84536082474226
677,PRECIS-2,"The actual intervention with the H-CAD system at home consisted of one month, whereby the patients had an average of 30 minutes for at least 5 days a week.",fulltext,"the actual intervention with the H-caD system at home consisted of one month, whereby the patients had an average of one training session a day lasting 30 minutes for at least 5 days a week.",100.0
677,PRECIS-2,"Patients were recruited from Unità Organica di Riabilitazione Intensiva Neuromotoria (UORIN, Italy), Foundation Institute Guttmann (FPING, Spain) and from National Multiple Sclerosis Centre (NMSC, Belgium).",fulltext,"Patients were recruited from Unità Organica di Riabilitazione Intensiva Neuromotoria (UORIN, Italy), Foundation Institute Guttmann (FPING, Spain) and from National Multiple Sclerosis Centre (NMSC, Belgium).",100.0
677,PRECIS-2,"The tele-rehabilitation service is mainly addressed to neurological patients affected by traumatic brain injury (TBI), stroke or multiple sclerosis (MS).",fulltext,"the tele-rehabilitation service is mainly addressed to neurological patients affected by traumatic brain injury (tBI), stroke or multiple sclerosis (MS).",100.0
678,PRECIS-2,"The PCT undertook assessments, suggested ways to improve problems, provided specialist welfare benefits advice and bereavement support, and liaised with and acted as a catalyst for local services, both primary and specialist teams.",fulltext,"The PCT undertook assessments, suggested ways to improve physical, emotional, social, and other problems, provided specialist welfare benefits advice and bereavement support, and liaised with and acted as a catalyst for local services, both primary and specialist teams.",100.0
678,PRECIS-2,"We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT.",fulltext,"We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT.",100.0
678,PRECIS-2,"We separately explored missing data30 and tested imputations (last value carried forward, next value carried backward, and mean value) in a sensitivity analysis.",fulltext,"We separately explored missing data 20 and tested imputations (last value carried forward, next value carried backward, and mean value) in a sensitivity analysis.",99.37888198757764
678,PRECIS-2,"Informal care costs included, over the 0–12-week follow-up were £1,789 lower for the fast-track group (bootstrapped 95% CI −£5,224 to £1,902).",fulltext,"informal care costs included, over the 0e12week follow-up were £1,789 lower for the fasttrack group (bootstrapped 95% CI £5,224 to £1,902).",97.88732394366197
678,PRECIS-2,"Patients were randomized to the fast-track and 21 of 26 control patients completed the trial20 (CONSORT diagram, Fig. 1).",fulltext," fast track and 21 of 26 control patients completed the trial 20 (CONSORT diagram, Fig. 1).",74.3801652892562
678,PRECIS-2,"Subjects were 69 people with MS, 52 of whom took part in the trial (Fig. 1). Inclusion criteria were patients in South East London, living with MS and one or more of unresolved symptoms, psychosocial concerns, end-of-life issues, progressive illness, or complex needs (for palliative care needs).",fulltext,"Subjects were 69 people with MS, 52 of whom took part in the trial (Fig. 1). Inclusion criteria were patients in South East London, living with MS and deemed (by clinicians) to have one or more of unresolved symptoms, psychosocial concerns, end-of-life issues, progressive illness, or complex needs (i.e., palliative care needs).",98.98648648648648
678,PRECIS-2,"Patients were randomized to receive a PCT immediately (fast track) or after a 12-week wait (usual best practice, control).",fulltext,"Patients were randomized to receive a PCT immediately (fast track) or after a 12-week wait (usual best practice, control).",100.0
678,PRECIS-2,"At baseline in both groups, over two-thirds were in contact with either district or practice nurses and half of each group were in contact with MS nurse specialists (Table 3). By the 12-week follow-up, 39% of the fast-track group reported having received palliative care nursing, with a mean of almost three contacts.",fulltext,"At baseline in both groups, over two-thirds were in contact with either district or practice nurses and half of each group were in contact with MS nurse specialists (Table 3). By the 12week follow-up, 39% of the fast-track group reported having received palliative care nursing, with a mean of almost three contacts.",99.6845425867508
678,PRECIS-2,"Our standardized questionnaires included the Palliative Care Outcome Scale (POS-8),24,25 comprising eight questions on anxiety, patient and carer needs, and practical needs, each rated 0–4; a single-item POS pain score (rated 0 [best] to 4 [worst]); and caregivers' burden (using the 12-item version of the Zarit Carer Burden Inventory [ZBI]).",fulltext,"Our standardized questionnaires included the Palliative Care Outcome Scale (POS8), 24,25 comprising eight questions on anxiety, patient and carer concerns, and practical needs, each rated 0e4; a single-item POS pain score (rated 0 [best] to 4 [worst]); and caregivers’ burden (using the 12-item version of the Zarit Carer Burden Inventory [ZBI]).",98.83381924198251
678,PRECIS-2,"Our standardized questionnaires included the Palliative Care Outcome Scale (POS-8),24,25 comprising eight questions on anxiety, patient and carer needs, and practical needs, each rated 0–4",fulltext,"Our standardized questionnaires included the Palliative Care Outcome Scale (POS8), 24,25 comprising eight questions on anxiety, patient and carer concerns, and practical needs, each rated 0",97.3404255319149
678,PRECIS-2,Higher scores represent greater problems on all the scales. We were unable to blind the interviewers or participants from group allocation.,fulltext,Higher scores represent greater problems on all the scales. We were unable to blind the interviewers or participants from group allocation.,100.0
678,PRECIS-2,"After initial assessment, treatment was recommended.18-20 Care was provided in a similar way to palliative care consultation services described elsewhere,9,11 although the PCT worked in both hospital and the community, and so could visit patients wherever they were.",fulltext,"After initial assessment, treatment was recommended. 18,20 Care was provided in a similar way to palliative care consultation services described elsewhere, 9,11 although the PCT worked in both hospital and the community, and so could visit patients wherever they were.",100.0
678,PRECIS-2,"In addition to continuing to receive usual services (see below), patients in the fast-track group received care from a PCT.18-20 This comprised one part-time consultant in palliative medicine, one part-time clinical nurse specialist, one administrator, and one psychosocial worker, and was based in a large teaching hospital.",fulltext,"In addition to continuing to receive usual services (see below), patients in the fast-track group received care from a PCT. 18,20 This comprised one part-time consultant in palliative medicine, one part-time clinical nurse specialist, one administrator, and one psychosocial worker, and was based in a large teaching hospital.",100.0
678,PRECIS-2,Referrals were screened by a consultant in palliative medicine who was independent from delivering the service (P. M. E./I. J. H).,fulltext,Referrals were screened by a consultant in palliative medicine who was independent from delivering the service (P. M. E./I. J. H).,100.0
679,PRECIS-2,The enrolment started February 2013 and ended April 2016. The follow-up started April 2013 (first 1-month assessment) and ended December 2016 (last 6-month assessment).,fulltext,The enrolment started February 2013 and ended April 2016. The follow-up started April 2013 (first 1-month assessment) and ended December 2016 (last 6-month assessment).,100.0
679,PRECIS-2,"All endpoints were analyzed according to the intention-to-treat principle using an ANCOVA with the 6-month value as dependent variable, and condition, baseline value, disease duration and gender as independent variables.",fulltext,"All endpoints were analyzed according to the intention-to-treat principle using an ANCOVA with the 6-month value as dependent variable, and condition, baseline value, disease duration and gender as independent variables.",100.0
679,PRECIS-2,"Participants were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands. Interested patients were contacted by a registered nurse experienced in MS (MH) by phone to check diagnosis and eligibility criteria.",fulltext,"Participants were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands. Interested patients were contacted by a registered nurse experienced in MS (MH) by phone to check diagnosis and eligibility criteria.",100.0
679,PRECIS-2,"Eligibility criteria for patients: diagnosis RRMS since at least one year, EDSS score ≤4.0, no symptoms suggestive of a relapse, no relapse in the preceding four weeks, willing and capable of participating in the investigations, and having access to the internet for performing the web-based assessments.",fulltext,"Eligibility criteria for patients: diagnosis RRMS since at least one year, EDSS score ≤4.0, no symptoms suggestive of a relapse, no relapse in the preceding four weeks, willing and capable of participating in the investigations, and having access to the internet for performing the web-based assessments.",100.0
679,PRECIS-2,"The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS [9]. All professional team members were formally trained in their respective disciplines and all members were experienced in the field of MS. The person with MS had experience with chronic symptoms and multiple disease-modifying treatments.",fulltext,"The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS [9]. All professional team members were formally trained in their respective disciplines and all members were experienced in the field of MS. The person with MS had experience with chronic symptoms and multiple disease-modifying treatments.",100.0
679,PRECIS-2,"We did a single-centre, randomized (1:1), unmasked, parallel-group, controlled trial in the Netherlands.",fulltext,"We did a single-centre, randomized (1:1), unmasked, parallel-group, controlled trial in the Netherlands.",100.0
679,PRECIS-2,"CDT is a social cognitive theory-based intervention aiming to uncover and promote existing capabilities, with the notion 'stressor' as central concept [9]. CDT is based on the identification and reduction of stressors, client-centeredness, and the notion of another significant informal caregiver group session; and self-reliance, autonomy and acceptance as central themes [9].",fulltext,"CDT is a social cognitive theory-based intervention aiming to uncover and promote existing capabilities, with the notion ‘stressor’ as central concept [9]. CDT is based on the identification and reduction of stressors; client-centeredness; potential inclusion of partner or another significant informal caregiver; group sessions; and self-reliance, autonomy and acceptance as central themes [9].",98.14323607427056
679,PRECIS-2,"Post hoc analyses included ANCOVA with the 1-month and 3-month values as dependent variables, and condition, baseline values, disease duration and gender as independent variables; multiple regression analysis to detect the contribution of age, gender, disease duration, EDSS score and education at six months.",fulltext,"Post hoc analyses included ANCOVA with the 1-month and 3-month values as dependent variables, and condition, baseline values, disease duration and gender as independent variables; multiple regression analysis to detect the contribution of age, gender, disease duration, EDSS score and education at six months,",100.0
679,PRECIS-2,During an optional joint activity (walk in the woods) at the start of the day the participants experiment with physical challenges and with the management of their energy [9].,fulltext,During an optional joint activity (walk in the woods) at the start of the day the participants experiment with physical challenges and with the management of their energy [9].,100.0
679,PRECIS-2,"Eligibility criteria for support partners: willing and capable of participating in the investigations, and having access to the internet.",fulltext,"Eligibility criteria for support partners: willing and capable of participating in the investigations, and having access to the internet.",100.0
679,PRECIS-2,"The primary study outcome was the change in control self-efficacy, assessed by the Multiple Sclerosis Self-Efficacy Scale (MSSES), at six months [12]. The MSSES is a specific and sensitive self-report questionnaire consisting of two 9-items subscales for control and functional self-efficacy, with a high internal consistency and test-retest reliability [12].",fulltext,"The primary study outcome was the change in control self-efficacy, assessed by the Multiple Sclerosis Self-Efficacy Scale (MSSES), at six months [12]. The MSSES is a specific and sensitive self-report questionnaire consisting of two 9-items subscales for control and functional self-efficacy, with a high internal consistency and test-retest reliability [12].",100.0
679,PRECIS-2,"Assessments were at baseline and at one, three and six months follow-up via online questionnaires (www.ms4ri.nl).",fulltext,"Assessments were at baseline and at one, three and six months follow-up via online questionnaires (www.ms4ri.nl).",100.0
679,PRECIS-2,"The members respected and understood the participants' individual qualities and differences, and they stimulated, defied and confronted them to explore and push their boundaries [9].",fulltext,"The members respected and understood the participants’ individual qualities and differences, and they stimulated, defied and confronted them to explore and push their boundaries [9].",100.0
679,PRECIS-2,"CDT focuses on the exploration of those stressors that confine patients to their physical, psychological or social roles regarding their disease and limitations; reduces these stressors; explores and pushes personal boundaries; and creates new personal boundaries by making optimal use of the existing potential [9].",fulltext,"CDT focuses on the exploration of those stressors that confine patients to their physical, psychological or social roles regarding their disease and limitations; reduces relevant stressors; explores and pushes personal boundaries; and creates new personal boundaries by making optimal use of the existing potential [9].",99.0506329113924
679,PRECIS-2,optional joint activity,fulltext,optional joint activity,100.0
680,PRECIS-2,The primary outcome was level of depressive symptoms at post and 20 weeks follow up which was measured with the Beck Depression Inventory-II (BDI-II) [26].,fulltext,The primary outcome was level of depressive symptoms at post and 3 month follow up which was measured with the Beck Depression Inventory-II (BDI-II) [26].,95.48387096774194
680,PRECIS-2,"The study took place at a large teaching and research hospital in Melbourne, Australia. Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.",fulltext,"The study took place at a large teaching and research hospital in Melbourne, Australia. Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.",100.0
680,PRECIS-2,"Consenting and eligible participants were invited to undertake a clinical interview at baseline with a clinical psychologist at the hospital. One female senior clinical psychologist and one male provisional clinical psychologist undertook assessments. During this baseline interview, the goals and procedures were explained in detail and written consent was obtained from all participants.",fulltext,"Consenting and eligible participants were invited to undertake a clinical interview at baseline with a clinical psychologist at the hospital. One female senior clinical psychologist and one male provisional clinical psychologist undertook assessments. During this baseline interview, the goals and procedures were explained in detail and written consent was obtained from all participants.",100.0
680,PRECIS-2,The Structured Clinical Interview of Disorders Research version (SCID-I/P) [28] was used to screen out patients with psychotic disorders and substance dependency.,fulltext,The Structured Clinical Interview of Disorders- Research version (SCID-I/P) [28] was used to screen out patients with psychotic disorders and substance dependency.,100.0
680,PRECIS-2,"Statistical analyses were performed using SPSS version 22 for Windows. To examine group differences at baseline individual analyses of variance (ANOVAs) were performed with all outcome variables. To examine group differences at post and 20 week follow up assessment, individual analyses of covariance (ANCOVAs) were performed with baseline treatment outcome scores used as the covariate.",fulltext," analyses Statistical analyses were performed using SPSS version 22 for Windows. To examine group differences at baseline individual analyses of variance (ANOVAs) were performed with all outcome variables. To examine group differences at post and 20 week follow up assessment, individual analyses of covariance (ANCOVAs) were performed with baseline treatment outcome scores used as the ",97.41602067183463
680,PRECIS-2,"The aim of the 8-week tailored intervention is to significantly decrease level of depressive symptoms (primary outcome), anxiety, fatigue and pain impact and to contribute to improvements in levels of quality of life, sleep difficulties, MS illness acceptance, active coping skills, social support and resilience (secondary outcomes) in those newly diagnosed with MS.",fulltext,"The aim of the 8-week tailored intervention is to significantly decrease level of depressive symptoms (primary outcome), anxiety, fatigue and pain impact and to contribute to improvements in levels of quality of life, sleep difficulties, MS illness acceptance, active coping skills, social support and resilience (secondary outcomes) in those newly diagnosed with MS.",100.0
680,PRECIS-2,"Additionally, the pilot trial aimed to assess the adherence and acceptability among participants (tertiary outcomes) of the tailored CBT program for individuals with MS.",fulltext,"Additionally, the pilot trial aimed to assess the adherence and acceptability among participants (tertiary outcomes) of the tailored CBT program for individuals with MS.",100.0
680,PRECIS-2,"Follow up assessments ended April, 2015. The trial was stopped after achieving a total number of 30 participants (15 in each group).",fulltext,"Follow up assessments ended April, 2015. The trial was stopped after achieving a total number of 30 participants (15 in each group).",100.0
680,PRECIS-2,"The study took place at a large teaching and research hospital in Melbourne, Australia.",fulltext,"The study took place at a large teaching and research hospital in Melbourne, Australia.",100.0
680,PRECIS-2,tailored CBT intervention,fulltext,tailored CBT intervention,100.0
680,PRECIS-2,Inclusion criteria were: 1) having a definite diagnosis of MS from a neurologist; 2) being within 5 years of receiving a diagnosis of MS; 3) scoring at least 10 on the Beck Depression Inventory-II (BDI-II) [26]; 4) not currently undertaking other psychological treatment for depressive or anxiety symptoms for the length of participation in the current trial; 5) speak English fluently; 6) no current or lifetime diagnosis of psychosis; 7) no current substance dependency; 8) no gross cognitive impairment; and 9) no changes to medications prior and during involvement in the trial.,fulltext,Inclusion criteria were: 1) having a definite diagnosis of MS from a neurologist; 2) being within 5 years of receiving a diagnosis of MS; 3) scoring at least 10 on the Beck Depression Inventory-II (BDI-II) [26]; 4) not currently undertaking other psychological treatment for depressive or anxiety symptoms for the length of participation in the current trial; 5) speak English fluently; 6) no current or lifetime diagnosis of psychosis; 7) no current substance dependency; 8) no gross cognitive impairment; and 9) no changes to medications prior and during involvement in the trial.,100.0
680,PRECIS-2,"All participants in the intervention (n=15) reported having a very strong therapeutic alliance with the psychologist (X=102.33, SD=9.59). All participants in the CBT intervention reported reading and completing most of the materials provided for homework and reported that the intervention was 'very useful', that all of the 8 intervention sessions were 'much to very much' useful and beneficial, that they would 'definitely' recommend the intervention to a close friend who had MS and that the early intervention should be offered as part of routine care straight after diagnosis.",fulltext,"ervention All participants in the intervention (n = 15) reported having a very strong therapeutic alliance with the psychologist (X = 102.33, SD = 9.59). All participants in the CBT intervention reported reading and completing all of the materials provided for homework and reported that the intervention was ‘very useful’, that all of the 8 intervention sessions were ‘much to very much’ useful and beneficial, that they would ‘definitely’ recommend the intervention to a close friend who had MS and that the early intervention should be offered as part of routine care straight after ",97.59036144578313
681,PRECIS-2,"Potential participants were excluded if they had experienced exacerbation of their multiple sclerosis symptoms three months prior to the study, or had any medical condition which may preclude them from taking part in the exercise intervention.",fulltext,"Potential participants were excluded if they had experienced exacerbation of their multiple sclerosis symptoms three months prior to the study, or had any medical condition which may preclude them from taking part in the exercise intervention.",100.0
681,PRECIS-2,Participants worked at a self-regulated pace for each exercise. Participants were provided with exercise progress cards and were asked to record which level they performed each exercise at each session.,fulltext,Participants worked at a self-regulated pace for each exercise. Participants were provided with exercise progress cards and were asked to record which level they performed each exercise at each session.,100.0
681,PRECIS-2,Forty-three potential participants expressed an interest in participating.,fulltext,Forty-three potential participants expressed an interest in participating.,100.0
681,PRECIS-2,Setting: Two community leisure centres.,fulltext,Setting: Two community leisure centres.,100.0
681,PRECIS-2,Of the 873 patients on the clinical register for multiple sclerosis 159 patients were deemed suitable for the study. These people were sent invitation letters and participant information sheets.,fulltext,Of the 873 patients on the clinical register for multiple sclerosis 159 patients were deemed suitable for the study. These people were sent invitation letters and participant information sheets.,100.0
681,PRECIS-2,Each group was led by two instructors (one physiotherapist and one fitness instructor). The same physiotherapist was present at both sites; however fitness instructors were different between sites.,fulltext,Each group was led by two instructors (one physiotherapist and one fitness instructor). The same physiotherapist was present at both sites; however fitness instructors were different between sites.,100.0
681,PRECIS-2,The Timed 25-Foot Walk Test was chosen as the primary outcome measure. The Timed 25-Foot Walk Test measures walking speed over a short distance and has shown good reliability and validity in the multiple sclerosis population as an individual component of the Multiple Sclerosis Functional Composite disability assessment.,fulltext,The Timed 25-Foot Walk Test 35 was chosen as the primary outcome measure. The Timed 25Foot Walk Test measures walking speed over a short distance and has shown good reliability and validity in the multiple sclerosis population as an individual component of the Multiple Sclerosis Functional Composite disability assessment.,99.68847352024922
681,PRECIS-2,The intervention took place at two different geographical locations (Site A and Site B).,fulltext,The intervention took place at two different geographical locations (Site A and Site B).,100.0
681,PRECIS-2,"Outcome measures were carried out within the local hospital's rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).",fulltext,"Outcome measures were carried out within the local hospital's rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).",100.0
681,PRECIS-2,Thirty-two participants with multiple sclerosis randomized into intervention or control groups.,fulltext,Thirty-two participants with multiple sclerosis randomized into intervention or control groups.,100.0
681,PRECIS-2,"The intervention group received 12 weeks of twice weekly, 60-minute group exercise sessions, including mobility, balance and resistance exercises.",fulltext,"The intervention group received 12 weeks of twice weekly, 60-minute group exercise sessions, including mobility, balance and resistance exercises.",100.0
681,PRECIS-2,Attendance of participants at each class was recorded.,fulltext,Attendance of participants at each class was recorded.,100.0
682,PRECIS-2,"As the outcomes were continuous, linear regression was used with study status (missing baseline, drop-out before end, or completer) as the explanatory variable, with baseline only serving as the reference category.",fulltext,"As the outcomes were continuous, linear regression was used with study status (missing baseline, baseline only, drop-out before end, or completer) as the explanatory variable, with baseline only serving as the reference category.",100.0
682,PRECIS-2,"Two different types of exercise interventions were contrasted. MSTEP©, a personally adapted exercise regimen including a variety of exercises targeting endurance, muscular, and core strength, balance, flexibility, muscular power, and speed of movement.",fulltext,"Two different types of exercise interventions were contrasted. MSTEP©, a personally adapted exercise regimen including a variety of exercises targeting endurance, muscular, and core strength, balance, flexibility, muscular power, and speed of movement.",100.0
682,PRECIS-2,"Main measures: Primary outcome was peak oxygen consumption (VO2peak) at 12 months; secondary outcomes were composite measures of physical function, fatigue, and health-related quality of life.",fulltext,"Main measures: Primary outcome was peak oxygen consumption (VO 2peak ) at 12 months; secondary outcomes were composite measures of physical function, fatigue, and health-related quality of life.",100.0
682,PRECIS-2,The target population was community dwelling individuals aged 19 to 65 who have been diagnosed after 1994 with multiple sclerosis.,fulltext,The target population was community dwelling individuals aged 19 to 65 who have been diagnosed after 1994 with multiple sclerosis.,100.0
682,PRECIS-2,Full details on the measures are presented in the protocol publication.9 The primary outcome was exercise capacity as measured by peak oxygen consumption (VO2peak) using a modified Bruce protocol on the cycle ergometer.,fulltext,Full details on the measures are presented in the protocol publication. 9 The primary outcome was exercise capacity as measured by peak oxygen consumption (VO 2peak ) using a modified Bruce protocol on the cycle ergometer.,100.0
682,PRECIS-2,Excluded were people who were (1) unable to speak and read English or French; (2) unable to respond to simple questions on orientation and memory; (3) have an additional illness that restricts their function; and/or (4) experienced a relapse during the past 30 days as this may affect physical activity/exercise participation.,fulltext,Excluded were people who were (1) unable to speak and read English or French; (2) unable to respond to simple questions on orientation and memory; (3) have an additional illness that restricts their function; and/or (4) experienced a relapse during the past 30 days as this may affect physical activity/exercise participation.,100.0
682,PRECIS-2,"All participants were contacted every two weeks during the first two months, then monthly thereafter by the exercise instructor by telephone or email for follow-up by the instructor. The purpose of follow-up contacts is to provide an opportunity to ask any questions they have and also to facilitate long-term retention in the study.",fulltext,"All participants were contacted every two weeks during the first two months, then monthly thereafter by the exercise instructor by telephone or email for follow-up by the instructor. The purpose of follow-up contacts is to provide an opportunity to ask any questions they have and also to facilitate long-term retention in the study.",100.0
682,PRECIS-2,The purpose of follow-up contacts is to provide an opportunity to ask any questions they have and also to facilitate long-term retention in the study.,fulltext,The purpose of follow-up contacts is to provide an opportunity to ask any questions they have and also to facilitate long-term retention in the study.,100.0
682,PRECIS-2,"Multiple imputation was used for missing data with 11 imputations used in the analysis. The primary analysis was of the proportion of people making an absolute improvement at the final time point, 12 months.",fulltext,"Multiple imputation was used for missing Mayo et al. 5 data with 11 imputations used in the analysis. The primary analysis was of the proportion of people making an absolute improvement at the final time point, 12 months.",100.0
682,PRECIS-2,"People were identified multiple sclerosis clinics in Montreal, Toronto, Winnipeg.",fulltext," were identified multiple sclerosis clinics in Montreal, Toronto, Winnipeg.",92.5925925925926
682,PRECIS-2,"As there were substantial losses to follow-up, only results after one year are presented.",fulltext,"As there were substantial losses to follow-up, only results after one year are presented.",100.0
682,PRECIS-2,"As there were four visits during the first year with four opportunities for missing data, the first set of analyses addressed whether the pattern of missing data was associated with the outcomes measured in this study.",fulltext,"As there were four visits during the first year with four opportunities for missing data, the first set of analyses addressed whether the pattern of missing data was associated with the outcomes measured in this study.",100.0
682,PRECIS-2,People were recruited from four multiple sclerosis clinics in three Canadian cities and from posting on media sites.,fulltext,People were recruited from four multiple sclerosis clinics in three Canadian cities and from posting on media sites.,100.0
682,PRECIS-2,"Specific inclusion criteria were (1) ambulatory (can walk 100 m, be capable of walking 100 metres without a walking aid corresponding to a classification of ⩽5.5 on the Expanded Disability Status Scale (EDSS),10 even if they do use an aid for daily activities; and (2) self-reported to be sedentary or irregularly active at time of study entry (i.e. do not exercise 30 minutes or more twice per week of moderate to vigorous activity).",fulltext,"Specific inclusion criteria were (1) ambulatory (can walk 100 m, be capable of walking 100 metres without a walking aid corresponding to a classification of ⩽5.5 on the Expanded Disability Status Scale (EDSS), 10 even if they do use an aid for daily activities; and (2) self-reported to be sedentary or irregularly active at time of study entry (i.e. do not exercise 30 minutes or more twice per week of moderate to vigorous activity).",100.0
682,PRECIS-2,"For the MSTEP© group, the sessions were used to assess individual needs and design an individualized programme. For the Guideline group, the sessions were used to instruct on the guidelines and learn how to apply principles of safe and effective exercise. All were provided with a portfolio of exercise instructions.",fulltext,"For the MSTEP© group, the sessions were used to assess individual needs and design an individualized programme. For the Guideline group, the sessions were used to instruct on the guidelines and learn how to apply principles of safe and effective exercise. All were provided with a portfolio of exercise instructions.",100.0
682,PRECIS-2,"All were provided with a portfolio of exercise instructions. All participants were contacted every two weeks during the first two months, then monthly thereafter by the exercise instructor by telephone or email for follow-up by the instructor. The purpose of follow-up contacts is to provide an opportunity to ask any questions they have and also to facilitate long-term retention in the study.",fulltext,"All were provided with a portfolio of exercise instructions. All participants were contacted every two weeks during the first two months, then monthly thereafter by the exercise instructor by telephone or email for follow-up by the instructor. The purpose of follow-up contacts is to provide an opportunity to ask any questions they have and also to facilitate long-term retention in the study.",100.0
682,PRECIS-2,The intention was to follow participants for the first year of the intervention when the exercise programme was designed and adjusted as needed and have a further follow-up after the second year.,fulltext,The intention was to follow participants for the first year of the intervention when the exercise programme was designed and adjusted as needed ,73.84615384615385
684,PRECIS-2,"Subjects: Thirty people moderately to severely affected by MS (Extended Disability Status Score, EDSS, 6.5–8) were randomized to an intervention or control group.",fulltext,"Subjects: Thirty people moderately to severely affected by MS (Extended Disability Status Score, EDSS, 6.5–8) were randomized to an intervention or control group.",100.0
684,PRECIS-2,"Subjects in both groups were assessed at the beginning and at the end of the eight-week intervention period (i.e. either physiotherapy or control) and then again eight weeks later. To improve the reliability of the data, all assessments were undertaken at the Douglas Grant Rehabilitation Centre, Irvine, and the assessor remained blind to the subjects' treatment group allocation.",fulltext,"Subjects in both groups were assessed at the beginning and at the end of the eight-week intervention period (i.e. either physiotherapy or control) and then again eight weeks later. To improve the reliability of the data, all assessments were undertaken at the Douglas Grant Rehabilitation Centre, Irvine, and the assessor remained blind to the subjects’ treatment group allocation.",100.0
684,PRECIS-2,The control group were not offered the intervention at the end of the study.,fulltext,The control group were not offered the intervention at the end of the study.,100.0
684,PRECIS-2,"Subjects were asked not to discuss their allocation with the assessor. Demographic information including gender, age, time since diagnosis, type of MS and medication history was recorded at baseline and the outcome measures (below) were taken at each of the three assessments.",fulltext,"Subjects were asked not to discuss their group allocation with the assessor. Demographic information including gender, age, time since diagnosis, type of MS and medication history was recorded at baseline and the outcome measures (below) were taken at each of the three assessments.",100.0
684,PRECIS-2,"Potential subjects were excluded if they had rapidly progressive disease, were already involved in a physiotherapy programme, had additional neurological conditions or other medical conditions which would preclude them taking part in the study.",fulltext,"Potential subjects were excluded if they had rapidly progressing disease, were already involved in a physiotherapy programme, had additional neurological conditions or other medical conditions which would preclude them taking part in the study.",99.18032786885246
684,PRECIS-2,"All outcome variables were summarized and comparisons made between groups and over time. Outcome variables that could be shown to be analysed using parametric procedures (e.g. FIM), were analysed using a two-factor repeated measures ANOVA with two factors being time (0, 8 and 16) and group (1,2), thus allowing for possible interaction effects to assess whether groups react differently over time.",fulltext,"All outcome variables were summarized and comparisons made between groups and over time. Outcome variables that could be shown to be analysed using parametric procedures (e.g. FIM), were analysed using a two-factor repeated measures ANOVA with the two factors being time (0, 8 and 16) and group (1,2), thus allowing for possible interaction effects to assess whether groups react differently over time.",100.0
684,PRECIS-2,Setting: Community; subjects' homes.,fulltext,Setting: Community; subjects' homes.,100.0
684,PRECIS-2,"Subjects assigned to Group 1 received physiotherapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist within their home. Each session lasted up to 60 minutes, and a task-specific programme included upper and lower limb strengthening using theraband, mobile pedals, and weights.",fulltext,"Subjects assigned to Group 1 received physiotherapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist within their home. Each session lasted up to 60 minutes, and a task-specific programme included upper and lower limb strengthening using theraband, mobile pedals, and weights.",100.0
684,PRECIS-2,"Main measures: The following outcome measures were recorded at baseline, post-intervention (Week 8) and at follow-up (Week 16). Primary outcome measure: Multiple Sclerosis Impact Scale (MSIS29) and secondary outcome measures assessed physical impairment, MS symptoms, quality of life, mood, and disability.",fulltext,"Main measures: The following outcome measures were recorded at baseline, post-intervention (Week 8) and at follow-up (Week 16). Primary outcome measure: Multiple Sclerosis Impact Scale (MSIS29) and secondary outcome measures assessed physical impairment, MS symptoms, quality of life, mood, and disability.",100.0
684,PRECIS-2,"Each session lasted up to 60 minutes, and a task-specific programme included upper and lower limb strengthening using theraband, mobile pedals, and weights. Repetition of tasks such as sit to stand, gait, balance (using gym balls and sit fits) and stretching activities were used depending on the subjects previously identified goals.",fulltext,"Each session lasted up to 60 minutes, and a task-specific programme included upper and lower limb strengthening using theraband, mobile pedals, and weights. Repetition of tasks such as sit to stand, gait, balance (using gym balls and sit fits) and stretching activities were used depending on the subjects previously identified goals.",100.0
684,PRECIS-2,"The MS impact scale (MSIS 29), which is a measure of the physical and psychological impact of MS,12 was the primary outcome measure for the study.",fulltext,"The MS impact scale (MSIS 29), which is a measure of the physical and psychological impact of MS, 12 was the primary outcome measure for the study.",100.0
685,PRECIS-2,Topics in the booklet covered many domains of life from the physical (e.g. mobility and exercises) to the social and the psychological (e.g. strategies to cope with stress). As findings from the Delphi study highlighted the need for flexibility and responsiveness to individuals the format of the discussion focused on individuals' interests and concerns rather than on covering all the information contained in the booklet.,fulltext,Topics in the booklet covered many domains of life from the physical (e.g. mobility and exercises) to the social and the psychological (e.g. strategies to cope with stress). As  ndings from the Delphi study highlighted the need for  exibility and responsiveness to individuals the format of the discussion focused on individuals’ interests and concerns rather than on covering all the information contained in the booklet.,99.05660377358491
685,PRECIS-2,"Individuals were assigned to group or one to one sessions by the health professional in consultation with each person, and based on their needs and wishes. Sessions were conducted either at participants' homes or in local therapy centres.",fulltext,"Individuals were assigned to group or one to one sessions by the health professional in consultation with each person, and based on their needs and wishes. Sessions were conducted either at participants’ homes or in local therapy centres.",100.0
685,PRECIS-2,The SDDR was developed out of the MRC Standard Day Interview and measures the extent to which people are assisted in activities of daily living.,fulltext,The SDDR was developed out of the MRC Standard Day Interview 14 and measures the extent to which people are assisted in activities of daily living.,100.0
685,PRECIS-2,"Changes in health status were small. However, at follow-up the intervention group had better SF-36 health scores, in mental health (p = 0.04), and vitality (p = 0.05) and considered help with daily activities to be less essential, as measured by the SDDR (p = 0.04), than the control group.",fulltext,"Changes in health status were small. However, at follow-up the intervention group had better SF-36 health scores, in mental health (p = 0.04), and vitality (p = 0.05) and considered help with daily activities to be less essential, as measured by the SDDR (p = 0.04), than the control group.",100.0
685,PRECIS-2,It was not possible to perform an 'intention to treat' analysis as those individuals who declined the intervention also withdrew from follow-up and therefore did not complete any follow-up assessments.,fulltext,It was not possible to perform an 'intention to treat' analysis as those individuals who declined the intervention also withdrew from follow-up and therefore did not complete any follow-up assessments.,100.0
685,PRECIS-2,Participants were invited to join the study and were accepted if they returned consent forms given in writing.,fulltext,Participants were invited to join the study and were accepted when informed consent had been given in writing.,86.36363636363636
685,PRECIS-2,"Participants were volunteers with MS who were recruited through voluntary organizations, who are community based and lived in West London and in counties contiguous with Greater London.",fulltext,"Participants were volunteers with MS who were recruited through voluntary organizations, were community based and lived in West London and in counties contiguous with Greater London.",97.83783783783784
685,PRECIS-2,The only selection criterion was that the diagnosis of MS was confirmed by the general practitioner. There were no exclusion criteria.,fulltext,The only selection criterion was that the diagnosis of MS was con rmed by the general practitioner. There were no exclusion criteria.,98.50746268656717
685,PRECIS-2,"The intervention comprised discussion of self-care based on client priorities, using an information booklet about self-care.",fulltext,"The intervention comprised discussion of self-care based on client priorities, using an information booklet about self-care.",100.0
685,PRECIS-2,Assessments were conducted at baseline and again six months later.,fulltext,Assessments were conducted at baseline and again six months later.,100.0
685,PRECIS-2,The self-care programme primarily comprised a discussion of self-care strategies supported by an information booklet developed for the study in line with consumer priorities.,fulltext,The self-care programme primarily comprised a discussion of self-care strategies supported by an information booklet developed for the study in line with consumer priorities.,100.0
685,PRECIS-2,"The study was a community-based research study, which was approved by the appropriate local research ethics committees, and was conducted at the Centre for Research in Rehabilitation at Brunel University's Osterley Campus in West London from June 1996 until February 1999.",fulltext," was a community-based research study, which was approved by the appropriate local research ethics committees, and was conducted at the Centre for Research in Rehabilitation at Brunel University’s Osterley Campus in West London from June 1996 until February 1999.",96.69117647058823
685,PRECIS-2,Seventy-three (43.2%) individuals in the intervention group and 96 (56.8%) individuals in the control group completed the trial.,fulltext,Seventy-three (43.2%) individuals in the intervention group and 96 (56.8%) individuals in the control group completed the trial.,100.0
685,PRECIS-2,"A range of physical and psychological scales was included in order to obtain a comprehensive evaluation of the intervention. Total scores on a postal version of the Barthel Index, a scale measuring mobility, the United Kingdom version of the SF-36 and one measure developed for the study; the Standard Day Dependency Record (SDDR), were the main outcome measures.",fulltext,"A range of physical and psychological scales was included in order to obtain a comprehensive evaluation of the intervention. Total scores on a postal version of the Barthel Index, 11 a scale measuring mobility, 12 the United Kingdom version of the SF-36 13 and one measure developed for the study; the Standard Day Dependency Record (SDDR), were the main outcome measures.",100.0
685,PRECIS-2,The study was conducted with people with MS living in the community.,fulltext,The study was conducted with people with MS living in the community.,100.0
686,PRECIS-2,"The primary outcome was the change in QoL from inclusion to M6, assessed by the Multiple Sclerosis Impact Scale (MSIS-29) self-questionnaire. The MSIS-29 is a validated, reproducible and specific MS QoL scale4–5 that consists of 29 simple questions including eight questions on motor function, cognitive function, urinary and bowel trouble, social, emotional and mobility). A higher MSIS-29 score corresponds to lower QoL. The questionnaire takes 25 minutes to complete.",fulltext,"months. The primary outcome was the change in QoL from inclusion to M6, assessed by the Multiple Sclerosis Impact Scale (MSIS-29) self-questionnaire. The MSIS-29 is a validated, reproducible and specific MS QoL scale 35 that consists of 29 simple questions including six different subdomains (fatigue, cognitive function, urinary and bowel trouble, social, emotional and mobility). A higher MSIS-29 score corresponds to lower QoL. The questionnaire takes 25 minutes to c",93.61702127659575
686,PRECIS-2,as treated,prompt,as treated,100.0
686,PRECIS-2,"For the sample size, calculations were based on a preliminary study,12 including 40 MS patients. In this pilot study a mean improvement of 10 points over six months on the MSIS-29 scale in the IMD group and a mean worsening of six points in the control group was observed. The standard deviation for the change in the MSIS-29 was 14 points. With the same hypotheses, 22 patients per group were necessary to provide the study a power of 90% with a type 1 error rate of 0.05. To take into account a possible dropout rate, we randomized 25 patients per group.",fulltext,"ical analyses For the sample size, calculations were based on a preliminary study 12 including 40 MS patients. In this pilot study a mean improvement of 10 points over six months on the MSIS-29 scale in the IMD group and a mean worsening of six points in the control group was observed. The standard deviation for the change in the MSIS-29 was 14 points. With the same hypotheses, 22 patients per group were necessary to provide the study a power of 90% with a type 1 error rate of 0.05. To take into account a possible dropout rate, we randomized 25 patie",97.48201438848922
686,PRECIS-2,MS patients from the outpatient clinic of the Neurology Department of Pitié-Salpêtrière Hospital were prospectively enrolled in the study between March 1st to July 2012.,fulltext,ents MS patients from the outpatient clinic of the Neurology Department of Pitie´-Salpeˆtrie`re Hospital were prospectively enrolled in the study between M,85.20710059171599
686,PRECIS-2,"MS patients from the outpatient clinic of the Neurology Department of Pitié-Salpêtrière Hospital were prospectively enrolled in the study between March 1st to July 2012. Inclusion criteria were: having MS (MacDonald criteria); being able to complete a questionnaire; and being in need for a multidisciplinary approach, defined by the requirement, in addition to the neurology specialist, of at least two different medical (rehabilitation specialist, neurourology specialist, psychiatrist) or allied health professionals (physiotherapist, occupational therapist, social worker, psychologist, and neuropsychologist).",fulltext,"ents MS patients from the outpatient clinic of the Neurology Department of Pitie´-Salpeˆtrie`re Hospital were prospectively enrolled in the study between March 2010 and July 2012. Inclusion criteria were: having MS (MacDonald criteria); being able to complete a questionnaire; and being in need for a multidisciplinary approach, defined by the requirement, in addition to the neurology specialist, of at least two different medical (rehabilitation specialist, neurourology specialist, psychiatrist) or allied health professionals (physiotherapist, occupational therapist, social worker, psychologist, and neuropsycholo",97.8827361563518
686,PRECIS-2,Patients in the community were excluded.,fulltext,g independently in the community were exc,75.0
686,PRECIS-2,"At the end of the inclusion visit (conducted by the evaluating neurologist participating in the multidisciplinary team), the patient was randomized via a central Web-based randomization system. Treatment was allocated according to a computer-generated randomization list in a 1:1 ratio. Patients were then randomized in two groups depending on the treatment strategy: (i) an integrated multidisciplinary (IMD) group, consisting of an IMD approach at the Pitié-Salpêtrière MS clinic, and (ii) a control group, consisting of successive, non-integrated interventions with different specialists and allied health professionals, at different times and sites (Figure 1). For patients in the IMD group, the multidisciplinary integrated outpatient clinic was planned at our MS clinic within a maximum three-month period after inclusion.",fulltext,"sion. At the end of the inclusion visit (conducted by the evaluating neurologist not participating in the multidisciplinary team), the patient was randomized via a central Web-based randomization system. Treatment was allocated according to a computer-generated randomization list in a 1:1 ratio. Patients were then randomized in two groups depending on the treatment strategy: (i) an integrated multidisciplinary (IMD) group, consisting of an IMD approach at the Pitie´-Salpeˆtrie`re MS clinic, and (ii) a control group, consisting of successive, non-integrated interventions with different specialists and allied health professionals, at different times and sites (Figure 1). For patients in the IMD group, the multidisciplinary integrated outpatient clinic was planned at our MS clinic within a maximum three-month period after inc",98.79227053140096
687,PRECIS-2,"Following baseline assessments, described below, participants were allocated to either Group 1 (intervention) who received 12 weeks of individualised web-based exercise or Group 2 (control) who received usual care.",fulltext,"Following baseline assessments, described below, participants were allocated to either Group 1 (intervention) who received 12 weeks of individualised web-based exercise or Group 2 (control) who received usual care.",100.0
687,PRECIS-2,Participants were advised to undertake the exercise programme a minimum of twice a week and to complete their online exercise diary which was seen remotely by the physiotherapist.,fulltext,Participants were advised to undertake the exercise programme a minimum of twice a week and to complete their online exercise diary which was seen remotely by the physiotherapist.,100.0
687,PRECIS-2,"Individualised therapeutic exercise programmes were developed for participants in Group 1, with exercises selected based on their baseline assessment and personal goals. Participants were given unique log-in details to view their own, online personalised exercise programme.",fulltext,"Individualised therapeutic exercise programmes were developed for participants in Group 1, with exercises selected based on their baseline assessment and personal goals. Participants were given unique log-in details to view their own, online personalised exercise programme.",100.0
687,PRECIS-2,"Individualised therapeutic exercise programmes were developed for participants in Group 1, with exercises selected based on their baseline assessment and personal goals.",fulltext,"Individualised therapeutic exercise programmes were developed for participants in Group 1, with exercises selected based on their baseline assessment and personal goals.",100.0
687,PRECIS-2,"Outcome measures were recorded at baseline and at the end of the intervention period (week 13). The primary outcome measure, the timed 25 foot walk,14 has good reliability and validity in the MS population.",fulltext,"Outcome measures were recorded at baseline and at the end of the intervention period (week 13). The primary outcome measure, the timed 25 foot walk, 14 has good reliability and validity in the MS population.",100.0
687,PRECIS-2,Thirty community dwelling adults moderately affected by MS (Expanded Disability Status Scale 5-6.5).,fulltext,Thirty community dwelling adults moderately affected by MS (Expanded Disability Status Scale 5-6.5).,100.0
687,PRECIS-2,"The website, which was used to deliver the intervention, was developed in collaboration with a patient steering group and incorporating recommendations from the MS Society accessibility policy and advice from the Scottish Accessible Information Forum.",fulltext,"The website, which was used to deliver the intervention, was developed in collaboration with a patient steering group and incorporating recommendations from the MS Society accessibility policy and advice from the Scottish Accessible Information Forum.",100.0
687,PRECIS-2,"Ethical approval was received from the West of Scotland Research Ethics Service (ref: 12/WS/0147) and participants were recruited from the Multiple Sclerosis Service, at the Douglas Grant Rehabilitation Centre, Irvine, Scotland.",fulltext,"Ethical approval was received from the West of Scotland Research Ethics Service (ref: 12/ WS/0147) and participants were recruited from the Multiple Sclerosis Service, at the Douglas Grant Rehabilitation Centre, Irvine, Scotland.",100.0
687,PRECIS-2,"Participants were contacted by the physiotherapist each week to discuss progress and update their exercise programme as appropriate by changing any combination of the exercises, level of difficulty or number of repetitions.",fulltext,"Participants were contacted by the physiotherapist each week to discuss progress and update their exercise programme as appropriate by changing any combination of exercises, level of difficulty or number of repetitions.",98.20627802690582
687,PRECIS-2,Setting: Rehabilitation centre and participants' homes.,fulltext,Setting: Rehabilitation centre and participants' homes.,100.0
687,PRECIS-2,"The primary outcome measure, the timed 25 foot walk,14 has good reliability and validity in the MS population.",fulltext,"The primary outcome measure, the timed 25 foot walk, 14 has good reliability and validity in the MS population.",100.0
688,PRECIS-2,"Ninety seven consecutive patients were assessed for suitability by the coordinator of the home based care team (LP). Written informed consent was obtained for entry into the trial from the patients and, when appropriate, from their carers.",fulltext,"le patients were assessed for suitability by the coordinator of the home based care team (LP). Written informed consent was obtained for entry into the trial from the patients and, when appropriate, from their carers.",90.3765690376569
688,PRECIS-2,The study was conducted in Rome and was approved by the ethics committee of La Sapienza University.,fulltext,The study was conducted in Rome and was approved by the ethics committee of La Sapienza University.,100.0
688,PRECIS-2,These were provided with cell phones and could easily be reached for advice (telephone intervention) or direct face to face intervention when required.,fulltext,These were provided with cell phones and could easily be reached for advice (telephone intervention) or direct face to face intervention when required.,100.0
688,PRECIS-2,"At the end of a one year follow up period, all patients underwent the same comprehensive interview as at baseline.",fulltext,"At the end of a one year follow up period, all patients underwent the same comprehensive interview as at baseline.",100.0
688,PRECIS-2,"Baseline data for intervention and control groups were compared using a χ2 test for categorical variables, a t test for normally distributed continuous variables, and the Wilcoxon rank-sum test for abnormally distributed variables.",fulltext,"Baseline data for intervention and control groups were compared using a χ 2 test for categorical variables, a t test for normally distributed continuous variables, and the Wilcoxon rank-sum test for abnormally distributed variables",99.56709956709958
688,PRECIS-2,"A dedicated phone number was available five days a week from 9 am to 5 pm, where an operator addressed questions or concerns from patients and caregivers and contacted an on-call neurologist if needed.",fulltext,"A dedicated phone number was available five days a week from 9 am to 5 pm, where an operator addressed questions or concerns from patients and caregivers and contacted th",84.07960199004975
688,PRECIS-2,"Patients underwent the same comprehensive medical, functional, neurological and psychological assessments at baseline and at 12 months.",fulltext,"tion, neurological and psychological assessment, cognitive and ",41.48148148148149
688,PRECIS-2,Ninety seven consecutive patients were assessed for suitability by the coordinator of the home based care team (LP).,fulltext,le patients were assessed for suitability by the coordinator of the home based care team (LP).,80.17241379310344
688,PRECIS-2,"The patients were randomised to home (intervention) or hospital care (control) in a ratio of 2:1, in order to ensure that the home care population was sufficiently represented.",fulltext,"The patients were randomised to home (intervention) or hospital care (control) in a ratio of 2:1, in order to ensure that the home care population was sufficiently represented.",100.0
688,PRECIS-2,"Functional outcomes were calculated as the mean change of scores from baseline to the final follow up at 12 months. No significant differences between intervention and control groups were detected for outcome measures, including EDSS, FIM, MMSE, CDQ, FSS, STAI, and STAXI.",fulltext,"Functional outcomes were calculated as the mean change of scores from baseline to the final follow up at 12 months. No significant differences between intervention and control groups were detected for outcome measures, including EDSS, FIM, MMSE, CDQ, FSS, STAI, and STAXI.",100.0
688,PRECIS-2,"Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.",fulltext,"Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.",100.0
688,PRECIS-2,A minority of refusers (n = 34) did not consent to participate because they were referred to the multiple sclerosis centres only for a second opinion but were regularly followed by their own neurologists.,fulltext,A minority of refusers (n = 34) did not consent to take part to the study because they were referred to the multiple sclerosis centres only for a second opinion but were regularly followed by their own neurologists.,97.54901960784314
689,PRECIS-2,Eighty-five treatment-naïve people with Multiple Sclerosis with persistent (>three months) foot drop.,fulltext,Eighty-five treatment-naïve people with Multiple Sclerosis with persistent (>three months) foot drop.,100.0
689,PRECIS-2,"Electrode position, pulse width, waveform and ramping parameters were adjusted for each participant in order to achieve a comfortable and efficient muscle contraction. The current amplitude ranged from 7 to 72 mA (mean = 40 mA).",fulltext,"Electrode position, pulse width, waveform and ramping parameters were adjusted for each participant in order to achieve a comfortable and efficient muscle contraction. The current amplitude ranged from 7 to 72 mA (mean = 40 mA).",100.0
689,PRECIS-2,"Participants in both groups were assessed and fitted with an Odstock Dropped Foot Stimulator Pace (OML, Salisbury) device by a physiotherapist experienced in functional electrical stimulation (A.L.). Wired heel switches and a stimulation frequency of 40 Hz were applied. Electrode position, pulse width, waveform and ramping parameters were adjusted for each participant in order to achieve a comfortable and efficient muscle contraction.",fulltext,"Participants randomized to the functional electrical stimulation group were assessed and fitted with an Odstock Dropped Foot Stimulator Pace (OML, Salisbury) device by a physiotherapist experienced in functional electrical stimulation (A.L.). Wired heel switches and a stimulation frequency of 40 Hz were applied. Electrode position, pulse width, waveform and ramping parameters were adjusted for each participant in order to achieve a comfortable and efficient muscle contraction.",99.31506849315068
689,PRECIS-2,"Outcome measures were administered by two unblinded assessors (Rebecca Hunter and A.L.) at baseline (0), 3, 6 and 12 months, except for the Psychological Impact of Assistive Devices Score15 which was administered at 12 months only.",fulltext,"Outcome measures were administered by two unblinded assessors (Rebecca Hunter and A.L.) at baseline (0), 3, 6 and 12 months, except for the Psychological Impact of Assistive Devices Score 15 which was administered at 12 months only.",100.0
689,PRECIS-2,Participants were instructed to gradually increase the wear of their devices over the first six weeks.,fulltext,Participants in both groups were instructed to gradually increase the wear of their devices over the first six weeks.,100.0
689,PRECIS-2,The primary outcome was walking speed as measured by the 5-minute self-selected walk test.,fulltext,The primary outcome was walking speed as measured by the 5-minute self-selected walk test.,100.0
689,PRECIS-2,"Participants walked at their preferred walking speed around a 9.5 m elliptical course for 5 minutes, resulting in a 10-meter shuttle length.",fulltext,"Participants walked at their preferred walking speed around a 9.5 m elliptical course for 5 minutes, resulting in a 10-meter shuttle length.",100.0
689,PRECIS-2,"A Restricted Maximum Likelihood approach to fitting mixed models was employed to allow intention to treat assumptions to cope with missing data. All analysis was performed on IBM SPSS v24, using a 5% level of significance (IBM, New York, USA).",fulltext,"A Restricted Maximum Likelihood approach to fitting mixed models was employed to allow intention to treat assumptions to cope with missing data. All analysis was performed on IBM SPSS v24, using a 5% level of significance (IBM, New York, USA).",100.0
689,PRECIS-2,"Potential participants were screened for eligibility, and written informed consent was gained prior to randomization. Participants were randomly assigned (1:1) to receive an ankle-foot orthosis or functional electrical stimulation device, by selecting the next envelope from 85 randomly ordered prefilled sealed opaque envelopes.",fulltext,"Potential participants were screened for eligibility, and written informed consent was gained prior to randomization. Participants were randomly assigned (1:1) to receive an ankle-foot orthosis or functional electrical stimulation device, by selecting the next envelope from 85 randomly ordered prefilled sealed opaque envelopes.",100.0
689,PRECIS-2,"Participants were screened for eligibility, and written informed consent was gained prior to randomization.",fulltext,"participants were screened for eligibility, and written informed consent was gained prior to randomization.",100.0
689,PRECIS-2,Setting: Seven Multiple Sclerosis outpatient centres across Scotland.,fulltext,Setting: Seven Multiple Sclerosis outpatient centres across Scotland.,100.0
690,PRECIS-2,"After a comprehensive assessment of the dyad needs based on direct observation and (available via the eCRF), the HPA team defined the contents of the intervention, involving the dyad and the patient caring physician or emergency medical services.",fulltext,"After a comprehensive assessment of the dyad needs based on direct observation and on visit 1 information (available via the eCRF), the HPA team defined the contents of the intervention, involving the dyad and the patient caring physician (the intervention was not intended to replace existing services)",95.9349593495935
690,PRECIS-2,"The pre-specified primary endpoints were changes in patient quality of life (SEIQoL-DW) and symptom burden (PC Outcome Scale-Symptoms-MS, POS-S-MS).",fulltext,"The pre-specified primary endpoints were changes in patient quality of life (SEIQoL-DW) and symptom burden (PC Outcome Scale-Symptoms-MS, POSS-MS).",99.32432432432432
690,PRECIS-2,The protocol was approved by the local ethics committees and the study was undertaken in accordance with the Declaration of Helsinki.,fulltext,The protocol was approved by the local ethics committees and the study was undertaken in accordance with the Declaration of Helsinki.,100.0
690,PRECIS-2,"Participants were non-institutionalized adults (age ⩾ 18 years) with severe MS and their primary carers. Other patient inclusion criteria were primary or secondary progressive MS. Expanded Disability Status Scale (EDSS) score ⩾ 8.0, complex symptoms, and ⩾2 unmet care needs.",fulltext,"Participants were non-institutionalized adults (age ⩾ 18 years) with severe MS and their primary carers. Other patient inclusion criteria were primary or secondary progressive MS, 1,13 Expanded Disability Status Scale (EDSS) score ⩾ 8.0, 14 complex symptoms, 15 and ⩾2 unmet care needs.",100.0
690,PRECIS-2,"3 centers: 1 HPA team for each center. Number of dyads treated: 16 (Milan), 15 (Rome), 19 (Catania)",fulltext,"ss centers (Table 2) except for the number of visits performed by two or more HPs (Milan 4%, Rome 14%, Catani",63.63636363636363
690,PRECIS-2,"Figure 2 reports the pre-specified care needs addressed by the HPA teams, and those fulfilled at the end of the intervention, based on team reports.",fulltext,". Figure 2 reports the pre-specified care needs 16 addressed by the HPA teams, and those fulfilled at the end of the intervention, based on team report",98.64864864864865
690,PRECIS-2,"HPs. On average, dyads received 4.9 home visits in the first 3 months and 2.8 in the second 3 months. The nurse (team leader) performed 152 visits (33%), followed by the psychologist (25%), the physician (25%), and the social worker (17%).",fulltext,"r HPs. On average, dyads received 4.9 home visits in the first 3 months and 2.8 in the second 3 months. The nurse (team leader) performed 152 visits (33%), followed by the psychologist (25%), the physician (25%), and the social worker (17%",99.16317991631799
690,PRECIS-2,"The carer (a family member, relative, or friend of the patient) was his or her next of kin and was designated by the patient except for patients with severe cognitive compromise.",fulltext,"The carer (a family member, relative, or friend of the patient) was his or her next of kin and was designated by the patient except for patients with severe cognitive compromise.",100.0
690,PRECIS-2,"Adults with severe MS-carer dyads were assigned (2:1 ratio) to either HPA or usual care (UC). At each center, a multi-professional team delivered the 6-month intervention.",fulltext,"Adults with severe MS-carer dyads were assigned (2:1 ratio) to either HPA or usual care (UC). At each center, a multi-professional team delivered the 6-month intervention.",100.0
690,PRECIS-2,All team activities (except for HPA team meetings) were performed at patient's home.,fulltext,All activities (except for HPA team meetings) were performed at patient’s hom,91.66666666666666
690,PRECIS-2,Time from randomization to HPA team assessment was shorter in Catania (median 8 days) compared to Milan (11 days) and Rome (12.5 days; p=0.11).,fulltext,j Time from randomization to HPA team assessment was shorter in Catania (median 8 days) compared to Milan (11 days) and Rome (12.5 days; p = 0.,97.9020979020979
690,PRECIS-2,We performed a multicenter RCT involving adults with severe MS and their carers to assess the effectiveness of a home-based palliative approach (HPA) added to usual care (UC).,fulltext,We performed a multicenter RCT involving adults with severe MS and their carers to assess the effectiveness of a home-based palliative approach (HPA) added to usual care (UC).,100.0
690,PRECIS-2,Two-sided p values of less than 0.05 were judged to be significant; p values were not adjusted for multiple comparisons. Analyses were done with Stata (version 13.0) and SAS (version 9.4).,fulltext,Two-sided p values of less than 0.05 were judged to be significant; p values were not adjusted for multiple comparisons. Analyses were done with Stata (version 13.0) and SAS (version 9.4).,100.0
690,PRECIS-2,"The SEIQoL-DW is administered in an interview in which respondents nominate the five areas of life that are most important in determining their QoL, and rate the satisfaction/functioning and weight/importance in each of these areas.",fulltext,"The SEIQoL-DW is administered in an interview in which respondents nominate the five areas of life that are most important in determining their QoL, and rate the satisfaction/functioning and weight/ A Solari, A Giordano et al. journals.sagepub.com/home/msj 3 importance in each of these areas.",100.0
690,PRECIS-2,50 dyads were analysed. 2 dyads were excluded from analysis - 2 did not receive allocated intervention,fulltext, Dyads were randomly assigned (2:1) to receive HPA or UC. Allocat,42.15686274509803
690,PRECIS-2,"At each center, a multi-professional team delivered the 6-month intervention.",fulltext,"At each center, a multi-professional team delivered the 6-month intervention.",100.0
691,PRECIS-2,"The incorporation of flipchart exercises, group discussions and homework activities enables the tailoring of content to the individual circumstances and goals/priorities of group members.",fulltext,"The incorporation of flipchart exercises, group discussions and homework activities enables the tailoring of content to the individual circumstances and goals/priorities of group members.",100.0
691,PRECIS-2,A total of 72 (86%) attended ≥4 sessions and 66 (79%) attended the final session (see online supplementary tables S2a and S2b).,fulltext, A total of 72 (86%) attended ≥ 4 sessions and 66 (79%) attended the final session (see online supplementary tables S2a and S2b),99.21259842519686
691,PRECIS-2,"These were: (1) fatigue severity (Global Fatigue Severity (GFS) subscale of the Fatigue Assessment Instrument (FAI))18 (2) disease-specific quality of life (Multiple Sclerosis Impact Scale (MSIS-29, V.1))19 and (3) self-efficacy for managing fatigue (Multiple Sclerosis-Fatigue Self-Efficacy scale—adapted from the Control subscale of the MS Self-Efficacy scale).",fulltext,"These were: (1) fatigue severity (Global Fatigue Severity (GFS) subscale of the Fatigue Assessment Instrument (FAI)), 18 (2) disease-specific quality of life (QOL) (total score on the Multiple Sclerosis Impact Scale, V.1 (MSIS-29, V.1)) 19 and (3) self-efficacy for managing fatigue (Multiple Sclerosis-Fatigue Self-Efficacy scale—adapted from the Control subscale of the MS Self-Efficacy scale).",100.0
691,PRECIS-2,real-world,prompt,rent would,70.0
691,PRECIS-2,"Apart from one MS specialist nurse, facilitators were either occupational therapists or physiotherapists. Facilitators were all qualified to a senior/advanced level (in the UK minimum of a Band 7 on the NHS Agenda for Change (AfC) grading structure).17 Facilitators were trained to deliver the intervention at a 1-day workshop and were provided with a detailed manual describing all aspects of the intervention.",fulltext,"Apart from one MS specialist nurse, facilitators were either occupational therapists or physiotherapists. Facilitators were all qualified to a senior/advanced level (in the UK minimum of a Band 7 on the NHS Agenda for Change (AfC) grading structure). 17 Facilitators were trained to deliver the intervention at 1-day workshops and psychological advice and debriefing ",85.15815085158151
691,PRECIS-2,The primary 'intention-to-treat' analyses and results for the primary outcome measures are shown in table 2 and online supplementary figure S1.,fulltext, The primary ‘intention-to-treat’ analyses and results for the primary outcome measures are shown in table 2 and online supplementary figure S1,99.3006993006993
691,PRECIS-2,The primary 'intention-to-treat' analyses and results for the primary outcome measures are shown in table 2 and online supplementary figure S1. There were statistically significantly greater improvements in fatigue self-efficacy in the FACETS arm at follow-up 1 compared with the CLP arm.,fulltext, The primary ‘intention-to-treat’ analyses and results for the primary outcome measures are shown in table 2 and online supplementary figure S1. There were statistically significantly greater improvements in fatigue self-efficacy in the FACETS arm at follow-up 1 and 2 compared with the CLP arm,99.65277777777779
691,PRECIS-2,"Participants were recruited via three UK-wide sources (Poole, Bristol, Southampton/Portsmouth) from primary or secondary care, or via MS Society newsletters/websites.",fulltext,"Participants were recruited in three UK centres (Poole, Bristol, Southampton/Portsmouth) from primary or secondary care, or via MS Society newsletters/websites.",93.97590361445783
691,PRECIS-2,"First follow-up data are available for 146 (89%) and second follow-up for 144 (88%). Recruitment was 39 from the Bristol centre, 75 from the Southampton/Portsmouth Centre and 50 from the Poole centre. In all, 84 participants were randomised to FACETS and 80 to CLP. Overall, 10 FACETS programmes were run with group sizes ranging from 4 to 11 (mean=7.4; SD=2.1).",fulltext," First follow-up data are available for 146 (89%) and second follow-up for 144 (88%). Recruitment was 39 from the Bristol centre, 75 from the Southampton/Portsmouth Centre and 50 from the Poole centre. In all, 84 participants were randomised to FACETS and 80 to CLP. Overall, 10 FACETS programmes were run with group sizes ranging from 4 to 11 (mean=7.4; SD=2.1)",99.72375690607734
691,PRECIS-2,A total of 72 (86%) attended ≥4 sessions and 66 (79%) attended the final session (see online supplementary tables S2a and S2b). The reasons for non-attendance are reported in figure 1.,fulltext, A total of 72 (86%) attended ≥ 4 sessions and 66 (79%) attended the final session (see online supplementary tables S2a and S2b). The reasons for non-attendance are reported in figure 1,99.45652173913044
691,PRECIS-2,"FACETS was delivered in hotel meeting-room facilities, with the exception of one centre, where it was held in a hospital.",fulltext,"FACETS was delivered in hotel meeting-room facilities, with the exception of one centre, where it was held in a rehabilitation hospital.",100.0
691,PRECIS-2,"The intervention is highly structured. Each session follows the same general format, namely, facilitator-delivered presentations, flipchart discussions, group activities and homework.",fulltext,"The intervention is highly structured. Each session follows the same general format, namely, facilitator-delivered presentations, flipchart discussions, group activities and homework.",100.0
691,PRECIS-2,Three-centre parallel arm randomised controlled trial with economic evaluation. Patients with MS and fatigue were randomised to FACETS plus current local practice (FACETS) or current local practice alone (CLP) for an additional period of follow-up to 1 year.,fulltext,"Three-centre parallel arm randomised controlled trial with economic evaluation. Patients with MS and significant fatigue were randomised to FACETS plus current local practice (FACETS) or current local practice alone (CLP),",81.3953488372093
691,PRECIS-2,"The main inclusion criteria were: (1) clinically definite MS diagnosis, (2) fatigue impacting on daily life (Fatigue Severity Scale (FSS) score >4)16 and (3) ambulatory. The main exclusion criteria were: (1) having taken part in a fatigue programme in the last year, (2) cognitive impairments, (3) a relapse in the previous 3 months or (4) having started treatment with disease modifying or antidepressant drugs within the previous 3 months.",fulltext,"The main inclusion criteria were: (1) clinically definite MS diagnosis, (2) fatigue impacting on daily life (Fatigue Severity Scale total score >4) 16 and (3) ambulatory. The main exclusion criteria were: (1) having taken part in a fatigue programme in the last year, (2) cognitive impairments, (3) a relapse in the previous 3 months or (4) having started treatment with disease modifying or antidepressant drugs within the previous 3 months.",98.86621315192744
692,PRECIS-2,"Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center. Thirty-five patients (N = 28 Females) were recruited and gave their written consent to participate to this study. Inclusion criteria for the study included (1) a diagnosis of MS, (2) not currently engaged in rehabilitation, therapy or PA program and able to undertake PA without risk-factors (3) aged between 18 and 65 (4) able to give informed consent and to understand French.",fulltext,"Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center. Thirty-five patients (N = 28 Females) were recruited and gave their written consent to participate to this study. Inclusion criteria for the study included (1) a diagnosis of MS, (2) not currently engaged in rehabilitation, therapy or PA program and able to undertake PA without risk-factors (3) aged between 18 and 65 (4) able to give informed consent and to understand French.",100.0
692,PRECIS-2,"When we associate the MFIS score with the duration of the practice of the physical activity within the sessions, we noted, in the II group, no correlation at T1 between MFIS (physical component) and time spent in moderate to-vigorous physical activity (MVPA) per day by accelerometry. In contrast, we found at T2 a statistically significant negative correlation (r = −0.745; p = 0.008) between MFIS (physical component) and MVPA.",fulltext,"When we associate the MFIS score with the duration of the practice of the physical activity within the sessions, we noted, in the II group, no correlation at T1 between MFIS (physical component) and time spent in moderate to-vigorous physical activity (MVPA) per day by accelerometry. In contrast, we found at T2 a statistically significant negative correlation (r = −0.745; p = 0.008) between MFIS (physical component) and MVPA.",100.0
692,PRECIS-2,"The three groups received the same PA program, which was controlled for content and multiple applications of a kinesiologist (OH) at Poissy CHI Hospital (France) and a specialist in physical medicine and rehabilitation (DB) at Raymond-Poincaré Hospital - Garches (France). The PA program was manualized and available as a booklet.",fulltext,"The three groups received the same PA program, which was controlled for contraindications and delivered by a neurologist (OH) at Poissy CHI Hospital (France) and a specialist in physical medicine and rehabilitation (DB) at Raymond-Poincaré Hôpital – Garches (France). The PA program was manualized and available as a booklet.",92.12121212121212
692,PRECIS-2,"In MBI group, we noted no correlation in T1 and T2 between MFIS (physical component) and the time spent practicing PA (MVPA). Finally, in control group, we found at T2 a statistically significant positive correlation (r = 0.640; Puncorrected = 0.025) between MFIS (physical component) and MVPA, but this correlation did not survive when applying stringent adjustment for multiple comparisons across the correlations.",fulltext,"In MBI group, we noted no correlation in T1 and T2 between MFIS (physical component) and the time spent practicing PA (MVPA). Finally, in control group, we found at T2 a statistically significant positive correlation (r = 0.640; Puncorrected = 0.025) between MFIS (physical component) and MVPA, but this correlation did not survive when applying stringent adjustment for multiple comparisons across the correlations.",100.0
692,PRECIS-2,"The three groups received the same PA program, which was controlled for content and multiple applications of a kinesiologist (OH) at Poissy CHI Hospital (France) and a specialist in physical medicine and rehabilitation (DB) at Raymond-Poincaré Hospital - Garches (France). The PA program was manualized and available as a booklet. This program initiated after the primary activmetry measurement and maintained for 8 consecutive weeks with a frequency of 2 h weekly. Practicing sessions took place at home under the supervision of a physical and sports activity trainer specializing in sports training.",fulltext,"The three groups received the same PA program, which was controlled for contraindications and delivered by a neurologist (OH) at Poissy CHI Hospital (France) and a specialist in physical medicine and rehabilitation (DB) at Raymond-Poincaré Hôpital – Garches (France). The PA program was manualized and available as a booklet. This program initiated after the primary actimetry measurement and maintained for 8 consecutive weeks with a frequency of 2 h weekly. Practicing sessions took place at home under the supervision of a physical and sports activity trainer specializing in sports training.",95.50748752079868
692,PRECIS-2,"The aim of this study was to assess the efficacy of a PA program compared to two types of psychological interventions – Mindfulness and Implementation Intention – delivered via internet, in reducing consequences of MS. Effects of practicing were unrelated to degree of impairment (i.e., EDSS level).",fulltext,"The aim of this study was to assess the efficacy of a PA program compared to two types of psychological interventions – Mindfulness and Implementation Intention – delivered via internet, in reducing consequences of MS. Effects of practicing were unrelated to degree of impairment (i.e., EDSS level).",100.0
692,PRECIS-2,"Practicing sessions took place at home under the supervision of a physical and sports activity trainer specializing in sports training. Patients combined muscle building, 20 min of stretching and 20 min of coordination and balance.",fulltext,"Practicing sessions took place at home under the supervision of a physical and sports activity trainer specializing in sports training. Patients combined four activities per week: 40 min of walking, 40 min of muscle building, 20 min of stretching and 20 min of coordination and balance.",100.0
692,PRECIS-2,"Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",fulltext,"Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",100.0
692,PRECIS-2,"Two measurement times are carried out in pre-post intervention, at baseline and after eight weeks.",fulltext,"Two measurement times are carried out in pre-post intervention, at baseline and after eight weeks.",100.0
693,PRECIS-2,"Participants were randomized into SC or yoga group. There were no significant differences in age, gender, type of MS, or EDSS between the two groups. The median age in SC group was 42, median EDSS 4 and median EDSSpyr 4. In yoga group the median age was 41, median EDSS 4.2 and median EDSSpyr 2.5.",fulltext,"study. Participants were randomized into SC or yoga group. There were no significant differences in age, gender, type of MS, or EDSS between the two groups. The median age in SC group was 42, median EDSS 4 and median EDSSpyr 4. In yoga group the median age was 41, median EDSS 4.2 and median EDSSp",97.64309764309765
693,PRECIS-2,"Hatha yoga took place in the facilities of Institute of Rehabilitation, Republic of Slovenia. The program was adjusted for MS patients and was held by a MS specialist nurse who is a yoga instructor with a license for patients with physical disabilities.",fulltext,"point. Hatha yoga took place in the facilities of Institute of Rehabilitation, Republic of Slovenia. The program was adjusted for MS patients and was held by a MS specialist nurse who is a yoga instructor with a license for patients with physical disabi",97.23320158102767
693,PRECIS-2,SC and yoga programs were held under the supervision of two SC instructors with a Slovenian Sports Climbing Committee License. The climbing wall with an inclination of 90° and the height of 5 m was adjusted for patients with physical disabilities by adding numerous and bigger holds.,fulltext, and Care Centre under the supervision of two SC instructors with a Slovenian Sports Climbing Committee License. The climbing wall with an inclination of 90 ◦ and the height of 5 m was adjusted for patients with physical disabilities by adding numerous and bigger,90.81272084805654
693,PRECIS-2,"Twenty patients with relapsing–remitting MS, primary progressive MS or secondary progressive MS, aged 26–50 years, with an EDSS not more than 6 and EDSS pyramidal functions score (EDSSpyr) more than 2 were included in the prospective study.",fulltext,"usion. Twenty patients with relapsing–remitting MS, primary progressive MS or secondary progressive MS, aged 26–50 years, with an EDSS not more than 6 and EDSS pyramidal functions score (EDSSpyr) more than 2 were included in the prospective",97.08333333333333
693,PRECIS-2,The climbing wall with an inclination of 90° and the height of 5 m was adjusted for patients with physical disabilities by adding numerous and bigger holds.,fulltext,cense. The climbing wall with an inclination of 90 ◦ and the height of 5 m was adjusted for patients with physical disabilities by adding numerous and bigger,95.51282051282051
693,PRECIS-2,"Examinations were performed by the members of Multiple Sclerosis Center at the Division of Neurology, University Medical Center Ljubljana. We used the following assessment tools and procedures: The same neurologist specialized in MS care assessed disease disability with EDSS [15] before and after both programs in order to exclude interrater variability.",fulltext,"ssment Examinations were performed by the members of Multiple Sclerosis Center at the Division of Neurology, University Medical Center Ljubljana. We used the following assessment tools and procedures: The same neurologist specialized in MS care assessed disease disability with EDSS [15] before and after both programs in order to exclude interrater varia",98.02816901408451
693,PRECIS-2,"Data were analyzed by SPSS program for Windows®, version 17.0. Wilcoxon signed ranks test was used to compare the difference before and after each program. Statistical significance was set at p ≤ 0.05.",fulltext,"alysis Data were analyzed by SPSS program for Windows ® , version 17.0. Wilcoxon signed ranks test was used to compare the difference before and after each program. Statistical significance was set at p ",96.51741293532339
693,PRECIS-2,"The aim of our study was to evaluate the influence of SC and yoga on spasticity, cognitive function, mood and fatigue in MS patients.",fulltext,"ussion The purpose of our study was to determine the possible effects of SC and yoga on spasticity, cognitive function, mood and fatigue in pa",82.70676691729324
693,PRECIS-2,Both programs were held once a week for 10 weeks. Participants were asked to attend at least 9 out of 10 SC or yoga sessions.,fulltext,Both programs were held once a week for 10 weeks. Participants were asked to attend at least 9 out of 10 SC or yoga sessions.,100.0
694,PRECIS-2,"The primary endpoint was the change in the BBS (Berg Balance Scale) (0–13 (difference from BBS baseline to week 12). Secondary endpoints were changes from baseline in fatigue (Fatigue Severity Scale (FSS)),14,15 health-related quality of life (Multiple Sclerosis Quality of Life-54 (MSQoL-54)),16 pain (Visual Analogue Scale (VAS)),17,18 and spasticity (Numeric Rating Scale (NRS)).",fulltext,"The primary endpoint was the change in the BBS 10–13 (difference from BBS baseline to week 12). Secondary endpoints were changes from baseline in fatigue (Fatigue Severity Scale (FSS)), 14,15 health-related quality of life (Multiple Sclerosis Quality of Life-54 (MSQoL-54)), 16 pain (Visual Analogue Scale (VAS)), 17,18 and spasticity (Numeric Rating Scale (NRS)).",94.24083769633508
694,PRECIS-2,"In addition, hippotherapy promotes social communication in the patients' lives and strengthens their self-esteem.",fulltext,"In addition, hippotherapy promotes social communication in the patients' lives and strengthens their self-esteem.",100.0
694,PRECIS-2,"MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS)9 score between 4 and 6.5 were eligible for inclusion. Patients who had received hippotherapy within the last 12 months, a body weight over 90 kg, no balance while sitting, and acute exacerbation during the 4-week period before start of the therapy were excluded.",fulltext,"MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS) 9 score between 4 and 6.5 were eligible for inclusion. Patients who had received hippotherapy within the last 12 months, a body weight over 90 kg, no balance while sitting, and acute exacerbation during the 4-week period before start of the therapy were excluded.",100.0
694,PRECIS-2,Patients were individually instructed to keep confidentiality of their allocation group.,fulltext,Patients were individually instructed to keep confidentiality of their allocation group.,100.0
694,PRECIS-2,"Analyses were based on the modified intention-to-treat set (modified ITT). This set encompasses all randomized patients with valid baseline assessment. The primary endpoint change of BBS from baseline to 12 weeks was calculated using an analysis of covariance (ANCOVA) with the fixed effects group, center, age, gender, EDSS classification, and baseline BBS (type 2 sums of squares). Missing values were imputed through the last observation carried forward (LOCF) value.",fulltext," Analyses were based on the modified intention-totreat set (modified ITT). This set encompasses all randomized patients with valid baseline assessment. The primary endpoint change of BBS from baseline to 12 weeks was calculated using an analysis of covariance (ANCOVA) with the fixed effects group, center, age, gender, EDSS classification, and baseline BBS (type 2 sums of squares). Missing values were imputed through the last observation carried forward (LOCF) value",99.57446808510639
694,PRECIS-2,A planned start of treatment with new antispastic drugs or other medications that may have an influence on the assessed outcomes also resulted in exclusion.,fulltext,A planned start of treatment with new antispastic drugs or other medications that may have an influence on the assessed outcomes also resulted in exclusion.,100.0
694,PRECIS-2,The study was approved by the respective ethical committees of the participating sites and registered with the German Trial Registry (DRKS00005289).,fulltext,The study was approved by the respective ethical committees of the participating sites and registered with the German Trial Registry (DRKS00005289).,100.0
694,PRECIS-2,"MS-HIPPO was a prospective, randomized, examiner-blinded, multicenter, comparative trial with an allocation of 1:1 to the two groups: hippotherapy plus standard care compared to standard care alone (as prior to the study). The intervention lasted for 12 weeks.",fulltext,"MS-HIPPO was a prospective, randomized, examiner-blinded, multicenter, comparative trial with an allocation of 1:1 to the two groups: hippotherapy plus standard care compared to standard care alone (as prior to the study). The intervention lasted for 12 weeks.",100.0
694,PRECIS-2,"Hippotherapy as a complementary treatment can be defined as one-patient-one-horse physiotherapy treatment while on horseback. The primary goals of hippotherapy are regulating muscle tone (reduction in spasticity) and breathing, strengthening the torso muscles, improving balance control and coordination, as well as gait.",fulltext,"Hippotherapy as a complementary treatment can be defined as one-patient-one-horse physiotherapy treatment with and on the horse. The primary goals of hippotherapy are regulating muscle tone (reduction in spasticity) and breathing, strengthening the torso muscles, improving balance control and coordination, as well as gait.",97.81931464174455
694,PRECIS-2,"Moreover, a mixed-model repeated-measures (MMRM) analysis was done using non-imputed data with the fixed effects group, center, time, group by time, age, gender, EDSS classification, and baseline BBS (type 3 sums of squares, ARH1 covariance structure on time).",fulltext," Moreover, a mixed-model repeated-measures (MMRM) analysis was done using non-imputed data with the fixed effects group, center, time, group by time, age, gender, EDSS classification, and baseline BBS (type 3 sums of squares, ARH1 covariance structure on time)",99.61538461538461
694,PRECIS-2,"The study was conducted at five sites in Germany, all of which have hippotherapy experience as stipulated by the rules of the German Consortium for Therapeutic Riding.",fulltext,"The study was conducted at five sites in Germany, all of which have hippotherapy experience as stipulated by the rules of the German Consortium for Therapeutic Riding.",100.0
694,PRECIS-2,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment). Physiotherapists who assessed the endpoints in a separate room were blinded and explicitly trained not to question patients or hippotherapists.",fulltext,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment). Physiotherapists who assessed the endpoints in a separate room were blinded and explicitly trained not to question patients or hippotherapists.",100.0
695,PRECIS-2,"Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",fulltext,"Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",100.0
695,PRECIS-2,From July 1998 we approached the 177 GPs based within the City of Nottingham boundaries (population 282 000).,fulltext,From July 1998 we approached the 177 GPs based within the City of Nottingham boundaries (population 282000). ,99.08256880733946
695,PRECIS-2,Setting: Participants' homes in the City of Nottingham.,fulltext,Setting: Participants' homes in the City of Nottingham.,100.0
695,PRECIS-2,"At interview, participants were asked 'In the past 12 months, have you had a fall or skin sore?' Participants were assessed at baseline and 12 months later.",fulltext," interview, participants were asked 'In the past 12 months, have you fallen? Have you had a skin sore?' Participants were assessed at baseline and 12 months later.",94.23076923076923
695,PRECIS-2,"Primary outcome measures were reports of one or more falls or skin sores. At interview, participants were asked 'In the past 12 months, have you had a fall? Have you had a skin sore?'",fulltext,"Primary outcome measures were reports of one or more falls or skin sores. At interview, participants were asked 'In the past 12 months, have you fallen? Have you had a skin sore?'",96.72131147540983
695,PRECIS-2,"Information on adverse events was collected by phone at two-monthly intervals between baseline and 12-month assessments, when a general enquiry was made without specific reference to falls or sores.",fulltext,"Information on adverse events was collected by phone at two-monthly intervals between baseline and 12-month assessments, when a general enquiry was made without specific reference to falls or sores.",100.0
695,PRECIS-2,"An action plan was proposed, and relevant information supplied. Approximately two weeks later, EG participants received a single follow-through phone call from the research OT to confirm and reinforce the educational content of the visit, after which EG patients had no subsequent contact with the OT (see Figure 1).",fulltext,"An action plan was then proposed, and relevant phone numbers supplied. Approximately two weeks later, EG participants received a single follow-through phone call from the research OT to confirm and reinforce the educational content of the visit, after which EG patients had no subsequent contact with the OT (see Figure 1).",97.15189873417721
695,PRECIS-2,"The educational intervention Baseline information from individuals in the EG was presented to an expert panel, which consisted of the research occupational therapist (OT) who carried out the subsequent education visit, a consultant in neurology and rehabilitation medicine, a GP, a social worker, a speech and language therapist, a physiotherapist and a nurse.",fulltext,"The educational intervention Baseline information from individuals in the EG was presented to an expert panel, which consisted of the research occupational therapist (OT) who carried out the subsequent education visit, a consultant in neurology and rehabilitation medicine, a GP, a social worker, a speech and language ",88.61111111111111
695,PRECIS-2,Participants whose clinical features appeared incompatible with the recorded diagnosis were excluded.,fulltext,"Participants whose clinical features appeared incompatible with the recorded diagnosis were excluded,",100.0
696,PRECIS-2,Candidates were excluded from the study if active disease was identified at baseline per clinical (presence of a relapse during the previous 30 days) and/or MRI evaluation (active gadolinium (Gd)-enhancing lesions).,fulltext,Candidates were excluded from the study if active disease was identified at baseline per clinical ( presence of a relapse during the previous 30 days) and/or MRI evaluation (active gadolinium (Gd)-enhancing lesions).,100.0
696,PRECIS-2,"The classification of hyperintense T2 and hypointense T1-lesion evolution into several groups of increases such as new/enlarging was obtained. All number and activity analysis were performed at time points 0, 6 and 12 months after discontinuation of infusion.",fulltext,"The classification of hyperintense T2 and hypointense T1-lesion evolution on serial MRI scans into categories such as new/enlarging was obtained. All number and activity analysis were performed at time points 0, 6 and 12 months after last natalizumab infusion.",89.57528957528957
696,PRECIS-2,"The clear explanation of the benefit seen in our study when comparing the TG versus IDG is not fully understood. Recent data from a large retrospective multicenter experience suggest that extending the interval between natalizumab infusions may provide similar efficacy as compared to the monthly infusions, but with an increased safety profile.",fulltext,"The clear explanation of the benefit seen in our study when comparing the TG versus IDG is not fully understood. Recent data from a large retrospective multicenter experience suggest that extending the interval between natalizumab infusions may provide similar efficacy as compared to the monthly infusions, but with an increased safety profile.",100.0
696,PRECIS-2,"Clinical assessments were performed at baseline, 3, 6 and 12 months postdiscontinuation (counted from the last natalizumab infusion, as per protocol).",fulltext,"ical assessment was administered at baseline, 3, 6 and 12 months postdiscontinuation (counted from the last natalizumab infusion), as we",82.66666666666667
696,PRECIS-2,"Fifty patients with relapsing MS, followed at the Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA, were enrolled in this study.",fulltext,"Fifty patients with relapsing MS, followed at the Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA, were enrolled in this study.",100.0
696,PRECIS-2,"IDG: Patients who discontinued natalizumab therapy at once and initiated another DMT (interferon, GA therapy or an oral DMT: fingolimod, dimethyl fumarate or teriflunomide) at 1–6 months following the last natalizumab infusion (1–2 months for the injectable DMTs and 3–6 months for the oral DMTs) and tapered group (TG): patients administered two additional natalizumab infusions, one at 6 weeks and one at 8 weeks (14 weeks from study entry).",fulltext,"IDG: Patients who discontinued natalizumab therapy at once and initiated another DMT (interferon, GA therapy or an oral DMTfingolimod, dimethyl fumatate or teriflunomide) at 1–6 months following the last natalizumab infusion (1–2 months for the injectable DMTs and 3–6 months for the oral DMTs) and tapered group (TG): patients administered two additional natalizumab infusions, one at 6 weeks and one at 8 weeks (14 weeks from study entry).",99.32279909706546
696,PRECIS-2,"Fifty patients with relapsing MS, followed at the Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA, were enrolled in this study. Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria, being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0.",fulltext,"Fifty patients with relapsing MS, followed at the Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA, were enrolled in this study. Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria, 19 being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0.",100.0
696,PRECIS-2,The primary objective of this study was to compare two modes of natalizumab cessation interventions: immediate discontinuation (IDG) versus a TG approach as measured by serial MRI and number of relapses during a 12-month period in patients treated with natalizumab for at least 24 months.,fulltext,The primary objective of this study was to compare two modes of natalizumab cessation interventions: immediate discontinuation group (IDG) versus a TG approach as measured by serial MRI and number of relapses during a 12-month period in patients treated with natalizumab for at least 24 months.,100.0
696,PRECIS-2,"A physical examination and neurological assessment was administered at baseline, 3, 6 and 12 months postdiscontinuation (counted from the last natalizumab infusion, as per the unscheduled visits due to relapses (within 3–5 days of any new symptom development).",fulltext,"A physical examination and neurological assessment was administered at baseline, 3, 6 and 12 months postdiscontinuation (counted from the last natalizumab infusion), as well as during unscheduled visits due to relapses (within 3–5 days of any new symptom development).",98.07692307692307
696,PRECIS-2,"Standardised MRI were performed using the same 3 T General Electric Signa HDxT MRI (General Electric, Milwaukee, Wisconsin, USA) right-handed scanner using a multichannel head and neck coil at baseline, 6 and 12 months following the discontinuation of natalizumab therapy.",fulltext,"Standardised MRI were performed using the same 3 T General Electric Signa Excite HD 12.0 (General Electric, Milwaukee, Wisconsin, USA) right-handed scanner using a multichannel head and neck coil at baseline, 6 and 12 months following the discontinuation of natalizumab therapy.",98.16176470588235
697,PRECIS-2,"Eligible participants were excluded from the study if they were already engaged in a formal exercise program lasting >30 minutes twice per week, experienced an exacerbation within the past 4 weeks, had their MS immunomodulation medications altered in the previous 4 weeks or during the trial period, or declined to be randomly allocated.",fulltext,"Eligible participants were excluded from the study if they were already engaged in a formal exercise program lasting >30 minutes twice per week, experienced an exacerbation within the past 4 weeks, had their MS immunomodulation medications altered in the previous 4 weeks or during the trial period, or declined to be randomly allocated.",100.0
697,PRECIS-2,Ethical approval was obtained through the University of Queensland Institutional Human Research Ethics Committee and the Multiple Sclerosis New South Wales Ethics Review Board.,fulltext,Ethical approval was obtained through the University of Queensland Institutional Human Research Ethics Committee and the Multiple Sclerosis of New South Wales Ethics Review Board.,100.0
697,PRECIS-2,"Participants in both groups were encouraged to maintain their usual activity levels and engagement in any other exercise throughout the trial, with any variation self-reported to the treating physiotherapist.",fulltext,"Participants in both groups were encouraged to maintain their usual activity levels and engagement in any other exercise throughout the trial, with any variation self-reported to the treating physiotherapist.",100.0
697,PRECIS-2,"Exercises were aimed at improving gait speed, endurance, and balance. They were individualized, specific, and progressed in load, and performed at a moderate to high intensity.",fulltext,"Exercises were aimed at improving gait speed, endurance, and balance. They were individualized, specific, progressed in load, and performed at a moderate to high intensity.",97.72727272727273
697,PRECIS-2,"Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia. Inclusion criteria were the following: diagnosis of MS made by a neurologist, able to walk 10 meters with or without an aid within 2 minutes, no relapse of their MS in the past 4 weeks, and no other non-motor symptoms that could affect function in MS simultaneously.",fulltext,"Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia. Inclusion criteria were the following: diagnosis of MS made by a neurologist, able to walk 10 meters with or without an aid within 2 minutes, no relapse of their MS in the past 4 weeks, and no other ",82.99492385786802
697,PRECIS-2,"The primary outcome measure was gait speed, measured using the 10-meter walk test.",fulltext,"The primary outcome measure was gait speed, measured using the 10-meter walk test.",100.0
697,PRECIS-2,"Guidelines were provided to physiotherapists and participants for exercises to be adapted and progressed to suit individual functional ability via increasing repetitions, amplitude of movement, speed of movement, and modifying base of support.",fulltext,"Guidelines were provided to physiotherapists and participants for exercises to be adapted and progressed to suit individual functional ability via increasing repetitions, amplitude of movement, speed of movement, and modifying base of support.",100.0
697,PRECIS-2,Group participants were provided with an illustrated exercise booklet at the completion of the intervention based on their class program and were encouraged to continue this level of exercise during the 8-week follow-up period.,fulltext,Group participants were provided with an illustrated exercise booklet at the completion of the intervention based on their class program and were encouraged to continue this level of exercise during the 8-week follow-up period.,100.0
697,PRECIS-2,"Two baseline assessments were conducted 8 weeks apart to evaluate the stability of each presentation, with presentation considered stable if there was no significant difference between baseline assessments.",fulltext,"Two baseline assessments were conducted 8 weeks apart to evaluate the stability of clinical presentation, with presentation considered stable if there was no significant difference between baseline assessments.",98.54368932038835
697,PRECIS-2,The group program was conducted at a local community center for six participants in each group.,fulltext,The group program was conducted at a local community center and included four to six participants per class. Group,93.6842105263158
697,PRECIS-2,"Groups were led by a physiotherapist employed by the Multiple Sclerosis Society who received training to ensure a standard approach to intervention, intensity, and progression.",fulltext,"Groups were led by a physiotherapist employed by the Multiple Sclerosis Society who received training to ensure a standard approach to intervention, intensity, and progression.",100.0
697,PRECIS-2,"Participants in both groups were encouraged to work at a pace which they could sustain for 6 minutes, but could rest if they felt fatigue, or had a perceived exertion of greater than 7/10 on the modified Borg scale.",fulltext,"Participants were encouraged to work at a pace at which they could exercise for the full 6 minutes, but could rest if they felt fatigue, or had a perceived exertion of greater than 7/10 on the modified Borg scale.",90.23255813953487
697,PRECIS-2,"Participants attended a local community center to complete all assessments at pre-intervention (week 0), post-intervention (week 8), and at follow-up (week 16).",fulltext,"Participants attended a local community center to complete all assessments at pre-intervention (week 0), post-intervention (week 8), and at follow-up (week 16).",100.0
705,PRECIS-2,"Program sessions comprised the following: 1) classroom-based teaching of behavior change techniques and simple information sharing on PA and healthy eating, delivered via presentation, participant interaction, and mutual learning, and 2) exercise sessions where men performed aerobic, strength, and flexibility exercises, incorporating their passion for hockey off the ice.",fulltext,"Program sessions comprised the following: 1) classroom-based teaching of behavior change techniques and simple information sharing on PA and healthy eating, delivered to encourage participant interaction and mutual learning, and 2) exercise sessions where men performed aerobic, strength, and flexibility exercises, incorporating their passion for hockey off the ice.",96.24664879356568
705,PRECIS-2,One individual withdrew after randomization because he was displeased with allocation to the comparator group.,fulltext,One individual withdrew after randomization because he was displeased with allocation to the comparator group.,100.0
705,PRECIS-2,"Male fans of two ice hockey teams (35–65 yr; body mass index ≤28 kg·m−2) located in Ontario (Canada) were randomized to intervention (Hockey FIT) or comparator (wait-list control). Hockey FIT included a 12-week active phase including provision of dietary information, practice of behavior change techniques, and safe exercise sessions plus incremental pedometer walking)",fulltext,"Male fans of two ice hockey teams (35–65 yr; body mass index Q28 kgIm j2 ) located in Ontario (Canada) were randomized to intervention (Hockey FIT) or comparator (wait-list control). Hockey FIT includes a 12-wk active phase (weekly, coach-led group meetings including provision of dietary information, practice of behavior change techniques, and safe exercise sessions plus incremental pedometer walking)",98.64864864864865
705,PRECIS-2,"We analyzed outcome data to examine the potential effectiveness of the Hockey FIT program on the basis of an intent-to-treat approach. We examined differences between groups in mean weight loss at 12 wk using a linear mixed-effects model, including a random effect for the intervention group assignment (i.e., including those with missing follow-up data and regardless of compliance with the intervention) and adjusted for age and site.",fulltext,"We analyzed outcome data to examine the potential effectiveness of the Hockey FIT program on the basis of an intent-to-treat approach. We examined differences between groups in mean weight loss at 12 wk using a linear mixedeffects model, including all randomized participants per group assignment (i.e., including those with missing followup data and regardless of compliance with the intervention) and adjusted for age and site.",95.18348623853211
705,PRECIS-2,"At baseline, groups were balanced on most demographic and health history characteristics, as well as study outcomes. Mean (SD) BMI values (36.5 (6.0)) correspond to class II (39); on average, participants reported daily step counts corresponding to a low active lifestyle (i.e., 5000–7499 steps per day) (38), and most participants consumed fruit/vegetables less than three times per day (see Table 1).",fulltext,"At baseline, groups were balanced on most demographic and health history characteristics, as well as study outcomes. Mean (SD) BMI values (36.5 (6.0)) correspond to obese class II (39); on average, participants reported daily step counts corresponding to a low active lifestyle (i.e., 5000– 7499 steps per day) (38), and most participants consumed fruit/vegetables less than three times per day (see Table 1).",100.0
705,PRECIS-2,"Hockey FIT coaches (coach to participant ratio 2:20) from the central research team (see Gill et al. [14] for information on coach background and training). Program sessions comprised the following: 1) classroom-based teaching of behavior change techniques and simple information sharing on PA and healthy eating, delivered via presentation, participant interaction, and mutual learning, and 2) exercise sessions where men performed aerobic, strength, and flexibility exercises, incorporating their passion for hockey off the ice.",fulltext,"Hockey FIT coaches (coach to participant ratio 2:20) from the central research team (see Gill et al. [14] for information on coach background and training). Program sessions comprised the following: 1) classroom-based teaching of behavior change techniques and simple information sharing on PA and healthy eating, delivered to encourage participant interaction and mutual learning, and 2) exercise sessions where men performed aerobic, strength, and flexibility exercises, incorporating their passion for hockey off the ice.",97.35849056603773
705,PRECIS-2,"Recruitment occurred using a variety of methods (e.g., hockey team e-mail blasts and social media accounts, study Web site (http://hockeyfansintraining.org/), posters, traditional media advertisements, word of mouth, direct contact at team arena). Eligible participants were male 35–65 yr old with a BMI of ≥28 kg·m−2 and met PA safety requirements (i.e., no risk indicated by the Physical Activity Readiness Questionnaire [36] or clearance from a health care provider).",fulltext,"Recruitment occurred using a variety of methods (e.g., hockey team e-mail blasts and social media accounts, study Web site (http://hockeyfansintraining.org/), posters, traditional media advertisements, word of mouth, direct contact at team arena). Eligible participants were male 35–65 yr old with a BMI of Q28 kgIm j2 and met PA safety requirements (i.e., no risk indicated by the Physical Activity Readiness Questionnaire [36] or clearance from a health care provider).",99.57446808510639
705,PRECIS-2,"Participants were encouraged to continue with their lifestyle prescriptions and sustain their behavior changes with the support of free-of-charge eHealth tools and HealtheSteps smartphone app providing tools to track and sustain PA (www.healthesteps.ca) and 2) Hockey FIT social network, a secure Web-based network tailored to each site and including only group members",fulltext,"Participants were encouraged to continue with their lifestyle prescriptions and sustain their behavior changes with the support of free-ofcharge eHealth tools: 1) HealtheSteps smartphone app providing tools to track and sustain PA (www.healthesteps.ca) and 2) Hockey FIT social network, a secure Web-based network tailored to each site and including only group members",98.91598915989161
705,PRECIS-2,Measurement sessions were held at baseline and 12 wk (both groups) and 12 months (intervention group only).,fulltext,Measurement at baseline and 12 wk (both groups) and 12 months (intervention group only) ,82.2429906542056
705,PRECIS-2,"A sample size calculation for the definitive RCT was based on a 5% difference in weight loss between intervention and comparator at 12 months (20). Assuming an SD of 19.9%, 80% power, a 0.05 two-sided significance level, and a conservative 25% loss to follow-up estimate, 335 men in each arm (670 total) would be required.",fulltext,"A sample size calculation for the definitive RCT was based on a 5% difference in weight loss between intervention and comparator at 12 months (20). Assuming an SD of 19.9%, 80% power, a 0.05 two-sided significance level, and a conservative 25% loss to follow-up estimate, 335 men in each arm (670 total) would be required.",100.0
705,PRECIS-2,Eighty male fans of two ice hockey teams from two cities in Canada (London and Sarnia) were recruited and randomized to either intervention (Hockey FIT) or comparator (wait-list control).,fulltext,Eighty male fans of two ice hockey teams from the Ontario Hockey League (40 men from each of London and Sarnia) were recruited and randomized to either intervention (Hockey FIT) or comparator (wait-list control).,94.11764705882352
705,PRECIS-2,"The full study protocol has been published elsewhere (14). Briefly, we conducted a pilot, pragmatic randomized controlled trial (pRCT; parallel groups, stratified by site) in Ontario, Canada. Eighty male fans of two ice hockey teams from two cities in Ontario (London and Sarnia) were recruited and randomized to either intervention (Hockey FIT) or comparator (wait-list control).",fulltext,"The full study protocol has been published elsewhere (14). Briefly, we conducted a pilot, pragmatic randomized controlled trial (pRCT; parallel groups, stratified by site) in Ontario, Canada. Eighty male fans of two ice hockey teams from the Ontario Hockey League (40 men from each of London and Sarnia) were recruited and randomized to either intervention (Hockey FIT) or comparator (wait-list control).",97.10526315789474
712,PRECIS-2,Analyzed (n = 52) (VAS60* and the Perception of pain after 60 mins) (n = 44),fulltext, VAS60 variables and based on the perception of pain with 60 min,56.57894736842105
712,PRECIS-2,VAS was used to evaluate the pain and for pre-developed questions. The women were able to classify their perception of the pain (Table 3).,fulltext,VAS was used to evaluate the pain and for predeveloped questions. The women were able to classify their perception of the pain (Table 3).,99.27536231884058
712,PRECIS-2,"*VAS60 = the Visual Analogical Scale, after 60 minutes of treatment",fulltext,"*VAS60 = the Visual Analogical Scale, after 60 minutes of treatment",100.0
712,PRECIS-2,The researcher that was responsible for applying the acupressure went through 32 hours' worth of training. A child-cushioned electronic anthropometric scale was used to control and to put consistent pressure on the thumps until the researcher could apply such pressure for the SP6 and TG groups.,fulltext,The researcher that was responsible for applying the acupressure went through 32 hours' worth of training. A child-cushioned electronic anthropometric scale was used to control and to put consistent pressure on the thumps until the researcher could apply such pressure for the SP6 and TG groups.,100.0
712,PRECIS-2,"The pregnant women in labor were allocated through a sequential list of random numbers in blocks of six patients generated using the program Excel® and they were distributed in three groups: acupressure (SP6), touch group (TG)/placebo and the control group (CG).",fulltext,"The pregnant women in labor were allocated through a sequential list of random numbers in blocks of six patients generated using the program Excel® and they were distributed in three groups: acupressure (SP6), touch group (TG)/placebo and the control ",95.80152671755725
712,PRECIS-2,"156 pregnant women in their ≥ 37 week/s, who had cervical dilations of ≥ 4 cm and with two or more contractions in 10 minutes, were randomly divided into three groups at a university hospital in the suburbs of Sao Paulo, Brazil, in order to receive either acupressure treatment, a placebo or participate as part of a control group.",fulltext,"156 pregnant women in their ≥ 37 week/s, who had cervical dilations of ≥ 4 cm and with two or more contractions in 10 minutes. The pregnant women were randomly divided into three groups at a university hospital in the suburbs of Sao Paulo, Brazil, in order to receive either acupressure treatment, a placebo or participate as part of a control group.",100.0
712,PRECIS-2,"Objective: to analyze the effects of acupressure on the sanyinjiao point for pregnant women in labor at public maternity wards. Method: single-blind controlled clinical trial, randomly done employing a pragmatic profile. We selected 156 pregnant women in their ≥ 37 week/s, who had cervical dilations of ≥ 4 cm and with two or more contractions in 10 minutes.",fulltext,"Objective: to analyze the effects of acupressure on the sanyinjiao point for pregnant women in labor at public maternity wards. Method: single-blind controlled clinical trial, randomly done employing a pragmatic profile. We selected 156 pregnant women in their ≥ 37 week/s, who had cervical dilations of ≥ 4 cm and with two or more contractions in 10 minutes.",100.0
712,PRECIS-2,The acupressure was applied on the sanyinjiao point during the contractions for 20 minutes. Then the intensity of the pain was evaluated using the Visual Analogue Scale (VAS).,fulltext,The acupressure was applied on the sanyinjiao point during the contractions for 20 minutes. Then the intensity of the pain was evaluated using the Visual Analogue Scale (VAS).,100.0
712,PRECIS-2,"The pregnant women in labor obtained normal obstetrical treatment. Where the study was carried out, the following was permitted: the presence of someone to accompany the pregnant lady, the use of methods other than drugs such as taking a shower, massages in the lower back region and breathing exercises as well as liberty of movement (in cases where this did not go against medical advice).",fulltext,"The pregnant women in labor obtained normal obstetrical treatment. Where the study was carried out, the following was permitted: the presence of someone to accompany the pregnant lady, the use of methods other than drugs such as taking a shower, massages in the lower back region and breathing exercises as well as liberty of movement (in cases where this did not go against medical advice).",100.0
713,PRECIS-2,The aim of this study was to evaluate the effectiveness of a partnership-based self-management programme for patients with mild and moderate COPD. The intervention was provided for 6 months with a subsequent follow-up for additional 6 months.,fulltext,The aim of this study was to evaluate the effectiveness of a partnership-based self-management programme for patients with mild and moderate COPD. The intervention was provided for 6 months with a subsequent follow-up for additional 6 months.,100.0
713,PRECIS-2,The control group received usual care.,fulltext,The control group received usual care.,100.0
713,PRECIS-2,The intervention was an addition to traditional health care which the control group received. Traditional health care refers to services provided by general practitioners at primary health care centres and visits to lung physicians based on referral from general practitioners or self-initiated appointments.,fulltext,The intervention was an addition to traditional health care which the control group received. Traditional health care refers to services provided by general practitioners at primary health care centres and visits to lung physicians based ©,77.59740259740259
713,PRECIS-2,All potentially relevant patients (n = 291) were contacted for enrolment in the study from primary healthcare settings (n = 8) and the offices of private lung physicians (n = 6) in the Reykjavik capital area of Iceland.,fulltext,All potentially relevant patients (n = 291) were contacted for enrolment in the study from primary healthcare settings (n = 8) and the offices of private lung physicians (n = 6) in the Reykjavik capital area of Iceland.,100.0
713,PRECIS-2,Data collection lasted from June 2009–March 2013.,fulltext,Data collection lasted from June 2009–March 2013.,100.0
713,PRECIS-2,Enrolment ended when patients' registry in all possible clinical sites had been scanned. Data collection lasted from June 2009–March 2013.,fulltext,Enrolment ended when patients' registry in all possible clinical sites had been scanned. Data collection lasted from June 2009–March 2013.,100.0
713,PRECIS-2,Intention-to-treat analysis was not carried out.,fulltext,Intention-to-treat analysis was not carried out.,100.0
713,PRECIS-2,The treatment site was a clinical research centre located on a university-hospital campus. Enrolment ended when patients' registry in all possible clinical sites had been scanned. Data collection lasted from June 2009–March 2013.,fulltext,The treatment site was a clinical research centre located on a university-hospital campus. Enrolment ended when patients’ registry in all possible clinical sites had been scanned. Data collection lasted from June 2009–March 2013.,100.0
714,PRECIS-2,"Sample size and statistical methods—An 80% power, at the 5% significance level (two tailed test), of detecting a 20% difference in the proportion of patients reviewed",fulltext,"Sample size and statistical methods — An 80% power, at the 5% significance level (two tailed test), of detecting a 20% difference in the proportion of patients reviewed",100.0
714,PRECIS-2, a validated score incorporating three questions recommended by the Royal College of Physicians as outcome indicators for routine use in asthma care.,fulltext, a validated score incorporating three questions recommended by the Royal College of Physicians as outcome indicators for routine use in asthma care.,100.0
714,PRECIS-2,Patients were randomised to either telephone review or face to face consultation with the asthma nurse.,fulltext,pants were randomised to either telephone review or face to face consultation with the asthma nurse.,97.0873786407767
714,PRECIS-2,To measure asthma morbidity we used the ,fulltext,To measure asthma morbidity we used the ,100.0
714,PRECIS-2,"A large US trial that compared normal clinic visits with a mix of face to face consultations and telephone reviews (the recommended interval for clinic visits was doubled and three telephone reviews took place in the intervening period) showed that telephone review has the potential to reduce morbidity, use of medication, and use of the health service in patients with a range of chronic disorders.",fulltext,"A large US trial that compared normal clinic visits with a mix of face to face consultations and telephone reviews (the recommended interval for clinic visits was doubled and three telephone reviews took place in the intervening period) showed that telephone review has the potential to reduce morbidity, use of medication, and use of the health service in patients with a range of chronic disorders.",100.0
714,PRECIS-2,Objective To determine whether routine review by telephone of patients with asthma improves access and is a good alternative to face to face reviews in general practices.,fulltext,Objective To determine whether routine review by telephone of patients with asthma improves access and is a good alternative to face to face reviews in general practices.,100.0
714,PRECIS-2,Nurses arranged any follow up consultations (whether in the surgery or by telephone) they deemed clinically necessary. Patients were free to arrange any consultations they wished.,fulltext,Nurses arranged any follow up consultations (whether in the surgery or by telephone) they deemed clinically necessary. Patients were free to arrange any consultations they wished.,100.0
714,PRECIS-2,"Main outcome measures Primary outcome measures were the proportion of participants who were reviewed within three months of randomisation and disease specific quality of life, as measured by the Juniper mini asthma quality of life questionnaire.",fulltext,"Main outcome measures Primary outcome measures were the proportion of participants who were reviewed within three months of randomisation and disease specific quality of life, as measured by the Juniper mini asthma quality of life questionnaire.",100.0
714,PRECIS-2,Recruitment—All four general practices that took part in the study had nurses who were trained and experienced in providing proactive asthma care (table 1). From their computerised records the practices identified adults (>18 years) who had asked for a bronchodilator inhaler prescription in the previ-,fulltext,Recruitment— All four general practices that took part in the study had nurses who were trained and experienced in providing proactive asthma care (table 1). From their computerised asthma registers the practices identified adults (>18 years) who had asked for a bronchodilator inhaler prescription in the previ-,99.00662251655629
714,PRECIS-2,Setting Four general practices in England.,fulltext,Setting Four general practices in England.,100.0
714,PRECIS-2,Nurses arranged any follow up consultations (whether in the surgery or by telephone) they deemed clinically necessary.,fulltext,Nurses arranged any follow up consultations (whether in the surgery or by telephone) they deemed clinically necessary.,100.0
714,PRECIS-2,Telephone consultations are safe alternatives in the triage of requests for same day appointments.,fulltext,Telephone consultations are safe alternatives in the triage of requests for same day appointments.,100.0
715,PRECIS-2,Analysis followed per-protocol (PP) and intention-to-treat (ITT) approaches.,fulltext,Analysis followed per-protocol (PP) and intention-to-treat (ITT) approaches.,100.0
715,PRECIS-2,"Ninety-two per cent (83/90) of patient under NLC attended all five clinic sessions, with a mean total consultation time of 111 min compared to 85% (77/91) of the RLC group who had a mean total consultation time of 71 min.",fulltext,"Ninety-two per cent (83/90) of patient under NLC attended all five clinic sessions, with a mean total consultation time of 111 min compared to 85% (77/91) of the RLC group who had a mean total consultation time of 71 min.",100.0
715,PRECIS-2,"Exclusions were: unstabilised concomitant disease, awaiting major surgery and inability to complete questionnaires unaided.",fulltext,"Exclusions were: unstabilised concomitant disease, awaiting surgery and ",58.53658536585367
715,PRECIS-2,The CNS have experience in running nurse-led clinics and usually have a postgraduate qualification in rheumatology nursing and/or prescribing. Independent assessors were health professionals trained to perform joint counts and calculating the DAS28.,fulltext,The CNS have experience in running nurse-led clinics and usually have a postgraduate qualification in rheumatology nursing and/ or prescribing. Independent assessors were health professionals trained to perform joint counts and calculating the DAS28.,100.0
715,PRECIS-2,"When patients arrived at the clinic, the independent assessor performed 'joint counts' for DAS28 and then oversaw the completion of self-reported pain visual analogue scale (pain-VAS), fatigue-VAS and duration of morning stiffness. The patients were then given questionnaires in 'freepost' return envelopes before consultation with their allocated practitioner.",fulltext,"When patients arrived at the clinic, the independent assessor performed ‘joint counts’ for DAS28 and then oversaw the completion of self-reported pain visual analogue scale (pain-VAS), fatigue-VAS and duration of morning stiffness. The patients were then given questionnaires in ‘freepost’ return envelopes before consultation with their allocated practitioner.",100.0
715,PRECIS-2,"This study required three practitioners at each centre; a CNS, a rheumatologist and a blind independent assessor.",fulltext,"This study required three practitioners at each centre; a CNS, a rheumatologist and a blind independent assessor.",100.0
715,PRECIS-2,Nine CNS and 10 rheumatologists delivered the interventions. The CNS had a median experience of 10 years in their current post while the rheumatologists had a median of 9 years at consultant level.,fulltext,Nine CNS and 10 rheumatologists delivered the interventions. The CNS had a median experience of 10 years in their current post while the rheumatologists had a median of 9 years at consultant level.,100.0
715,PRECIS-2,"The primary outcome was DAS28 and secondary outcomes were pain severity (pain-VAS), fatigue (fatigue-VAS) and duration of morning stiffness measured at each study visit. Other secondary outcome measures were at baseline, weeks 26 and 52: RA quality of life; health assessment questionnaire disability index; hospital anxiety and depression scale; arthritis self-efficacy scale; and Leeds satisfaction questionnaire (LSQ).",fulltext,"The primary outcome was DAS28 and secondary outcomes were pain severity (pain-VAS), fatigue (fatigue-VAS) and duration of morning stiffness measured at each study visit. Other secondary outcome measures were at baseline, weeks 26 and 52: RA quality of life; 31 health assessment questionnaire disability index; 32 hospital anxiety and depression scale; 33 arthritis self-efficacy scale; 34 and Leeds satisfaction questionnaire (LSQ).",100.0
715,PRECIS-2,"The former was based on evaluation of all participants who completed the five treatment sessions and focused on a complete case analysis; the latter was based on evaluation of all trial participants as allocated. For the ITT approach, missing data were imputed via multiple imputation using chained equations; 20 imputed datasets were computed on guidance that the number needed should approximate the percentage of incomplete cases.",fulltext,"The former was based on evaluation of all participants who completed the five treatment sessions and focussed on a complete case analysis; the latter was based on evaluation of all trial participants as allocated. For the ITT approach, missing data were imputed via multiple imputation using chained equations; 20 imputed datasets were computed on guidance that the number needed should approximate the percentage of incomplete cases.",100.0
715,PRECIS-2,Available cases for baseline PP analysis (n=88),prompt,available data; score 1 for a very explanatory analysis ,68.08510638297872
715,PRECIS-2,The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria); 18 years or older and the ability to complete questionnaires unaided.,fulltext,"The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria), 29 age 18 years or older and the ability to complete questionnaires unaided.",100.0
715,PRECIS-2,Nine CNS and 10 rheumatologists delivered the interventions.,fulltext,Nine CNS and 10 rheumatologists delivered the interventions.,100.0
722,PRECIS-2,"Participants comprised 50.6% Indigenous Australians and 60.8% had established CVD. At baseline, use of combination treatment was 50.1%.",fulltext,"Participants comprised 50.6% Indigenous Australians and 60.8% had established CVD. At baseline, use of combination treatment was 50.1%.",100.0
722,PRECIS-2,"We conducted a randomized, open-label trial involving 623 participants from Australian general practices.",fulltext,"We conducted a randomized, open-label trial involving 623 participants from Australian general practices.",100.0
722,PRECIS-2,"Patients may adopt strategies to reduce costs, including not filling prescriptions and omitting doses.",fulltext,"Patients may adopt strategies to reduce costs, including not filling prescriptions and omitting doses.",100.0
722,PRECIS-2,"Self-reported use of all medications was assessed at each visit, recorded at local centres on which medication was taken in the immediately preceding week.",fulltext,"Self-reported use of all medications was assessed at each visit, recorded as the number of days on which medication was taken in the immediately preceding week.",93.5483870967742
722,PRECIS-2,All participants were reviewed one month post-randomization and at three monthly intervals thereafter.,fulltext,"All participants were also reviewed one month post-randomization and at intervening six month intervals, but these",89.21568627450979
722,PRECIS-2,"Primary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and ≥2 BP lowering therapies for ≥4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.",fulltext,"Primary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and 2 BP lowering therapies for 4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.",100.0
722,PRECIS-2,Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter.,fulltext,Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter.,100.0
722,PRECIS-2,The polypill was dispensed without charge at Indigenous health services operating under the Section 100 scheme of the National Health Act.,fulltext,The polypill was dispensed without charge at Indigenous health services operating under the Section 100 scheme of the National Health Act.,100.0
722,PRECIS-2,All analyses were conducted on an intention-to-treat basis without imputation of missing data.,fulltext,All analyses were conducted on an intention-to-treat basis without imputation of missing data.,100.0
722,PRECIS-2,The study failed to recruit the numbers of participants originally planned as a result of limited resources and was therefore under-powered to demonstrate significant differences in BP and cholesterol.,fulltext,The study failed to recruit the numbers of participants originally planned as a result of limited resources and was therefore under-powered to demonstrate significant differences in BP and cholesterol.,100.0
722,PRECIS-2,Participants were excluded if they had a usual clinic BP of <130/80mmHg and were not taking any BP lowering medications.,fulltext,Participants were excluded if it was felt clinically inappropriate to alter medications.,55.833333333333336
725,PRECIS-2,The data for 231 patients (114 in surgical group and 117 in nonsurgical group) were included in the primary analysis.,fulltext,The data for 231 patients (114 in surgical group and 117 in nonsurgical group) were included in the primary analysis.,100.0
725,PRECIS-2,"A pragmatic, multicenter, parallel-group, randomized clinical trial, the Proximal Fracture of the Humerus Evaluation by Randomization (PROFHER) trial, recruited 250 patients aged 16 years or older (mean age, 66 years [range, 24-92 years]; 192 [77%] were female; and 249 [99.6%] were white) who presented at the orthopedic departments of 32 acute UK National Health Service hospitals between September 2008 and April 2011 within 3 weeks after sustaining a displaced fracture of the proximal humerus involving the surgical neck.",fulltext,"A pragmatic, multicenter, parallel-group, randomized clinical trial, the Proximal Fracture of the Humerus Evaluation by Randomization (PROFHER) trial, recruited 250 patients aged 16 years or older (mean age, 66 years [range, 24-92 years]; 192 [77%] were female; and 249 [99.6%] were white) who presented at the orthopedic departments of 32 acute UK National Health Service hospitals between September 2008 and April 2011 within 3 weeks after sustaining a displaced fracture of the proximal humerus involving the surgical neck.",100.0
725,PRECIS-2,Patients were followed up at 2 years (up to April 2013) and 215 had complete follow-up data.,fulltext,Patients were followed up for 2 years (up to April 2013) and 215 had complete follow-up data.,97.82608695652173
725,PRECIS-2,"Of 1250 patients assessed for eligibility, 563 (45%) were eligible and 687 (55%) were ineligible (Figure 1). The most common reason for exclusion (>1 reason per patient possible) was that a patient had comorbidities that precluded surgery or anesthetic.",fulltext,"s Of 1250 patients screened, 563 (45%) were eligible and 687 (55%) were ineligible (Figure 1). The most common reason for exclusion (>1 reason per patient possible) was that a patient had ",71.93675889328064
725,PRECIS-2,"The primary analysis compared OSS data from the surgical and nonsurgical treatment groups over all 3 follow-up assessments (6, 12, and 24 months).",fulltext,"The primary analysis compared OSS data from the surgical and nonsurgical treatment groups over all 3 follow-up assessments (6, 12, and 24 months).",100.0
725,PRECIS-2,"Surgeons (median of 1 patient per surgeon; IQR, 1-3 patients) performed the surgical procedures.",fulltext,"6 Surgeons (median of 1 patient per surgeon; IQR, 1-2 patients) 165 Physiot",68.75
725,PRECIS-2,"The primary outcome was the Oxford Shoulder Score (OSS), which is a shoulder-specific outcome measure validated in a UK population.",fulltext,"The primary outcome was the Oxford Shoulder Score (OSS), which is a shoulder-specific outcome measure validated in a UK population.",100.0
725,PRECIS-2,"The OSS provides a total score based on the patient's subjective assessment of pain and function. It contains 12 items, each with 5 categories of response, and a range of total scores of 0 (worst outcome) to 48 (best outcome).",fulltext,"The OSS provides a total score based on the patient’s subjective assessment of pain and function. It contains 12 items, each with 5 categories of response, and a range of total scores of 0 (worst outcome) to 48 (best outcome).",100.0
725,PRECIS-2,"192 [77%] were female, and 249 (99.6%) were white.",fulltext,"192 [77%] were female, and 249 (99.6%) were white.",100.0
725,PRECIS-2,"The mean age of the trial participants was 66 years (range, 24-92 years)",fulltext,"The mean age of the trial participants was 66 years (range, 24-92 years)",100.0
725,PRECIS-2,"Physiotherapists (median of 4 sessions for each physiotherapist; IQR, 2-8 sessions) provided conservative treatment to both groups.",fulltext,"5 Physiotherapists (median of 5 sessions for each physiotherapist; IQR, 2-8 sessions) 27 Centers provided conservative treatmen",86.25954198473282
725,PRECIS-2,Standardized outpatient and community-based rehabilitation was provided to both groups.,fulltext,Standardized outpatient and community-based rehabilitation was provided to both groups.,100.0
725,PRECIS-2,Surgeons experienced in these techniques performed the surgical procedures.,fulltext,surgeons experienced in these techniques. Nonsurgical tr,69.33333333333334
725,PRECIS-2,"All analyses followed a prespecified analysis plan, endorsed by the data monitoring and ethics committee, and were performed using Stata version 12 (StataCorp). All analyses were on an intention-to-treat basis and included all randomized patients in the groups to which they were randomized.",fulltext," Analyses followed a prespecified analysis plan, endorsed by the data monitoring and ethics committee, and were performed using Stata version 12 (StataCorp). All analyses were on an intention-to-treat basis and included all randomized patients in the groups to which they were randomized.",98.96907216494846
725,PRECIS-2,"These characteristics were similar to patients who refused consent (mean age, 68 years; 75% female). Ineligible patients tended to be older (mean age, 70 years) and there were slightly fewer females (72%) (eTable 1 in Supplement 2).",fulltext,". These characteristics were similar to patients who refused consent (mean age, 68 years; 75% female). Ineligible patients tended to be older (mean age, 70 years) and there were slightly fewer females (72%) (eTable 1 in Supplement 2",99.13793103448276
733,PRECIS-2,"Adherence was defined as the proportion of participants who reported reaching ≥150 minutes of MVPA per week. Physical activity was assessed using three validated questionnaires: Phone-FITT, the Physical Activity Scale for the Elderly (PASE), and the Community Healthy Activities Model Program for Seniors (CHAMPS). The primary outcome measure was the CHAMPS questionnaire.",fulltext,"come was the proportion of participants who reported reaching ≥150 minutes of MVPA per week. Physical activity was assessed using three validated questionnaires: Phone-FITT, the Physical Activity Scale for the Elderly (PASE), and the Community Healthy Activities Model Program for Seniors (CHAMPS). The primary outcome measure was the CHAMPS questionnaire.",95.16129032258065
733,PRECIS-2,All analyses were carried out on data from participants in the FaME arm: • assuming that those not returning relevant diaries had not undertaken any exercise during that 4-week period; and • omitting any participant who had not returned all six diaries.,fulltext, analyses were carried out on data from participants in the FaME arm: • assuming that those not returning relevant diaries had not undertaken any exercise during that 4-week period; and • omitting any participant who had not returned all six diaries.,98.81422924901186
733,PRECIS-2,"The proportions reporting at least 150 minutes of MVPA per week rose from 40% (136/342) to 49% (95/193) in the FaME arm, 41% (150/362) to 43% (99/185) in the OEP arm, and 37.5% (150/400) to 38% (84/222) in the usual-care arm, 12 months after the end of the intervention.",fulltext," 40% (136/342) to 49% (95/193) in the FaME arm, 41% (150/362) to 43% (79/185) in the OEP arm, and 37.5% (150/400) to 38% (84/222) in the usual-care arm 12 months after the end of the intervention.",72.22222222222221
733,PRECIS-2,Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate if they were:,fulltext,Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate by letter from their GP. Patients were ,98.38709677419355
733,PRECIS-2,"Patients in the FaME arm received group exercise once a week for 12 weeks, and participants in the OEP arm received per protocol peer mentor support. Baseline characteristics of practices and participants are shown by arm in Table 1; treatment arms were well balanced.",fulltext,where 17 ) and not all participants in the OEP arm received per protocol peer mentor support. Baseline characteristics of practices and participants are shown by arm in Table 1; treatment arms were well balanced.,75.74626865671642
733,PRECIS-2,Patients were eligible to participate if they were: • community dwelling aged ≥65 years; • independently mobile (with or without a walking aid); and • physically able to take part in group exercise.,fulltext,Patients were eligible to participate if they were: • community dwelling aged ≥65 years; • independently mobile (with or without a walking aid); and • physically able to take part in group exercise.,100.0
733,PRECIS-2,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham. Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate if they were:",fulltext,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham. Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate by letter from their GP. Patients were ",99.15254237288136
733,PRECIS-2,"Follow-up assessments were carried out at 6, 12, 18, and 24 months after the end of the intervention period.",fulltext,"nts were followed up every 6 months after the end of the intervention period,",60.18518518518518
733,PRECIS-2,"Exercise instructors were the home-based OEP arm, and postural stability instructors were the FaME arm.",fulltext,"ity instructors. Volunteer peer mentors supported participants in the OEP arm, and weekly FaME classes were run in local venues by postural stability instructors trained to work with",75.72815533980582
733,PRECIS-2,The cost per additional volunteer peer mentor time for the OEP was established by replacement cost methods using the human capital approach.,fulltext,f volunteer peer mentor time for the OEP was established by replacement cost methods using the e7,67.14285714285715
733,PRECIS-2,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham.",fulltext,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham.",100.0
733,PRECIS-2,Patients were excluded if they: • had experienced ≥3 falls in the previous year; • had unstable clinical conditions; • would be unable to follow instructions about exercising safely; or • were receiving palliative care.,fulltext,Patients were excluded if they: • had experienced ≥3 falls in the previous year; • had unstable clinical conditions; • would be unable to follow instructions about exercise safely; or • were receiving palliative care.,98.63013698630137
